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Abstract 
Gonorrhoea and chlamydia are curable, bacterial, sexually transmitted infections (STIs) 
of humans, with important long term consequences for health. Their epidemiology and 
biology are reviewed in chapter one.  
The way the biology of the organisms and the behaviour of human hosts interact to 
influence the patterns of infection and the potential impact of interventions is the subject 
of the main body of the thesis. Mathematical models are presented, together with 
empirical data, to gain a better understanding of the epidemiology of gonorrhoea and 
chlamydia. New approaches are applied, using more complex measures of disease 
occurrence including reinfection (subsequent infection by the same organism) or 
coinfection (infection with both organisms simultaneously). Coinfection with 
gonorrhoea and chlamydia is investigated in chapter two. 
The third chapter investigates the importance of heterogeneity in human behaviour (i.e. 
level of sexual activity, mixing patterns within and between populations) on the spread 
of disease in subpopulations, using a model incorporating race, gender and sexual 
activity level. This was parameterised and validated using data collected in South East 
London.  
In chapter four, models of reinfection are used to investigate the interaction of 
population level parameters such as degree of assortative mixing and rates of 
reinfection. In chapter five, the characteristics of individuals coinfected with both 
organisms are shown to provide additional information useful in determining how 
infection is distributed across a population. 
The biology of the organism is demonstrated, in the fifth chapter, to play an important 
role in the prevalence and incidence of disease within the host population. The impact 
of the emergence of resistant or asymptomatic phenotypes under selective pressure by 
different treatment regimens is quantified using a two strain model, including 
asymptomatic and symptomatic infections. The final chapter considers the contribution 
of the research and discusses the implications of the results for STI intervention 
strategies. 
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Chapter 1  Introduction 
Summary 
This chapter provides a brief introduction to the epidemiology of gonorrhoea and 
chlamydia in the developed world. The impact of control strategies and interventions 
are considered in the context of the biology and behaviour of the host and pathogen. 
Particular attention is drawn to the following areas which will be explored further in the 
thesis: coinfection with gonorrhoea and chlamydia (chapter 2), the sexual mixing 
patterns of host populations (chapter 3), reinfection with gonorrhoea (chapter 4) and the 
evolution of sexually transmitted bacteria (chapter 5). Treatment guidelines are outlined, 
as a reference for discussions of best treatment practice and the prevention of the 
evolution and spread of resistant strains. A mathematical framework for modelling 
sexually transmitted diseases is introduced and used in the body of the thesis to test 
predictions about the effect of interventions on the epidemiology of gonorrhoea and 
chlamydia. 
Katherine Turner 
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Overview of gonorrhoea and chlamydia 
Gonorrhoea and chlamydia are sexually transmitted infections, caused by the bacteria 
Neisseria gonorrhoeae and Chlamydia trachomatis, respectively. This study will focus 
on resource-rich settings, such as in the UK and USA, where the prevalence of these 
infections among sexually active adults is low: less than 1% for gonorrhoea and up to 
10% for chlamydia, (CDC 2003; HPA 2003b; Rottingen, Cameron et al. 2001). Both 
organisms are readily transmissible, but C. trachomatis more often causes asymptomatic 
infections, has a longer duration of infectiousness and is therefore able to infect a larger 
fraction of the population, including those with a lower rate of sexual partner change, 
than gonorrhoea (Brunham and Plummer 1990; Stoner, Whittington et al. 2000). The 
incidence of both infections is either stable or rising in the USA and UK, despite a 
variety of health care efforts. Case numbers for gonorrhoea and chlamydia, diagnosed in 
the UK and USA from 1990-2002 are illustrated in Figure 1.1 (MMWR 2002b; PHLS 
2002, HPA 2003). 
It is useful to study N. gonorrhoeae and C. trachomatis together because they share 
several features (summarised in Box 1.1). They are transmitted in the same way, 
through direct sexual contact and hence the risk behaviours associated with both 
infections is similar. Table 1.1 summarises the defining features of gonorrhoea and 
chlamydia infection. 
Coinfection is correspondingly common, with approximately 20-40% of people infected 
with gonorrhoea also infected with chlamydia (Radcliffe, Ahmed-Jushuf et al. 1999) 
(Chapter 2, Table 2.1 summarises the estimates of the extent of coinfection). Routine 
cotreatment is recommended in the USA, but not in the UK, unless a patient is unlikely 
to return for test results or there is a high risk of coinfection (MMWR 1998; Radcliffe, 
Ahmed-Jushuf et al. 1999). Both chlamydia and gonorrhoea can be acquired repeatedly, 
and such repeat infections represent a significant proportion of the case load of sexually 
transmitted infections. Despite the similarities between chlamydia and gonorrhoea, there 
are important differences in the distribution of infection and the characteristics of those 
infected. These differences can provide information about the natural history of both 
pathogens. 
Katherine Turner 
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Table 1.1 Properties of Neisseria gonorrhoeae and Chlamydia trachomatis 
 N. gonorrhoeae C. trachomatis 
Type of 
bacteria 
Gonococcal, aerobic, gram-
negative bacteria 
Gram-positive bacteria 
Complex developmental cycle 
Site of infection Grows on mucosal membranes Obligate intracellular bacteria 
Ability to 
transform 
Piliated strains (P+) are able to 
transform by conjugation – enables 
gene transfer between strains – 
rapid evolution and spread of novel 
genes (e.g. drug resistance) 
No transformation. 
Drug resistance Drug resistant strains becoming 
increasingly common since 
penicillin resistance first reported 
1976 (Phillips 1976). May be 
plasmid-mediated or 
chromosomally-mediated. High 
level of variation. 
No drug resistance reported until 
2000 (Somani, Bhullar et al. 2000). 
Little strain variation. 
Persistence 
within host 
None published May have mechanisms for 
persistence (Dreses-Werringloer, 
Padubrin et al. 2000) 
WHO estimates 
of incidence 
WHO estimate of 62 million new 
cases worldwide in 1995) (WHO 
2001) 
WHO estimate of 89 million new 
cases worldwide in 1995) (WHO 
2001) 
Transmission 
probability 
Female-male transmission 
probability 20% after one exposure 
(vaginal-penile), 60-80% after 4 
exposures (Hook and Handsfield 
1999) 
Transmission probability high. 
Table 2.2 
2/3 males with infected partner and 
2/3 of females with an infected 
partner were also infected (Quinn, 
Gaydos et al. 1996).  
 
Transmission probability high. 
Table 2.2 
Incubation 
period 
Relatively short incubation time 
(Men; mean 8.3 days) (Sherrard 
1996) 
Onset of disease usually rapid, 
especially in males. Moderate 
symptoms 
Incubation period not well 
characterised (Golden, Schillinger 
et al. 2000) 
Onset usually gradual with mild 
symptoms 
Katherine Turner 
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Gonorrhoea and chlamydia are a significant burden to health in the developed world. 
Infections with Chlamydia trachomatis or Neisseria gonorrhoeae may result in pelvic 
inflammatory disease (PID) and the associated sequelae of ectopic pregnancy and 
infertility in women and possibly infertility in men (Hook and Handsfield 1999).  
Together, they account for the majority of preventable infertility among women and 
possibly men. The economic burden is considerable, estimated to be $2013 million for 
chlamydia and $1051 million for gonorrhoea in the US in 1994 (Institute of Medicine. 
The Hidden Epidemic: confronting sexually transmitted diseases 1997). Despite the fact 
that both infections respond well to antibiotic treatment, patients may not seek or 
receive treatment for prolonged periods after infection, due to asymptomatic and 
unrecognised infections (Farley, Cohen et al. 2003). An increase in the proportion of 
gonorrhoea isolates with reduced susceptibility or resistance to antibiotics makes 
accurate diagnosis and effective treatment a priority (CDC 2000a; CDSC 2003; GRASP 
2002). 
In Western Europe (including the UK) and in the USA (MMWR 2002b; PHLS 2002; 
Van der Heyden, Catchpole et al. 2000), there was a significant decline in incidence of 
gonorrhoea throughout the 1980s, attributed to a decrease in risky sexual activity 
including an increase in the use of condoms (Bankole, Darroch et al. 1999). During the 
same period there was an increase in the incidence of pharyngeal gonorrhoea and a 
decrease in the incidence of rectal gonorrhoea in men who have sex with men (MSM), 
indicating a shift in behaviour to safer (in terms of HIV risk) sexual practices (MMWR 
1984). Since the mid 1990s incidence of both gonorrhoea and chlamydia have stabilised 
at high levels (USA) or risen (UK). In the UK, sustained increases have been seen since 
1994. Between 1996 and 2002, gonorrhoea case reports have more than doubled and 
chlamydia case reports have increased even more, by 139% (HPA 2003b). In the UK, a 
national survey of the sexually active population (16-44 yrs old, NATSAL, 2000) found 
that overall 2.2% of men and 1.5% of women were infected with chlamydia (Fenton, 
Korovessis et al. 2001). Chlamydia screening and changes in reporting practice may 
partly explain the rise in diagnoses; however the increases have continued even when 
there have been no significant changes in public health provision from year to year 
(MMWR 1997b; PHLS 2002).  
Katherine Turner 
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Figure 1.1 Incidence of gonorrhoea and chlamydia in the UK and USA, 1990 – 
2002 
(CDC 2003; HPA 2003b) 
0
10000
20000
30000
40000
50000
60000
70000
80000
1990 1992 1994 1996 1998 2000 2002
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
1990 1992 1994 1996 1998 2000 2002
Year 
N
u
m
be
r 
o
f c
as
es
 
N
u
m
be
r 
o
f c
as
es
 
Year 
Chlamydia 
Chlamydia1 
Gonorrhoea 
Gonorrhoea 
United States 
England & Wales 
1Chlamydia reportable in UK from 1995 onwards 
1.1a 
1.1b 
Katherine Turner 
Chapter 1 - Introduction 
 14 
National statistics are useful for investigating large scale temporal trends, but may mask 
wide variation in disease burden between different population subgroups. The 
difference in the prevalence of infection between groups may be many-fold. Risk 
factors associated with infection with either gonorrhoea or chlamydia include, urban 
residence, young age, low socio-economic status, sex work and intravenous drug use 
(IVDU). Low et al showed that a disproportionate burden of disease in the UK falls 
upon young, non-White ethnic groups (Low, Daker-White et al. 1997). In Seattle, USA, 
an annual incidence of gonorrhoea among inner city, low socio-economic level black 
African and Afro-Caribbean adolescent girls (aged 16-18) has been found to be as high 
as 1 in 4 (Hook and Handsfield 1999). 
The epidemiology of gonorrhoea and chlamydia differs in men and women. Women 
experience a higher incidence and prevalence of chlamydia infection than their male 
counterparts, whereas men make up a greater proportion of gonorrhoea case reports. As 
symptoms are more likely in men this is probably not a true reflection of the sex ratios 
for incidence. Amongst MSM, gonorrhoea is more common than chlamydia. (CDC 
2003; HPA 2003b) 
Most STIs are concentrated in urban areas (CDC 2000b; PHLS 2002), although in some 
circumstances, specific features of rural areas such as poverty and poor access to care 
may also result in significant burden of disease (Thomas, Schoenbach et al. 1996). In 
both the UK and USA, the incidence of gonorrhoea and chlamydia are highest among 
Box 1.1 Summary of clinical features of Neisseria gonorrhoeae and Chlamydia 
trachomatis 
• Sexually transmitted bacteria, causative agents of infectious disease of the 
genital tract  
• Infection spread by contact of mucous membranes i.e. by sexual contact 
• Variety of non-specific urogenital symptoms 
• Long-term complications e.g. pelvic inflammatory disease (PID), leading to 
infertility, ectopic pregnancy 
• Curable: effective antibiotics readily available 
• Asymptomatic infections occur at a high rate in women 
• High level of local variability in burden of disease 
• Coinfection with both organisms is common, although prevalence estimates 
vary considerably 
• Condom use protects against transmission, but probably has greater impact in 
men (Fitch, Stine et al. 2002) 
• N. gonorrhoeae and C. trachomatis both probably enhance HIV transmission 
(Rotchford, Strum et al. 2000; Rottingen, Cameron et al. 2001) 
Katherine Turner 
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young women aged 15-19 and men aged 20-24, in urban areas (CDC 2000b; Fenton, 
Korovessis et al. 2001). Within a geographic area, sexually transmitted infections are 
highly clustered in space, with overlapping core area distributions (Law, Serre et al. 
2003). 
The marked heterogeneity in incidence and prevalence of disease across a population is 
a key feature of STI epidemiology and challenges healthcare providers to reach those 
most at risk. Further heterogeneity is found locally in sexual behaviour and mixing 
patterns, which mediate risk of infection. Understanding how biological factors, such as 
natural history of infection in different individuals, interact with the behaviour of 
individuals and groups, to determine the distribution of disease in a population is the 
aim of this thesis. 
Epidemiology of gonorrhoea and chlamydia 
The epidemiology of any infectious disease is ultimately controlled by the basic 
reproductive number (R0) of the organism, which is defined as the average number of 
secondary cases resulting from a typical index case in a fully susceptible population 
(Anderson and May 1991; Hethcote and Yorke 1984). For a sexually transmitted 
disease the R0 is determined by transmission probability during sexual contact, the rate 
of sexual contact of the host and duration of infection. This can be expressed in the 
following equation, which provides the conceptual framework for the models used in 
this thesis: 
Dc.  R 0 .= β          Equation 1.1 
For gonorrhoea and chlamydia one can consider three components: host factors, e.g. 
sexual partner change rate or susceptibility; public health interventions, e.g. treatment 
strategies or screening programmes and bacterial factors, e.g. transmissibility, duration 
of infection and severity of symptoms. These are considered in terms of biology, 
behaviour, and their effect on the basic reproductive number (R0) and consequently the 
epidemiology of the organism. 
Katherine Turner 
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Host factors 
Both behaviour and biology have a role in determining the risk of a person becoming 
infected with gonorrhoea or chlamydia. Sexual behaviour determines the probability of 
coming into contact and engaging in sexual acts with an infected individual. Biological 
factors such as host susceptibility and previous exposure to infection, modulate the 
probability of transmission occurring within a particular partnership. 
Behaviour 
The best defined measure of risk of acquiring an STI for an individual is the rate of 
partner change. Those with a high rate of sexual partner change are at higher risk of 
acquiring an STI than those with few partners. The distribution of partner change rates 
within a population is highly heterogeneous, with most people having few partners per 
unit time and a small number having many (Johnson, Mercer et al. 2001).  
In addition to an individual’s actions, the behaviour of their sexual partner is an 
important determinant of STI risk (Ghani and Garnett 2000). Mutually monogamous 
partnerships represent a transmission ‘dead end’ for an STI. Conversely, partnerships in 
which one or other person has other partners, either concurrently or serially, represent 
routes for STI spread. So a monogamous person in a partnership with someone who has 
other partners, is at elevated risk of STI compared with a mutually monogamous pair 
(Gorbach, Stoner et al. 2002; Morris and Kretzschmar 1997). The characteristics of the 
members and the timing of a partnership i.e. the pattern of mixing within a population, 
will determine the sexual network structure and accordingly, the epidemiology of STIs. 
An important component of mixing is the degree of assortativity (like-with-like mixing). 
There is a tendency for humans to choose sex partners similar to themselves in some 
way, e.g. age, ethnicity, geographic location and possibly rate of partner change (Aral 
2000; Garnett and Anderson 1993a; Johnson 1994; Laumann, Gagnon et al. 1994). In 
recent years, STI research has focused increasingly on population level or network 
measures of risk rather than simply on individuals (Aral 1999; Ghani and Garnett 2000; 
Morris 1997). 
Besides direct behavioural factors, many other characteristics of people and populations 
play a role in determining the distribution of gonorrhoea and chlamydia, for example, 
age, geographical location (urban vs. rural), socioeconomic status and ethnic group 
(Aral 2002a; Aral, Hughes et al. 1999; Johnson, Mercer et al. 2001; Low, Sterne et al. 
2001; Radcliffe, Ahmad et al. 2001). All these interact in complex ways to determine 
Katherine Turner 
Chapter 1 - Introduction 
 17 
the pattern of sexual partnerships between infected and susceptible individuals, which 
ultimately determines the epidemiology of the disease.  
Sexual behaviour  
Opportunities for the transmission of gonorrhoea occur during sexual contact, so to 
understand the epidemiology of the bacteria accurate measurement of sexual behaviour 
of the human host is essential. Sexual behaviour is highly variable both between 
individuals or populations and over the course of an individual’s lifetime. An important 
risk factor for an individual is their rate of sexual partner change, which is a measure of 
their exposure to potential infection. Early mathematical modelling work (Hethcote and 
Yorke 1984) suggested that gonorrhoea could only persist if there was a “core group” of 
people with very high rates of partner change, which maintained infection within the 
population. This core group concept has remained a powerful influence in 
understanding sexually transmitted infections. A distinction can be drawn between those 
individuals who are at risk of acquiring disease from their partner and those who are 
likely to transmit infection further to additional partners (Ghani and Garnett 2000). 
Behaviour during infection 
Behaviour whilst infectious also affects the basic reproductive number (R0) of the 
infection. If all infected individuals ceased sexual activity until fully recovered, the 
transmission chain would be broken. However, even if a patient becomes symptomatic, 
there is a time lag between infection and symptom onset. Many patients never become 
symptomatic and only realise they are infected through partner notification or screening. 
Clinical guidelines recommend ceasing sexual activity for 7 days after receiving 
treatment, although evidence suggests that compliance with this is poor. Patients are 
more likely to notify regular partners and ensure that they obtain treatment than casual 
partners (Golden, Whittington et al. 1999; Golden, Whittington et al. 2001; van de Laar, 
Termorshuizen et al. 1997). 
Treatment seeking behaviour and condom use 
The likelihood of an individual seeking treatment and the speed of their doing so will be 
influenced by various factors including ability to recognise symptoms and degree of 
symptoms, perception of risk from partner(s), availability of treatment facilities and 
whether a partner or health provider informs them of potential infection. 
A recent meta-analysis of studies of condom use indicated that transmission of 
gonorrhoea was reduced by using condoms, especially to men, but results for women 
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were equivocal (Fitch 2001; Fitch, Stine et al. 2002). Studies have shown consistent 
condom use to be protective against gonorrhoea, chlamydia, genital ulcer disease, 
bacterial vaginosis (BV) and pelvic inflammatory disease (PID) (Baeten, Nyange et al. 
2001). 
One of the difficulties in accounting for behaviour in predicting the future course of 
disease or understanding historical trends is the fluid nature of human behaviour over 
time. In a longitudinal study in London of female behaviour, significant changes were 
noted in consistent condom use, which increased from 3.6% in 1982 to 20.7% in 1992. 
There was also a decrease in the number of sex partners in the previous year reported 
and a decrease in incidence of gonorrhoea, chlamydia and trichomoniasis by 
approximately 60% (Evans, McCormack et al. 1995). 
Mixing patterns and the sexual network 
The sexual behaviour of an individual does not provide a full measure of their risk of 
acquiring infection. Recent work on sexual partner networks has illustrated that an 
individual’s position within the sexual partner network, especially the behaviour of their 
nearest neighbours, has a significant impact on disease risk (Ghani and Garnett 2000). 
The most obvious example is that of a monogamous woman whose husband visits 
female sex workers. Her partnership with a high activity individual places her at 
increased risk of infection, despite her own low risk behaviour (Rothenberg 2001). 
Partner choice is a complex process combining current situation (single, married, co-
habiting etc.), desired numbers of partners, availability of, and ability to obtain those 
partners, as well as social factors such as stigmatisation or approval of different sexual 
behaviours. From an epidemiological point of view it is necessary to go beyond 
considerations of individual risk, to group effects such as mixing patterns within 
populations, as these can also be shown to have a crucial role to play in determining the 
population level dynamics of disease (Aral, Holmes et al. 1996; Low, Sterne et al. 
2001). 
Mixing patterns within a population can have a dramatic influence on the incidence and 
prevalence of disease (Aral, Garnett et al. 2000). Mixing patterns between the highest 
activity group and the rest of the population will affect the overall prevalence of disease 
in the population. Garnett et al suggest that mixing between people of different 
activities is near random, (Garnett, Hughes et al. 1996), but other studies demonstrated 
a preference for assortative mixing, where high activity individuals report partnerships 
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with other people with higher numbers of partnerships, i.e. slightly assortative mixing 
(Renton, Whitaker et al. 1995). 
There is a general tendency for respondents to underestimate the activity of their 
partners and for men to report more partners than women (Johnson 1994). Those with a 
high turnover of partners are less able to make accurate estimates of their numbers of 
sexual partners than those with few partners. In the National Survey of Sexual Attitudes 
and Lifestyles (NATSAL 1990 and 2000) (Fenton, Korovessis et al. 2001; Johnson, 
Mercer et al. 2001; Johnson 1994), those who report having more partners are more 
likely to report that their partners also have multiple partners, i.e. most people assume 
that their partner’s behaviour is similar to their own. To what extent this reflects actual 
mixing patterns or the perceptions of individuals are not entirely clear. 
The discordance between reporting by males and females may be due to social factors 
which may encourage men to overestimate and women to underestimate their sexual 
activity (Johnson 1994). Another factor may be under-representation of female sex 
workers (FSW) in probability samples. FSW may have a very high number of sexual 
partners which may reduce the apparent discrepancy in reported behaviour. Most of the 
discrepancy occurs in the tail of the distribution, among those with higher numbers of 
sexual partners, which lends support to the hypothesis that FSW or a few very high 
activity women contribute disproportionately to the number of partnerships reported by 
females, who are not captured in random sample surveys (Morris 1993). 
Biology of host infection 
Coinfection 
Patients with STIs such as chlamydia or gonorrhoea, are at higher risk of contracting 
other sexually transmitted infections, e.g. syphilis, herpes simplex virus (HSV) or 
human immunodeficiency virus (HIV). Transmission of additional pathogens may occur 
at the same time as initial infection from a coinfected partner or during subsequent 
contacts with the same or different partners. The biology of coinfection is very poorly 
described in most cases. For example, infection could result in increased risk for further 
infections, e.g. if the host is more susceptible through inflammation. There is good 
evidence to suggest that gonorrhoea is a cofactor for acquisition and transmission of 
HIV, via increased susceptibility and increased shedding of virus (Rottingen, Cameron 
et al. 2001). However for other organisms the interactions are less well described.  
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Coinfection of cases of gonorrhoea with chlamydia is particularly common. There have 
been significant improvements in the sensitivity of diagnostic tests for chlamydia using 
nucleic acid amplification in recent years, so earlier studies tend to underestimate the 
incidence and transmission of infection, especially in men. A recent study in a Glasgow 
GUM clinic suggests that up to 30% of heterosexual men and 50% of women infected 
with gonorrhoea are also infected with chlamydia (Hijazi, Thow et al. 2002). Other 
studies have shown considerable variation, dependent on the population tested, 
diagnostic test used and clinic location. These are summarised in Chapter 2, Table 2.1. 
Most cephalosporins, spectinomycin and quinolones used for treating gonorrhoea are 
not active against chlamydia. In the UK, testing for chlamydia is recommended before 
cotreatment commences unless the patient is unlikely to return for test results or 
reinfection rates are high, in which case treatment should be administered. In practice 
however, most patients receive cotreatment for chlamydia when they are diagnosed with 
gonorrhoea (Personal communication, H. Ward). In the USA, cotreatment with 
doxycycline has been routine for 10 years and is believed to have reduced the 
prevalence of chlamydia (MMWR 1998). Coinfection with gonorrhoea may also cause 
reactivation of persistent chlamydia infection (Batteiger, Fraiz et al. 1989). Whether 
reactivated chlamydial infections are more transmissible than asymptomatic cases is not 
well understood, although no evidence was found that transmission of either infection 
was different if coinfection was present (Lin, Donegan et al. 1998). 
Several studies have investigated the characteristics of patients with chlamydia and/or 
gonorrhoea and found that there is not a simple relationship. A higher fraction of those 
infected with gonorrhoea are also infected with chlamydia than the converse although 
there are important differences in the rate of coinfection by gender, age and sexual 
orientation. Simplistically, those infected with both pathogens have the highest mean 
rates of partner change, those with gonorrhoea the next highest and those with 
chlamydia the lowest but sexual activity is not a perfect predictor of infection due to the 
effects of chance and differences in treatment outcomes (Stoner, Whittington et al. 
2000). Stoner et al. also found more complex relations between the infection networks 
in the study; with those in the gonococcal network more likely to report having used 
crack cocaine, sexual assault and incarceration than those in the chlamydial network i.e. 
the gonorrhoea network members occupy a more marginalised status in society. Men 
with gonorrhoea and chlamydia report higher rates of partner change than women, 
which may reflect the greater susceptibility of women to infections with either organism 
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or reporting biases (Zimmerman, Potterat et al. 1990). Other infections such as HIV, 
bacterial vaginosis, syphilis are associated with gonorrhoea and chlamydia infection to 
some extent. 
The presence of gonorrhoea infection is a marker of risk behaviour which increases the 
risk of HIV infection (Pinkerton 2001; Wardropper and Pattman 1995). Gonorrhoea 
infection as a proxy for HIV risk should be used cautiously, however, since the 
networks of these infections may be quite distinct and vary over time and place. 
Reinfection 
Repeated attendance at a clinic with gonorrhoea or chlamydia is common and may 
occur via transmission of infection from an existing or new partner or treatment failure, 
due to drug resistance or persistent infection. Due to the significant proportion of 
asymptomatic and untreated infections, reinfection from existing partners is likely. The 
risk of reinfection is also modified by behavioural factors which can increase 
(continuing high risk behaviour or sex with a high risk partner) or reduce (by adopting 
safer sexual practices or abstaining) risk following infection. There may be gender-
specific differences in behaviour following infection with an STI. A French 
investigation found that women showed a statistically significant change in their 
behaviour following STI infection to adopt preventative behaviours, but men did not 
men (Warszawski and Meyer 2002). 
A study of reinfection in adolescents showed that almost half of partners uninfected at 
baseline were infected by 7 months follow up and 60% of men and 73% of women 
infected initially were estimated to be reinfected within 7 months (Orr, Johnston et al. 
2001). Approximately 18% of individuals, who had repeat infections, contributed 30% 
of total cases of gonorrhoea, between 1976-9 in a study in Sheffield (Kinghorn, Pryce et 
al. 1982). More recently in the USA, 24% of index cases were reinfected with either 
chlamydia or gonorrhoea within 18 months (Thomas, Weiner et al. 2000). In a recent 
study over nearly 5 years, the median time to reinfection was 1.0 year which suggests 
that behavioural risk persists for a considerable time after initial infection and these 
patients may represent a target for screening even several years after initial infection 
(Mehta, Erbelding et al. 2003). 
Incidence of reinfection may provide information about sexual mixing patterns, phase of 
the epidemic and behaviour occurring in the population most at risk. Individuals who 
have previously been treated but then become infected again are prime targets for health 
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education messages. A recent attempt to quantify the effective reproductive number for 
those with repeat infections showed that is higher than 1, but is less than 1 in ‘non-
repeaters’. The difference was because of a higher average rate of partner change in 
those individuals with repeated infections. Hence those with repeat infections maintain 
the disease, constituting a population where interventions could be effectively targeted 
(Jolly and Wylie 2002). 
Susceptibility and acquired immunity 
An individual may be repeatedly infected with gonorrhoea or chlamydia (Fortenberry, 
Brizendine et al. 1999; Mehta, Erbelding et al. 2003; Orr, Johnston et al. 2001; 
Whittington, Kent et al. 2001). There is debate over whether strain-specific immunity to 
gonorrhoea can be acquired. The microbiological evidence for immunity is equivocal. 
One longitudinal study found no evidence of strain specific immunity, in fact, 
reinfection with the same strain was slightly more common than would be expected by 
chance, but this is confounded by the potential for repeated exposure to the same strain 
from an untreated partner (Fox, Thomas et al. 1999). The poor immune response to 
infection is likely due to the high variability of surface antigens expressed during 
infection. One study showed that those that did resist infection had a greater immune 
response than those who did not (Schmidt, Schneider et al. 2001). There is some 
evidence that serious sequelea are less likely with repeat infections of the same strain, 
compared with different strains of gonorrhoea (Buchanan, Eschenbach et al. 1980). 
Acquired resistance to chlamydia has been demonstrated (Loomis and Starnbach 2002). 
Chapter 4 on reinfection reviews the evidence for of acquired immunity to gonorrhoea 
and chlamydia. 
Another line of evidence for some level of acquired immunity to gonorrhoea and 
chlamydia is based on estimates of the basic reproductive number using mathematical 
modelling approaches, which gave low estimates of the reproductive number (Brunham, 
Nagelkerke et al. 1994). The authors conclude that some form of acquired immunity 
occurs with both chlamydia and gonorrhoea (Brunham, Nagelkerke et al. 1994), 
although this assumes that the underlying model captured sufficient complexity to 
accurately assess the reproductive number. Age-stratified disease reports show declining 
incidence with age, even when accounting for sexual activity, which suggests either that 
older women are less susceptible, or have acquired some degree of protection from 
previous infections (Stamm 1999). Previous infection does not provide complete 
protection against future infection, however and reinfection is very common especially 
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amongst young people, and is associated with increasing risk of the serious long-term 
sequelae. 
There is considerable between-host variability in susceptibility to infection with 
gonorrhoea or chlamydia. During a single act of penile-vaginal intercourse, women are 
twice as likely to become infected with gonorrhoea as men (a transmission probability 
of 0.5 - 0.7 compared with 0.2 - 0.3) (Wiesner and Thompson 1980). The transmission 
probability of chlamydia per act is not well defined. One recent study using PCR tests 
found that roughly two thirds of the partners of people infected with chlamydia were 
also infected and there was no gender difference (Quinn, Gaydos et al. 1996). Young 
women are likely at greater risk of becoming infected with gonorrhoea and chlamydia 
than older women, because of differences in the lining of the womb (Cohen, Britigan et 
al. 1987). Use of the oral contraceptive pill is associated with an increased risk of 
gonorrhoea (Louv, Austin et al. 1989) and chlamydia (Baeten, Nyange et al. 2001) 
apparently due to changes in vaginal flora. Previous infection with gonorrhoea or 
chlamydia is a risk factor for PID and associated sequelae, although the mechanism for 
this is not clearly established. 
Intervention strategies 
Treatment 
Highly effective therapy is available for gonorrhoea and chlamydia. Control efforts in a 
developed setting centre on speeding up treatment rates, through education to better 
recognise symptoms, screening to identify asymptomatic cases and partner notification 
or contact tracing to identify individuals who have been exposed to infection. 
Syndromic management, where treatment is prescribed on the basis of signs and 
symptoms without waiting for test results is more appropriate for a developing world 
setting e.g. Peru, where facilities for testing are not easily accessible (Adams, Garcia et 
al. 2003). 
Current treatment guidelines for UK and USA are summarised in the Appendix in Table 
A.1 and Table A.2. The main difference concerns cotreatment of gonorrhoea infections 
for chlamydia, which is recommended in the USA, but not UK. Although it is not clear 
how different clinical practice is in reality on the basis of these recommendations. Until 
the mid twentieth century there was no effective treatment for gonorrhoea, when highly 
effective therapies became available: sulfonamides (1936) and penicillin (1943). Since 
the introduction of penicillin, several classes of antibiotics have been used successfully 
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to treat gonorrhoea (Appendix). Neisseria gonorrhoeae has evolved resistance to most 
of these classes of drugs (Table 1.2), resulting in changes to treatment guidelines in 
1989, when penicillin was no longer recommended as first line therapy (MMWR 1989; 
Radcliffe, Ahmed-Jushuf et al. 1999). Guidelines were changed again in 2003 in the UK 
and ciprofloxacin is no longer recommended as first line therapy as the proportion of 
resistant isolates has risen above the 5% level (CDSC 2003). Single-dose oral therapy is 
the preferred mode of treatment for STIs, since compliance is better than with multiple 
dose regimes. 
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Table 1.2 Different antibiotics and the susceptibility of Neisseria gonorrhoeae 
and Chlamydia trachomatis demonstrated in selected studies 
Unless Chlamydia trachomatis resistance is stated, the bacteria referred to Neisseria 
gonorrhoeae 
Antibiotic  MICs 
(µg/mL) 
Comments (Sparling 1999) 
 1940s penicillin was effective therapy 
for gonorrhoea 
Now penicillin resistance is a problem 
globally 
(Sparling 1999) WHO 
report. 
http://www.who.int/HI
V_AIDS/figures/global
_report.html 
1 Independent chromosomal mutations in 
penA, mtr and penB. Low level 
resistance 
(Sparling 1999) 
2-4 1985 increased chromosomally 
mediated resistance, mechanism not 
known. Outbreak in USA. All isolates 
had same serotype profile  
(Faruki 1985) 
10 First documented in 1976. Also 
resistant to ampicillin, cephaloridine 
and spectinomycin. 
Plasmid-mediated (PPNG) resistance 
5.3 or 7.2 kb plasmid (Pcr). May have 
‘jumped’ from H. ducreyi 
(Phillips 1976) 
(Ashford 1976) 
(Brunton and Bennett 
1981) (Anderson, 
Albritton et al. 1984) 
Penicillin (Pc) 
 PPNG prevalence remains high in The 
Netherlands, 1995 and surveillance 
data suggest that sensitivity to other 
antimicrobials is decreasing amongst 
PPNG strains 
(van de Laar, van 
Duynhoven et al. 
1997) 
2 - 4 Low level resistance from 
chromosomal mutations in mtr, penB 
and tet  
(Sparling 1999) 
16 to 64 
≥64 
High level resistance. 38 kb (25.2 
MDa) conjugative plasmid-derived 
from 36 kb (24.5 MDa) conjugal 
plasmid plus tetM determinant. TetM 
encodes a protein that protects 
ribosomes from Tc. Conjugation can 
still occur efficiently, thus providing a 
pathway for the transfer of the plasmid 
into other gonococci 
(Morse, Johnson et al. 
1986) 
(Sparling 1999) 
Tetracycline (Tc) 
 High level tetracycline resistant N. 
gonorrhoeae (TRNG) first reported in 
(Ison, Bindayna et al. 
1988; Reimann, 
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Antibiotic  MICs 
(µg/mL) 
Comments (Sparling 1999) 
1985, now spreading worldwide  
First reported: 1988 UK, 1989 France, 
1989 Denmark, and 1990 Spain.  
Bollerup et al. 1992; 
van de Laar, van 
Duynhoven et al. 
1997; Vazquez, Berron 
et al. 1990)  
Spectinomycin 
(Spc) 
 High level resistance can occur via 
chromosomal mutation of spc locus, 
which alters ribosomal target for spc. 
Spc resistance seen in Korea in 1987 
(Sparling 1999) 
 
 
(Boslego, Tramont et 
al. 1987) 
Streptomycin (Str)  High level resistance common. Str 
locus near to spc, also linked to 
resistance genes for tetracycline (tet), 
rifampin (rif) and others. Not used for 
gonorrhoea treatment.  
(Sparling 1999) 
Fluoroquinolones  Resistance increasing in certain areas, 
especially to ciprofloxacin. 
Resistance to fluoroquinolones 
endemic in many Asian countries and 
Western Pacific region. 
WHO 
http://www.who.int/HI
V_AIDS/figures/global
_report.html 
Ciprofloxacin (Fq)  Increased incidence reported in 
Scotland, 1991-99 
Increased incidence in Newcastle-
upon-Tyne, UK 1995-7 
Resistance reported in Hawaii, 1999 
(Forsyth, Moyes  et al. 
2000) 
(Tayal, Sankar et al. 
1999)  
(MMWR 2000) 
Azithromycin  Decreased susceptibility reported in 
Missouri, 1999 
(MMWR 2000) 
Multidrug >4 Chlamydia: clinically significant multi-
drug resistance to doxycycline, 
azithromycin and ofloxacin reported in 
2000 
(Somani, Bhullar et al. 
2000) 
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Providing appropriate, accessible care is an issue in STI management. A recent survey 
in UK showed that a significant proportion of patients attending genitourinary (GU) 
clinics have already attended their general practice (GP) and that attending a GP delays 
getting appropriate treatment by 2 days on average compared with those who attend the 
GU clinic straightaway (Cassell, Brook et al. 2003). The study does not take account of 
those who are seen, treated and not referred on from a GP, but there remain a significant 
proportion of patients who could potentially be treated earlier. In the UK the policy is to 
shift a larger proportion of STI care into the primary care setting, therefore it is 
important to ensure that treatment, counselling and partner tracing provision is adequate 
and that those who never attend a GP for STI care are not “lost” due to difficulties 
accessing a GP (Cassell, Brook et al. 2003). In the USA STI care is split between public 
STI clinics and private physicians. In a recent study of STI care, Golden et al found that 
private providers did inform patients to notify partners, but that few knew whether 
partners did in fact, seek treatment or not (Golden, 2001). 
Screening and diagnostic tests 
In the late twentieth century rapid advances in genetic techniques enabled new 
diagnostic tests to be developed with increased sensitivity and acceptability of testing 
for both gonorrhoea and chlamydia, e.g. urine PCR tests or other gene detection tests, 
which makes screening a viable option (Tapsall, Limnios et al. 1998). These 
improvements have made screening more cost-effective and accurate diagnosis and 
treatment easier.  
Changes in screening practice or sensitivity of diagnostic tests may alter the apparent 
incidence (increased screening may increase diagnoses), whilst the real incidence 
remains unchanged. Incidence measures the number of new cases of an infection over a 
given period of time (usually a year). Reported diagnoses in clinics underestimate the 
numbers of cases of disease within a population, since some people with disease will 
not attend a clinic and not all infections are reported. Prevalence measures the number 
of people infected in a population at a given time point. 
The calculation of specificity, sensitivity and positive predictive value (PPV) of a 
hypothetical diagnostic test are defined below in Table 1.3. (Adapted from Modern 
Epidemiology (Weiss 1998))  
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Table 1.3 Calculation of sensitivity and specificity 
(Adapted from Modern Epidemiology (Weiss 1998)) 
Test criterion General reference 
criterion 
Positive Negative 
Positive a b 
Negative c d 
Sensitivity (Sens) = a/(a+b) 
Proportion of those with the condition who test positive 
Specificity (Spec) = d/(c+d) 
Proportion of those without the condition who test negative 
Positive predictive value (PPV) = a/(a+c) 
Proportion of those who test positive that have the disease, assuming (a+b)/n is 
representative of the true prevalence (Prev) in the population. 
Estimate of PPV, using Bayes theorem:  
PPV = (Sens*Prev)/[(Sens*Prev)+(1-Spec)*(1-Prev)] 
If screening is done in a low prevalence setting, a non-trivial number of false positive 
tests are expected. For example, Zenilman used Bayes’ theorem to estimate the positive 
predictive value; at a prevalence of 0.5%, nearly 20% of positive tests would be false, 
even if the test has a 99% sensitivity and 95% specificity (Zenilman, Miller et al. 2003). 
The possibility of false positives therefore needs to be made clear to those undergoing 
screening. 
Screening programmes require satisfactory, cheap diagnostic tests to be available which 
produce results rapidly. The disease being tested for must have a long latent period or 
asymptomatic infection and early detection should improve health outcomes. A full list 
of the criteria for adopting a screening program and applicability to chlamydia and 
gonorrhoea are illustrated in Table 1.4, based on Wilson and Jungner 1968, WHO 
criteria. The costs and benefits of screening programmes are summarised in  
Table 1.5. 
Chlamydia fits the criteria for screening somewhat better than gonorrhoea although it 
may be worth testing patients for gonorrhoea who test positive for chlamydia, especially 
if they fall into higher risk groups (Harindra, Tobin et al. 2002). Alternatively, targeted 
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screening of particular risk groups may be appropriate. Various studies of chlamydia 
screening programs have demonstrated their cost-effectiveness (Yeh 2003). A pilot 
study in Portsmouth UK detected an overall prevalence of chlamydia of 9.6%, with 
significantly higher levels in women attending for termination of pregnancy or antenatal 
care, and women and men with GU symptoms or attending GU clinics (Gleave 2002; 
Pimenta, Catchpole et al. 2003; Underhill, Hewitt et al. 2003). In the Pacific Northwest 
USA, a screening program was implemented in women attending family planning 
clinics (1988) and in STD clinics (1993) to test for Chlamydia trachomatis. The 
prevalence of chlamydia was reduced from 10-12% in late 1980s to 4-5% in 1995 
(MMWR 1997b). 
If screening programmes are successful at reducing the prevalence, careful planning and 
resource allocation is required to determine if or when screening could be relaxed, since 
incidence could rise rapidly in new cohorts of adolescents entering the sexually active 
population if screening is stopped. Other methods of maintaining a decline in incidence 
are needed, for example testing during six monthly blood pressure checks to get oral 
contraceptive pill prescriptions or school-based education programmes. One advantage 
of screening programmes is that they provide useful data on prevalence of infection in 
the screened population. 
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Table 1.4 Criteria for screening for gonorrhoea and chlamydia 
 Comment Chlamydia Gonorrhoea 
Important health problem,  
 
>5% 
prevalence 
found in pilot 
studies 
<1% overall 
prevalence  
Well recognized pre-clinical stage,  Asymptomatic infection 
common 
Disease 
status 
Long period between first signs and 
overt disease 
Yes, main morbidity due to 
PID, infertility can occur 
many years after initial 
infection 
Valid (sensitive and specific) Yes 
Simple and cheap Yes 
Safe and acceptable Yes 
Diagnostic 
test 
Reliable Yes 
Facilities are adequate,  Yes 
Effective, acceptable and safe treatment 
is available 
Yes 
Diagnosis 
and 
treatment 
Cost effective, sustainable Yes No 
 
Table 1.5 Costs and benefits of screening for gonorrhoea and chlamydia 
Benefits Costs 
Allows early identification and treatment 
of infection 
Takes time and resources to organise 
Provides basis for national surveillance 
schemes – identify changes in incidence 
and prevalence 
People at most risk are often least likely to 
attend screening clinics (e.g. young 
people, low socio-economic status, black 
African/Caribbean (gonorrhoea) 
Identifies asymptomatic infections early, 
prevents further spread 
May not identify them early enough to 
have a significant impact 
Provides forum for health education Psychological ‘cost’ of false positives, 
especially when screening in low 
prevalence populations. 
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Partner notification (contact tracing) and partner delivered therapy 
An important part of the control of STIs is through contact tracing or partner 
notification either by the patient or clinic staff. Approximately two thirds of untreated 
partners of gonorrhoea or chlamydia patients are infected (Lin, Donegan et al. 1998). 
Therefore, partners of those infected represent a high risk population. Treating partners 
as quickly as possible benefits the individual who may not have known they were 
infected, their partner since reinfection is prevented and the population in general. In 
this way, part of the transmission chain is broken, decreasing the size of that particular 
network component.  
Partner notification by clinic staff is time consuming and resource intensive (NIH 
report) so recent efforts have been undertaken to redesign partner notification systems in 
the USA (Golden 2003; Schillinger, Kissinger et al. 2003). Golden et al describe a 
randomised controlled trial of patient delivered therapy (PDT), where partners are not 
only notified by the index patient that they may be infected, but also receive a treatment 
pack for immediate, presumptive therapy (Golden 2003; Golden, Whittington et al. 
2001). Schillinger and colleagues undertook a multicentre-randomised controlled trial of 
partner delivered azithromycin therapy to prevent reinfection with Chlamydia 
trachomatis in a variety of settings (Schillinger, Kissinger et al. 2003). Whilst they 
found no statistically significant improvement in the incidence of reinfection with 
chlamydia, Golden and colleagues found that overall, reinfection with chlamydia and 
gonorrhoea was reduced significantly, with the greatest reduction in reinfection with 
gonorrhoea. This study also provides tentative evidence for persistent chlamydial 
infection, since several patients (6%) who reported no sexual activity between 
interviews were found to be infected with chlamydia. Most patients appear willing to 
contact partners and chlamydia patients were more successful in contacting all untreated 
partners than were gonorrhoea patients (Golden 2003; Golden, Whittington et al. 2001). 
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Bacterial factors 
The properties of sexually transmitted bacteria which determine the basic reproductive 
number and epidemiology of the diseases they cause are primarily biological, i.e. 
transmissibility, duration of infectiousness, pathology and symptoms. Bacteria cannot 
be said to have behaviour in the same way as human sexual behaviour, but as will be 
shown, they are able to evolve rapidly and develop new ways of surviving in a 
changing, competitive environment.  
Pathogen biology 
The bacterial characteristics which affect the basic reproductive number (R0) and 
consequently the rate of growth of an epidemic and endemic prevalence are 
transmissibility and duration of infection. Genetic mechanisms, population dynamics 
and behaviour (of the host and of the bacteria) interact to determine the course of 
disease in the individual and in the population as a whole. Clinical presentation of the 
disease may affect duration of infection or transmission through differences in seeking 
treatment or host behaviour. Drug resistant infections may result in extended duration of 
infectiousness due to treatment failure or suboptimal treatment.  
Clinical properties of bacteria 
There is considerable heterogeneity in the clinical presentation of both gonorrhoea and 
chlamydia, ranging from no clinical signs (asymptomatic) to severe symptoms (Table 
1.6) (Hook and Handsfield 1999; Stamm 1999). Asymptomatic infections are more 
common for chlamydia than for gonorrhoea: up to 50% of men with chlamydia and up 
to 75% - 80% of women may be asymptomatic (Radcliffe, Ahmed-Jushuf et al. 1999). 
Clinical symptoms of the disease will influence the selective pressures acting on the 
organism. For example, intensive case finding, contact tracing and pharmacotherapy 
will select for drug resistance strains, whereas syndromic management of cases will 
select for less symptomatic infections.  
The influence of treatment strategies on the evolutionary pressures on the organism is 
investigated further in Chapter 5. The differences in symptom severity are partly due to 
differences in host immune response and partly due to differences in bacterial strains. 
Other phenotypic differences such as the ability to survive in different microhabitats 
will also play a role in the distribution of disease within a population. 
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Multiple strains of Neisseria gonorrhoeae and Chlamydia trachomatis 
A variety of strains of Neisseria gonorrhoeae and Chlamydia trachomatis can be 
distinguished. N. gonorrhoeae has been typed in various ways according to available 
technology. Serotyping, auxotyping and drug susceptibility testing methods were the 
earliest ways of discriminating different strains, with genetic tests coming into use more 
recently. Chlamydia variants are discriminated on the basis of serovar type and 
genotype, and these may be related to disease symptoms in women (Geisler, Suchland 
et al. 2003) or epidemiological characteristics of patients (Geisler, Whittington et al. 
2002). N. gonorrhoeae strains have been associated with particular specialisations or 
phenotypic effects e.g. AHU auxotype is associated with asymptomatic infection 
(Handsfield, Knapp et al. 1980; Whittington and Holmes 2000) 
Infection with multiple strains of Neisseria gonorrhoeae can also occur. Neisseria 
gonorrhoea is constitutively able to recombine and this may represent an important 
route for the transmission of novel genetic material (Hook and Handsfield 1999; Spratt, 
Bowler et al. 1992). For an obligate human parasite like gonorrhoea recombination  
with multiple genotypes requires coinfection. It is not known how frequently 
individuals become infected with multiple strains, but recent typing studies have 
demonstrated the existence of coinfection in a few samples (Martin and Ison 2003). The 
effect of existing infection on the risk of acquiring additional strains is not known. 
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Table 1.6 Symptoms and sites of infection with gonorrhoea and chlamydia 
Gonorrhoea (Hook and Handsfield 
1999) 
Chlamydia (Schachter 1999) 
Causative bacteria 
Neisseria gonorrhoeae Chlamydia trachomatis 
Site of infection 
Urethra 
Endocervix 
Rectum 
Pharynx 
Cervix 
Urethra 
Rectum 
 
Asymptomatic infection 
Infection is asymptomatic in 10% of men 
and up to 50% of women (CEG and 
Bignell 2002) 
Infection is asymptomatic in up to 50% of 
men and up to 80% of women (CEG, 
Horner et al. 2002) 
Syndromes 
Urethritis 
Cervicitis 
Proctitis 
Pharyngitis 
Bartholinitis 
Conjunctivitis 
Nongonococcal urethritis 
Endocervicitis,  
Cervicitis 
Cervical metaplasia 
Bartholinitis 
Inclusion conjunctivitis 
Local complications 
Salpingitis 
Epididymitis 
Bartholin abscess 
Lymphangitis 
Penile oedema 
Periurethral abscess/Prostatis 
Salpingitis 
Epididymitis 
Bartholinitis 
 
Systemic disease 
Disseminated gonococcal infection (DGI) 
 
Sequelae 
Pelvic inflammatory disease (PID), 
infertility and ectopic pregnancy 
PID, infertility and ectopic pregnancy 
Reactive arthritis (previously known as 
Reiter’s disease)  
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Transmissibility  
Neisseria gonorrhoeae and Chlamydia trachomatis are highly transmissible pathogens, 
which appear to be somewhat more easily passed from males to females than vice versa. 
Obtaining good contemporary estimates of the per sex act probability of transmission is 
difficult for ethical reasons, due to availability of effective treatment and the obligation 
to treat diagnosed infections. In addition, it is not known how infectivity varies with 
duration of infection, infecting strain, duration of sex acts, frequency of sex acts per 
day, symptomatic or asymptomatic infection, susceptibility of partner, infection status 
of partner, immunocompetence of partner, or use of condoms (Garnett, Mertz et al. 
1999). 
For gonorrhoea, estimates of transmission probability in the region of 0.5-0.8 per 
partnership from men to women and slightly less from women to men seem to be 
reasonable (Table 2.2, Hook and Handsfield 1999). The transmission probability for 
chlamydia per partnership is comparable to that for gonorrhoea, but perhaps slightly 
lower (Lin, Donegan et al. 1998; Lycke, Lowhagen et al. 1980a). There is some 
evidence that host susceptibility may affect transmission, so that a higher fraction of 
people never become infected than would be predicted by simple models of 
transmission probability (Schmidt, Schneider et al. 2001) (Garnett and Rottingen 2001). 
Duration of infection 
Duration of infection is not well characterised for either gonorrhoea or chlamydia 
(Golden 2003). Early studies of gonorrhoea suggest a duration of about 6 months, 
followed by spontaneous cure, in the absence of treatment (Hook and Handsfield 1999). 
Time to recovery is likely to be highly variable for both infections. Infections with both 
pathogens may spontaneously clear, or persist for many months, although chlamydia 
appears to be more persistent than gonorrhoea, especially in women. Chlamydial 
infections appear to take longer to clear in women compared to men and in younger 
women compared to older women (Golden 2003). Assuming treatment is available and 
is effective, the time from infection to seeking treatment for gonorrhoea is in the order 
of 7-10 days for men (Garnett, Mertz et al. 1999; Hook and Handsfield 1999). The 
subjective view of the patient also plays an important role in the length of time to seek 
treatment, which is related to complex factors such as perceived risk, exposure, 
recognition of symptoms and partner referral. 
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Asymptomatic infection 
For both men and women, infections with gonorrhoea or chlamydia are often 
asymptomatic, which may delay or prevent treatment being sought. The WHO estimates 
that for gonorrhoea up to 80% of cases in women and 10% in men are asymptomatic 
(WHO 2001). The UK guidelines estimate that up to 50% of women and 10% of men 
with prevalent gonorrhoea infection are asymptomatic (CEG and Bignell 2002). It 
seems likely that asymptomatic or unnoticed infection will last for longer than 
symptomatic infection due to the delay or failure in obtaining treatment. It is not known 
whether asymptomatic infections are in fact less transmissible than symptomatic cases. 
However, asymptomatic infection may increase the relative probability of transmission, 
since patients with symptomatic disease may cease or reduce sexual activity or increase 
their use of condoms. There is some evidence to suggest however that a high proportion 
of symptomatic men with gonorrhoea continue sexual activity after diagnosis with an 
STI (Garnett, Mertz et al. 1999). This link between virulence (symptom severity) and 
transmission is not well established for gonorrhoea, although is biologically feasible. 
If asymptomatic infections are less transmissible than symptomatic cases, then strains 
with increased likelihood of fewer symptoms will only evolve if there is an evolutionary 
benefit to doing so, e.g. longer duration of infection in the host (Bull 1994; Lipsitch and 
Moxon 1997). Recent studies suggest that for chlamydia, asymptomatic infection in 
men may have been underestimated, in part due to lack of sensitivity of diagnostic tests 
previously used in men (LaMontagne, Fine et al. 2003). Estimates are also sensitive to 
whether one considers incident or prevalent infections. If asymptomatic infections tend 
to last longer than symptomatic infections, then they will tend to accumulate in the 
population. For modelling purposes one wishes to know what proportion of new 
infections will become symptomatic and remain asymptomatic, which is not the same as 
the proportion of infections at a given time in a population that are asymptomatic. 
Asymptomatic infections contribute disproportionately to the transmission of 
gonorrhoea and can result in serious sequelae of PID and infertility, in addition to 
transmission resulting in disease in partners. Sherrard and Barlow found that 
asymptomatic gonorrhoeal infections tend to be less susceptible to treatment and also 
that patients coinfected with Chlamydia trachomatis were more likely to be 
asymptomatic, which agreed with other findings (David, Wade et al. 1997; Sherrard and 
Barlow 1996).  
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Particular strains of gonorrhoea may be associated with asymptomatic or very mild 
infection e.g. the AHU auxotype (Brunham, Plummer et al. 1985; Crawford, Knapp et 
al. 1977). In Washington State, the prevalence of the AHU auxotype has declined 
steadily from 52% in 1971-74 to 0% in 1994–96. This was believed to be due to 
increased screening efforts, resulting in treatment of more asymptomatic infections. 
More recently, however between 1986-97 the CU auxotype, which is also associated 
with asymptomatic infection, has increased in prevalence in this region, despite an 
overall decline in gonorrhoea incidence of 80% (Whittington and Holmes 2000). The 
reasons for the changes in subtype distribution of gonorrhoea are not well understood. 
The CU auxotype may be more likely than other auxotypes to be misdiagnosed as non-
gonococcal urethritis (NGU), which may account for part of its increase. Other possible 
explanations include decreased screening, decreased competition between strains or 
stochastic genetic drift, leading to random introduction and disappearance of subtypes if 
incidence falls beneath a threshold for sustained transmission (Whittington and Holmes 
2000). Certain auxotypes of gonorrhoea are associated with an asymptomatic phenotype 
(Crawford, Knapp et al. 1977; Whittington and Holmes 2000) and other auxotypes are 
associated with rectal gonorrhoea (Handsfield, Knapp et al. 1980; Morse, Lysko et al. 
1982), but how these relate to other characteristics such as duration of infection or 
transmissibility are not well understood 
Drug resistance 
One of the biggest threats to long-term treatment and control of gonorrhoea is the ever 
expanding array of drug resistant strains of bacteria (Table 1.2). Since the first reports of 
high-level resistance to penicillin in 1976 (Phillips 1976), many Neisseria gonorrhoeae 
strains have now been isolated, which show reduced susceptibility to antimicrobial 
agents. In general Chlamydia trachomatis does not exhibit reduced sensitivity to 
antibiotics, but recent studies have demonstrated clinically significant resistance 
(Somani, Bhullar et al. 2000). Nevertheless, at present resistance in chlamydia is less of 
a problem than in gonorrhoea. If chlamydial cases are found and treated more often, as 
screening programmes continue to expand and there is routine co-treatment, there will 
be increasing selective pressure for the development of drug resistance. There is 
evidence to suggest that treatment with antibiotics can lead to persistent of chlamydia 
infection, which may test culture negative, but be positive by PCR (Dreses-Werringloer, 
Padubrin et al. 2000). However the clinical significance of persistent infection is not 
known. 
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Current guidelines recommend that 95% of those treated should be cured, so prevalence 
of resistance above 5% results in changes of treatment practice. US gonorrhoea 
treatment guidelines were changed in 1989 in response to increasing penicillin 
resistance. Recent reports in UK show levels of ciprofloxacin resistance have increased 
from 2.1% in 2000 to 3.1% in 2001 and again to 9.8% in 2002, with a higher level of 
resistance outside London compared with London (GRASP 2002; GRASP 2003; Ison, 
Martin et al. 2001). Older patients were more likely to be infected with resistant isolates 
(GRASP 2002). In some parts of the country, including Yorkshire and Humberside, 
prevalence of ciprofloxacin resistance has reached close to 20% (CDSC 2003). In 
response to the rapid rises to above 5% across most of the country the guidelines have 
been recently updated in the UK and ciprofloxacin is no longer recommended as first 
line therapy (Fenton, Rogers et al. 2000; GRASP 2003). Similarly in California, USA, 
the prevalence of ciprofloxacin resistant strains has increased from 1% in 2000 to 5% in 
2001 (CDC 2002a). These rapid rises in ciprofloxacin resistance have led to 
recommending other agents (e.g. ceftriaxone, penicillin, where local prevalence of 
resistance is low, or spectinomycin) as first line therapy. Although it was appreciated 
early on in the history of antimicrobials that resistance could emerge quickly, there was 
little response to these concerns in terms of patterns of prescribing antimicrobials and 
their consumption which has continued to rise (Austin, Kristinsson et al. 1999). 
Neisseria gonorrhoeae demonstrates a variety of mechanisms of resistance or decreased 
susceptibility to antibiotics. An understanding of the mechanisms of resistance and the 
mechanism of action of antibiotics is crucial in explaining the observed trends in the 
distribution of resistant strains of gonorrhoea (Appendix). Use of antibiotics exerts a 
selective pressure on the emergence of resistance at different scales, ranging from 
background levels of antibiotic use to specific pressure exerted by treatment of 
gonorrhoea, as illustrated in Table 1.2 (Austin, Kristinsson et al. 1999; Fox, del Rio et 
al. 2001; Fox and Knapp 1999; Fox, Knapp et al. 1997).  
Various studies have assessed the changes in resistant strains of gonorrhoea in the 
developed world, including Europe (Forsyth, Moyes et al. 2000; Ison and Martin 1999; 
Kyriakis, Tzelepi et al. 1999; McCutchan, Adler et al. 1982; Nissinen, Jarvinen et al. 
1997; van de Laar, van Duynhoven et al. 1997), USA(MMWR 1985; Schwarcz, 
Zenilman et al. 1990; Whittington and Knapp 1988), Australia (Tapsall, Limnios et al. 
1998) and Japan (Tanaka, Matsumoto et al. 1995). The changes seen in the patterns of 
drug resistance among N. gonorrhoeae isolates have resulted in treatment failure and 
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necessitated changes in treatment recommendations e.g. penicillin was no longer 
recommended after 1989 (MMWR 1989). Even in areas where sexually transmitted 
diseases continue to decrease, e.g. Scandinavia, the proportion of resistant strains 
appears to be rising (Nissinen, Jarvinen et al. 1997; Van der Heyden, Catchpole et al. 
2000). Recent years have seen a global increase in the total number and relative 
proportion of cases of gonorrhoea strains with reduced susceptibility or resistance to 
antibiotics (WHO 2001). Increased resistance results in economic and health costs, due 
to: 
• Increasing use of newer, more expensive drugs (effective and cheap treatments, 
such as penicillin and tetracycline are no longer recommended for first line 
therapy in the UK (CEG and Bignell 2002; CEG, Horner et al. 2002) or USA 
(MMWR 1998)). 
• Treatment failure, resulting in a need for repeated treatment and an increase in 
transmission to susceptible partners. 
• Costs associated with long-term effects of chronic infection, such as PID and 
subsequent infertility and ectopic pregnancy.  
Why do pathogens evolve? 
There are two reasons why bacterial pathogens are forced to evolve: firstly, due to 
competition with related organisms for hosts or resources within a host, and secondly, 
due to competition with the host. Competition with other bacteria may occur across a 
host population or within a host. Competition between the pathogen and host may occur 
through direct interaction with the host immune system which acts to kill the invading 
organism or indirectly via changes in the host behaviour in terms of sexual activity: rate 
of sexual partner change, type and frequency of sex acts or treatment with antibiotics. 
The competitive environment for the bacteria is therefore constantly changing, each new 
host is immunologically distinct and the immune response and host response (e.g. 
behavioural change, treatment seeking) changes during the course of an infection. The 
fitness of a strain relative to other strains present in a host population will vary as strains 
become extinct or new strains evolve or migrate in. 
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Mathematical models of sexually transmitted infections 
 
Mathematical models of the transmission dynamics of sexually transmitted infections 
may be formulated in a variety of ways. They have in common the three components of 
R0 (Equation 1.1) i.e. a description of the pattern of sexual contacts in the population 
(c), transmission of infection during a sexual contact and a probability of recovery based 
on the expected duration of infection (Anderson and May, 1991). The two main types of 
modelling approaches used for STIs are compartmental models and individual-based 
models. Both types may be stochastic (include random effects, each realisation is 
different) or deterministic (all outcomes are predetermined, so each time the model is 
run under a particular set of conditions the outcome is the same). Compartmental 
models make the assumption that the population can be divided into a finite number of 
discrete groups (e.g. men, women, high or low activity), who behave in the same way. 
These models are most often deterministic. Individual based models explicitly model 
each individual in the population and their sexual contacts.  
The particular choice of model depends on the question under consideration. 
Deterministic, compartmental models are the simplest to formulate and analyse. 
Hethcote and Yorke first used deterministic compartmental models for analysing 
gonorrhoea in the US (Hethcote and Yorke, 1984). They are useful for examining large 
scale effects and for initial insights into problems where parameters are poorly 
estimated as sensitivity analysis can be performed quickly.  
Individual based network models are more computationally intensive and require more 
advanced statistical analysis and interpretation. Recent advances in computing 
technology have stimulated the further development of such models. Several authors 
have used individual based models to investigate STIs, (Krestzchmar et al 1996, Ghani 
et al 1996). The advantages of individual based models are that one can track the 
infection history and sexual behaviour of individuals over time and observed stochastic 
events such as local extinctions. A difficulty with individual based network simulation 
models is determining when the sexual network simulated is representative of the true 
sexual network under study, in part due to difficulties in measuring sexual networks of 
humans (Ghani et al 1998). 
This thesis will use a series of deterministic compartmental models to investigate a 
range of questions on coinfection, mixing patterns, reinfection and the evolution of the 
organism.  
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Discussion 
Together, human biology and sexual behaviour, pathogen biology and public health 
interventions, interact to determine the epidemiology of sexually transmitted disease. 
Understanding the dynamics of this system requires an appreciation of each component 
and its effect on the rest of the system. Gonorrhoea and chlamydia share many 
characteristics; risk factors, clinical presentation, long term sequelae, asymptomatic 
infections, and they are both treatable and preventable. However there are important 
differences in the distribution of infection and in the networks which support infection. 
Many crucial parameters which describe the epidemiology of sexually transmitted 
infections are poorly estimated, e.g. the duration of untreated infections is very variable 
(Golden, Schillinger et al. 2000). Estimating the impact of interventions within a 
dynamic framework is important for planning policy. Mathematical modelling 
approaches provide a means of simulating and predicting the behaviour of a complex, 
dynamic situation. 
This thesis presents a series of mathematical models, together with new empirical data 
which will demonstrate how an integrated approach can be used in a variety of 
situations, to better understand and explain host behaviour, pathogen biology and public 
health interventions, to inform public health efforts. 
The distribution of gonorrhoea and chlamydia are modelled in Chapter 2 to investigate 
the patterns of coinfection and determine whether it is more likely in particular risk 
groups. The relative effectiveness of screening and cotreatment are assessed in a 
deterministic framework. 
Chapter 3 investigates the impact of host behaviour on the distribution of disease within 
a population. Data from a behavioural study and cross sectional study of incidence of 
gonorrhoea in South East London are used to parameterise and validate a model of 
gonorrhoea. The effect of partner choice in determining the network structure i.e. 
mixing patterns is investigated. Host behaviour is considered with respect to partner 
choice and rates of partner change for a population in South East London, in which 
mixing patterns play a crucial role in gonorrhoea epidemiology.  
Chapter 4 looks at reinfection and the biological features of STIs which make them able 
to infect the same individual many times. The model is used to compare with rates of 
reinfection and try to tease out biological characteristics of reinfection. A simple 
deterministic model of reinfection with gonorrhoea is compared with a more complex 
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model to quantify the difference in expected reinfection rates between the two 
scenarios. The ability of the models to predict reinfection with gonorrhoea is compared 
with empirical data from London GU clinic. 
Chapter 5 examines at the effect of different evolutionary strategies of gonorrhoea and 
chlamydia to investigate what effect interventions have on the evolutionary advantage 
of one strain or infection over another. Particular attention is paid to the evolution of 
drug resistance and bacterial mechanisms of gonorrhoea which allow it to develop drug 
resistance very quickly and spread rapidly within a population.  
In Chapter 6 the findings of the thesis are reviewed and the work placed in a wider 
context. Common themes and features from different chapters which are relevant to 
each other are highlighted. 
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Chapter 2  Coinfection with chlamydia and gonorrhoea 
Summary 
In this chapter, the epidemiology of infection with gonorrhoea, chlamydia and 
coinfection is examined. The risk factors for these infections are similar and coinfection 
is common. The chapter will examine the extent of coinfection and the epidemiological 
characteristics of patients with chlamydia, gonorrhoea or both, and how these are 
influenced by the biology of the pathogens and the sexual behaviour of the host. 
A review of the current literature regarding coinfection with gonorrhoea and chlamydia 
is presented. Estimates are made of additional parameters values for use in a 
mathematical model of single infection and coinfection. The relevant similarities and 
differences between the two pathogens and their treatment and control are highlighted. 
A mathematical model of two sexually transmitted pathogens is then developed. The 
model is used to examine the impact of different treatment and control options, such as 
routine cotreatment or chlamydia screening on prevalence and incidence. 
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Introduction 
Gonorrhoea and chlamydia share many epidemiological and clinical characteristics 
(Box 1.1, Table 1.1 and Table 1.6): they are both caused by sexually transmitted 
bacteria, are often asymptomatic and include in their sequelae, pelvic inflammatory 
disease (PID), ectopic pregnancy and infertility. There are also important differences 
between them: chlamydia is much more prevalent than gonorrhoea. Of reported 
diagnoses in women in the UK in 2002, chlamydia was diagnosed almost 6 times more 
often than gonorrhoea, and in heterosexual men more than twice as often (HPA 2003a). 
Gonorrhoea and chlamydia share the same mode of transmission and coinfection with 
both pathogens is common. Most estimates of coinfection are based on the proportion of 
patients with gonorrhoea who also have chlamydia, as this proportion is expected to be 
higher. 
In the UK, recent years have seen a marked increase in the number of diagnoses of 
gonorrhoea and chlamydia. Possible explanations for this change are an increase in 
sexual activity, an increase in testing and awareness or a reduction in the quality of 
healthcare provision. The national surveys of sexual attitudes and lifestyles undertaken 
in 1990 and 2000, offer a good opportunity to relate changes in sexual behaviour with 
changes in disease incidence (Johnson, Mercer et al. 2001). There is also some evidence 
that STI clinic services are not coping with this increased demand, resulting in a vicious 
cycle of longer time to recovery and therefore more opportunities for transmission of 
infection and long term sequelae of disease (Adler 2003; White, Cassell et al. 2003).  
Figure 2.1 shows the increase in diagnoses of gonorrhoea and chlamydia reported in the 
UK (on different axes) between 1995 and 2002. It is not clear how much of the 
increases can be explained by increased testing and diagnosis, especially of chlamydia. 
Data on the number of tests performed might provide some indication of whether the 
increased diagnoses are a result of increased testing or true increases in incidence. It is 
also important to estimate the proportion of false postitives detected. Both infections 
appear to have increased at the same rate, which suggests a possible common cause, e.g. 
a general trend of increasing sexual activity (Johnson, Mercer et al. 2001), or some 
other common factor e.g. declining STI health services (Adler 2003) could explain the 
temporal trends. Although this is a very simple approach, using information about both 
infections can provide additional information about the changing epidemiology. 
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Figure 2.1 Increase in gonorrhoea and chlamydia diagnoses reported to the 
HPA in the UK, 1994-2003 (HPA 2003b). 
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Understanding the epidemiology of coinfection with gonorrhoea and chlamydia is of 
clinical relevance because cotreatment of both infections is often implemented when a 
patient is diagnosed with gonorrhoea. Most antibiotics which are effective against one 
organism will not clear the other. In the USA, routine cotreatment of gonorrhoea 
patients for chlamydia is recommended, but in the UK presumptive cotreatment is only 
given if a patient is unlikely to return for a follow-up appointment (Appendix, 
Treatment Guidelines, Table A.1 and Table A.2). In the current context of a continuing 
failure to control both gonorrhoea and chlamydia, as evidenced by a sustained increase 
in gonorrhoea and chlamydia incidence in the UK, new approaches to the management 
and prevention of these infections are required. Interventions for chlamydia and 
gonorrhoea can be combined by health care providers as the risk groups for each 
infection are overlapping. In addition, screening programmes for chlamydia could 
potentially be used for identifying those who would benefit from additional screening 
for gonorrhoea (Fenton, Korovessis et al. 2001). 
There is debate over the usefulness and appropriateness of routine cotreatment. The 
advantage of presumptive cotreatment of patients who present with gonorrhoea is that 
there is a high index of suspicion that they are also infected with chlamydia, so 
treatment is likely to benefit the patient. The antibiotic drugs used to treat chlamydia are 
effective and very safe so there is a large potential benefit to the infected individual, 
balanced by a very small potential cost of therapy to an uninfected person. 
Epidemiologically there is an indirect benefit to society of preventing further 
transmission of chlamydia by treating the patient as soon as possible. In addition there 
are potential economic benefits as the cost of treating uncomplicated chlamydia is low, 
but long term complications such as infertility and PID are potentially very expensive. 
However, some would argue that routine cotreatment means unnecessary therapy for a 
significant number of people and that most of those infected get treated anyway (Das, 
Allan et al. 2002). 
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Extent of coinfection with gonorrhoea and chlamydia 
The proportion of patients coinfected with these bacteria varies by age, gender and 
sexual orientation. Young age and female gender are associated with an increased risk 
of coinfection (Creighton, Tenant-Flowers et al. 2003; Hijazi, Thow et al. 2002). Men 
who have sex with men (MSM) with gonorrhoea have been shown in most studies to be 
less likely to be coinfected with chlamydia than heterosexuals (Dragovic, Greaves et al. 
2002; Hijazi, Thow et al. 2002; HPA 2003a). In the UK in 2002, the GRASP survey 
found that 35% of females, 24% heterosexual males and 7% MSM infected with 
gonorrhoea were also infected with chlamydia (HPA 2003a). A similar level of 
coinfection have been reported in the USA, where two surveys of GU clinic attendees 
found that approximately 40% of women and 20% of men with gonorrhoea also had 
chlamydia and this proportion was highest in young age groups (Dicker, Mosure et al. 
2003; Lyss, Kamb et al. 2003). 
Various other studies have calculated the proportion of selected groups of patients with 
gonorrhoea or chlamydia who are also infected with the other pathogen. Table 2.1 
summarises these estimates of coinfection. The estimates vary considerably but show 
that coinfection in young females is more common than in men, reflecting the higher 
prevalence of chlamydia in women and longer duration of infection compared with 
men. For example 40-50% of young women with gonorrhoea are typically also infected 
with chlamydia (Dicker, Mosure et al. 2003).  
Coinfection is not reported directly in the national STI surveillance system (KC60), so 
other means for estimating temporal trends are required, to use in conjunction with 
studies, which directly measure the proportion of patients infected with gonorrhoea who 
are coinfected with chlamydia or vice versa. Reported diagnoses in clinics 
underestimate the numbers of cases of disease and infection within a population. Some 
people with disease will not attend a clinic because they are unaware of their infection 
(asymptomatic), they get treated elsewhere, or the infection is not reported. Changes in 
the relative level of reporting of gonorrhoea or chlamydia may influence the apparent 
rate of concurrent infection over time. For example, increases in screening or in the 
sensitivity of diagnostic tests may alter the apparent incidence of infection, whilst the 
real incidence remains unchanged. Trends in coinfection could shed light on the extent 
of reporting changes on the change in observed incident cases or true changes in disease 
occurrence. 
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The setting and test used in different studies may affect the comparability of the results. 
In particular, non-PCR methods tend to underestimate the number of men infected with 
chlamydia. Reports prior to the mid 1990s are likely to underestimate coinfection in 
men. From the late 1990s the sensitivity of available tests increased, especially in men. 
This has led to increased diagnoses of chlamydia and more coinfections with 
gonorrhoea and chlamydia observed in men which, has in turn, led to a greater 
awareness of the need to test and treat men for chlamydia too. Men who have sex with 
women (MSW) are more likely to be coinfected with chlamydia than MSM (Creighton, 
Tenant-Flowers et al. 2003; HPA 2003a). This is due to their contact with a higher 
prevalence population i.e. women. One USA study found a higher proportion men 
MSM coinfected than MSW, although this was not significant. The authors suggest that 
this could have been due to a reduction in immunity to chlamydia due to lower exposure 
to past infection (Ciemins, Flood et al. 2000). 
This can be further examined by plotting the number of cases of gonorrhoea divided by 
the number of cases of gonorrhoea and chlamydia combined, for females, heterosexual 
men and MSM, which is shown in Figure 2.2. In general the ratio of gonorrhoea and 
chlamydia infections has remained roughly stable over the last 5 years, the exception 
being in MSM, where diagnoses of chlamydia infections have increased faster than 
gonorrhoea infections, i.e. the proportion of infections due to gonorrhoea has declined. 
This could be explained by a slower increase in the incidence of gonorrhoea infections 
or due to increases in testing and increased test sensitivity of chlamydia tests, 
particularly changes in the ability to detect pharyngeal and rectal infection. 
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Table 2.1 Summary of estimates of coinfection with gonorrhoea and chlamydia 
% infected with GC, 
who have CT 
Gender % 
Comments  
(Study setting, diagnostic test)  
Reference  
(most recent first) 
F 
M 
MSM 
35 
22 
7 
UK national surveillance of GC isolates 
2001-2 
Variable chlamydia tests (majority 
sensitive) 
 
(HPA 2003a) 
 
 
F (136/353) 
MSW 
(124/512) 
MSM (5/73) 
 
 
 
38.5 
24.2 
6.9 
GUM clinic, London UK 1998 
LCR test: M first pass urine; F 
endocervical swab 
13% F with CT had GC (136/1022) 
18.8% MSW with CT had GC 
(124/660) 
20.0% MSM with CT had GC (5/25) 
Young age and female gender 
associated with CT coinfection: >50% 
of 15-19 women coinfection. 
Ethnicity had no effect (control age and 
gender) 
(Creighton, Tenant-
Flowers et al. 2003) 
F 
M 
34.7 
3.3 
GUM clinic, London, UK, 1999 
ELISA. 257 cases, from 238 patients, 
Don’t routinely screen M 
(Newell, Herbert et 
al. 2003) 
F (FPC) 
F (STD) 
F (Prenatal) 
43.1 
38.4 
49.2 
15-24 F, USA, 2000 
Nucleic acid probe  
(Dicker, Mosure et 
al. 2003) 
F (64/151) 
MSW (91/411) 
42 
20 
5 public STD clinics, USA 1993-95. 
PCR test 
3885 tested (%): CT (M=16, F=9), GC 
(M=19, F=15), Both (M=4, F=4) 
Age <25 associated with coinfection  
(>50% F) 
(Lyss, Kamb et al. 
2003) 
All 
All, not MSM 
F 
M 
MSW 
MSM 
10.7 
24.6 
41.4 
3.3 
10.8 
0 
London GUM clinic 1998 
ELISA test endocervical/urethral for 
W,  
urine for M 
May underestimate incidence in men 
(Dragovic, Greaves 
et al. 2002) 
F (29/64) 
M (57/287) 
MSM (15/134) 
MSW (42/153)  
48 
20 
11 
28 
Glasgow, STD clinic. 2000 
LCR test (M- urine, F – endocervical 
swab) 
Young age and female sex independent 
predictors of co-infection (logistic 
regression) 
(Hijazi, Thow et al. 
2002) 
All 26 GU clinic Coventry, UK. 1989-2000 
CT ELISA, confirmed with 
immunoassay 
8% CT cases had GC.  
1250 GC, 4127 CT, 332 Both 
(Das, Allan et al. 
2002) 
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% infected with GC, 
who have CT 
Gender % 
Comments  
(Study setting, diagnostic test)  
Reference  
(most recent first) 
MSM 
MSW 
15.2 
8.4 
San Francisco STD clinic 1997 
Urine LCR test. Young age associated 
with CT 
(Ciemins, Flood et 
al. 2000) 
F (24/69) 
M (10/134) 
36.4 
8 
GUM, Newcastle upon Tyne, UK, 
1999 
Lab culture for CT, EIA test, PCR 
confirmation 
65% GC cases - attendance of sex 
partners. 
CT screening/co-treating in 98% of 
cases of GC 
(Watson 2000) 
All 38 GUM, Coventry, UK, 1991-94. EIA 
test 
(David, Wade et al. 
1997) 
F  
M 
28 
15 
STD clinic attendees, Rotterdam, 
Netherlands, 1994. Culture, Gen-probe 
PACE-2. 
(Van Duynhoven, 
van de Laar et al. 
1997) 
F (6/34) 
M (4/113) 
17.6 
3.5 
Sydney, Australia (Tapsall and 
Kinchington 1996) 
F (pregnant) 46 Texas, USA. Pregnant women. CT 
culture 
(Christmas, Wendel 
et al. 1989) 
M 
F 
15 
26 
USA (Stamm, Guinan et 
al. 1984) 
F 48.3 474 women. CT significantly 
associated with GC, oral 
contraceptives, cervical ectopy, 
cervicitis and sex within a week. 
(Arya, Mallinson et 
al. 1981) 
F 44 STD clinic, UK. 638 women 
Cervical swab 
(Burns, Darougar et 
al. 1975) 
M (15/44) 34  (Oriel, Reeve et al. 
1975) 
 
26-48  (Washington, 
Browner et al. 1987) 
Notes: CT = Chlamydia trachomatis; NG = Neisseria gonorrhoeae; F = female; M  = 
male; MSM = men who have sex with men; MSW =men who have sex with women; 
GUM = genitourinary medicine; STD = sexually transmitted disease; EIA = enzyme 
immunoassay ; ELISA = enzyme-linked immunosorbent assay; PCR = polymerase 
chain reaction; LCR = ligase chain reaction 
ELISA or EIA tests may underestimate prevalence in men by up to 20% 
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Figure 2.2 The fraction of the combined reports of gonorrhoea and chlamydia 
in the UK represented by gonorrhoea 
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Behavioural aspects of coinfection 
Differences exist between patients with chlamydia, gonorrhoea or both. As described in 
chapter 1, gonorrhoea is highly clustered geographically and socially, whereas 
chlamydia is more widely dispersed within the general population, although still 
concentrated in particular risk groups. The sexual networks in which STIs are 
transmitted vary, e.g. MSM, sex workers and their clients and heterosexual adolescents. 
These networks provide different types of sexual contact (penile-vaginal or penile-anal 
sex) and involve different people (men or women). Such differences may favour one 
pathogen over another, due to differences in the transmissibility or duration of 
infectiousness in the members of the network. 
Men infected with gonorrhoea report higher rates of partner change than women with 
gonorrhoea and similarly for chlamydia (Zimmerman, Potterat et al. 1990). This may 
reflect the greater susceptibility of women to infections with either organism and longer 
duration of infection i.e. a difference in the natural history of infection between men and 
women. However, men report higher rates of partner change than women in general, so 
it may simply be reporting bias (Johnson 1994). Concurrency of sex partners may also 
play an important role in determining the likelihood of infection and coinfection with 
STI (Kraut-Becher and Aral 2003). It appears that differences exist between carriers of 
different strains of pathogen, for example, strains of gonorrhoea are better adapted to 
survival in the rectum and are therefore found more commonly among MSM 
(Whittington and Holmes 2000). This suggests that host characteristics do indeed affect 
the distribution of bacteria species or strains within a population, both spatially and 
temporally.  
The observed differences in individuals with gonorrhoea infection compared with 
chlamydia infection, have led to the suggestion that these represent different sexual 
networks (Jolly and Wylie 2002; Kretzschmar, van Duynhoven et al. 1996; Stoner, 
Whittington et al. 2000; Van Duynhoven, van de Laar et al. 1997). In a recent, detailed 
study of the epidemiology of gonococcal and chlamydial infection in sexual networks 
(Stoner, Whittington et al. 2000), patients infected with chlamydia had a lower average 
number of partners, and were less likely to report crack-cocaine use or to have served a 
prison sentence than gonorrhoea patients. In addition, chlamydia patients are on average 
wealthier and better educated than those infected with gonorrhoea.  
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This can be explained in terms of the basic reproductive number. For two infections 
(gonorrhoea and chlamydia) with a similar transmission probability, higher frequency 
transmitters can maintain an infection (gonorrhoea) with a fairly short duration because 
there are sufficient opportunities for transmission of the bacteria to new hosts. In 
contrast, a longer duration of infectiousness allows a pathogen (chlamydia) to persist in 
a population of lower frequency transmitters as well. The higher prevalence and 
incidence of chlamydia compared with gonorrhoea suggests that the reproductive 
number of chlamydia is higher than for gonorrhoea. Extending this line of reasoning, 
one would expect those infected with both pathogens to have the highest risk behaviour, 
those with gonorrhoea the next highest and those with chlamydia the lowest level of 
risk. People identified as coinfected are therefore potential targets for interventions. 
Other markers of increased STI risk, such as history of infection may indicate 
individuals in the core group who are likely to be important in the onward transmission 
and maintenance of endemic infection. The absence of such risk markers may indicate 
that a person represents the end of a chain of transmission or is non-core. Such proxy 
markers of risk behaviour are useful for identifying people who would benefit most 
from interventions. Rogers et al demonstrate this principle in finding that individuals 
with a current infection who self-reported a history of STI (marker of risk) were found 
to be more likely to have had multiple partners than those with no self-reported history 
(Rogers, Miller et al. 2002). In the same study however, behavioural characteristics did 
not describe those with current asymptomatic infection very well (Rogers, Miller et al. 
2002). 
A two-pathogen model with good parameter estimation of the natural history of 
infection, together with a good representation of sexual behaviour and mixing patterns 
should be able to produce realistic simulations of disease incidence and prevalence. 
Even if the parameters are estimated imperfectly, the relative effects can be analysed 
and compared with observed incidence of single infections with gonorrhoea or 
chlamydia or with coinfection. This could also be used to inform estimates of unknown 
parameters such as mixing by activity level and parameters related to the natural history 
of coinfection.  
Biology of coinfection 
The natural history of coinfection with gonorrhoea and chlamydia is not well described. 
Questions which remain unanswered include: what happens to the transmission 
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probability and rate of recovery from each infection? Is transmission of each infection 
independent or are both transmitted simultaneously more frequently than would be 
expected? What happens during treatment, are both infections cleared or only one? If 
the new infection results in overt symptoms then the duration of the existing infection 
may be reduced, due to the individual seeking care for an unrelated infection. 
Conversely, existing infection may increase susceptibility to acquiring further 
infections, due to inflammation in the genitourinary tract.  
Little is known about the interaction between gonorrhoea and chlamydia during 
coinfection. It is now accepted that gonorrhoea increases the transmission probability of 
HIV, which suggests that the presence of another pathogen can affect the replication or 
adhesion and hence the transmission of other pathogens (Rottingen, Cameron et al. 
2001). A study by Lin et al (Lin, Donegan et al. 1998), designed to investigate 
transmission of chlamydia and gonorrhoea, found that there was no difference in the 
transmission of gonorrhoea or chlamydia infection from coinfected versus singly 
infected individuals to naïve partners. Approximately two thirds of partners were 
infected with either chlamydia or gonorrhoea and more than half of the partners of 
coinfected patients were also coinfected. It is unknown how recovery is affected by 
coinfection. For example the rate of recovery in those coinfected who are treated for 
both infections is unknown, as is the fraction that remain infected with either Neisseria 
gonorrhoeae or Chlamydia trachomatis. 
The fraction of cases which do not develop symptoms has a strong influence on the 
epidemiology of the disease. For example, people with asymptomatic infections may be 
less likely than those with symptomatic infections to alter their sexual behaviour and 
less likely to seek care even if notified. For both gonorrhoea and chlamydia, 
asymptomatic infections comprise an important reservoir of infection, although 
gonorrhoea is more likely to cause symptoms than chlamydia. A potential means of 
treating some asymptomatic or unrecognised infections is to presumptively treat 
gonorrhoea cases for chlamydia as coinfection in gonorrhoea patients is common. The 
impact of asymptomatic disease adds to the need for effective screening programs for 
chlamydia in men and women. Where screening programs for chlamydia have been 
trialled, they have shown considerable success in reducing prevalence, e.g. in various 
US states (LaMontagne, Fine et al. 2003; MMWR 1997a). The proportion of contacts of 
infected cases that are asymptomatic may be very high, in the order of 80%. The same 
study found that only 10% of index cases were asymptomatic (David, Wade et al. 
Katherine Turner 
Chapter 2 - Coinfection with gonorrhoea and chlamydia 
 55 
1997). It is not known whether the transmissibility of asymptomatic infections is the 
same as that for symptomatic infections. Potentially there could be an increase in the 
relative transmissibility of asymptomatic infections due to lack of awareness of 
infections and therefore, no change in sexual behaviour (e.g. condom use or abstention).  
Coinfection may have an impact on the probability of a patient becoming symptomatic 
or having a symptomatic partner and therefore of seeking care. There is some evidence 
that infection with gonorrhoea may reactivate latent chlamydia infection (Batteiger, 
Fraiz et al. 1989). This may have benefits if chlamydia is diagnosed and treated due to 
attending a clinic for gonorrhoea when it would have otherwise gone unrecognised. 
Reactivation of chlamydia may have other implications for the patient, for example if it 
increases the risk of PID due to an enhanced inflammatory response, but these effects 
are not well characterised. It is not known whether coinfection results in an increased 
risk of PID compared with single infection with either bacterial species. 
Method 
Mathematical model 
A deterministic model of gonorrhoea and chlamydia which allows for coinfection with 
the two bacteria was developed, based on previous work (Anderson and May 1991; 
Garnett, Mertz et al. 1999; Hethcote and Yorke 1984). The model was developed to 
allow the introduction of various treatment or intervention strategies aimed at 
gonorrhoea, chlamydia or both during the course of the simulation. These could be 
targeted at specific groups or the whole population. The interventions act to reduce the 
duration of infection in those infected to simulate an increased rate of diagnosis and 
treatment. The influence of patterns of sexual partner choice and sexual mixing on the 
impact of treatment was also assessed. 
Model details 
The model represents an exclusively heterosexual population stratified according to 
gender, sexual activity based on rate of partner change and infection status: infected 
with gonorrhoea; chlamydia; or both, and whether infection is symptomatic or 
asymptomatic. The model population was a constant size with a constant supply of new 
susceptibles, balanced by a constant rate of loss representing death or cessation of 
sexual activity. All sexual contacts are assumed to be chosen from within the model 
population. 
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The literature was consulted to obtain parameter estimates of the natural history of the 
infections for the model. The available, observed values from empirical studies are 
presented in Table 2.2. The parameter values used in the model are presented in Table 
2.3. Those which directly affect the basic reproductive number are the rate of sexual 
contact (c), the transmission probability per partnership (β) and the duration of infection 
(D) (Chapter 1, Equation 1.1). The contact rates of each of four activity classes are 
given in Table 2.4. These values reflect observed trends; most people have few partners 
and a few have many, but the model does not directly aim to simulate observed values. 
Many of the parameters required for an accurate model of either gonorrhoea or 
chlamydia are poorly defined or unknown e.g. the transmissibility and duration of 
asymptomatic infections. Including both infections in the same model requires 
additional parameters to account for potential interactions during coinfection which may 
affect the transmission or duration of infection of the pathogens. The advantage of 
modelling both infections is it may be possible to extract additional information about 
both diseases. 
Parameters which are not well defined for a model of coinfection include the and 
transmission from or to a site with another pathogen present. Another unknown is how 
recovery is affected by coinfection. This is represented by a parameter, ω,  which 
determines the proportion of those recovering from coinfection who remain infected 
with either infection, or who recover from both infections at the same time (e.g. due to 
cotreatment). The extreme case is when all recovery is from coinfection to the 
susceptible class (ωCT = ωGC  = 0. Superscripts denote the proportion recovering from 
chlamydia (CT) or gonorrhoea (GC)); or all recovery is from one infection at a time 
(ωCT + ωGC   = 1). In the examples presented in the results, it assumed that 40% of 
recovery from coinfection is from a single strain (equally split between the two strains), 
and 60% is recovery to the susceptible class directly, e.g. due to treatment. The rate of 
recovery depends on the proportion of infected people that seek treatment, although this 
is likely to be different for asymptomatic and symptomatic infections. 
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Table 2.2 Parameters required for the mathematical model of Chlamydia 
trachomatis and Neisseria gonorrhoeae with estimates drawn from literature 
Chlamydia trachomatis Neisseria gonorrhoeae   
Estimate Comment Estimate Comment  Reference& 
type of study 
Transmission probability 
65%  
79%  
57%  
F - CT from M (CT only) 
F - CT from M (CT + GC) 
F - CT+GC, M (CT+GC) 
73%  
71% 
57%  
F- GC from M (GC only) 
F- GC from M (CT + GC)  
F - CT+GC, M (CT+GC) 
Study designed to evaluate male to female transmission of CT and NG  
No difference in treatment observed between coinfected and singly 
infected people 
(Lin, 
Donegan et 
al. 1998) 
 
68%  
70 % 
M (42% culture positive)  
F (57% culture positive) 
  
PCR test of sex partners of those infected with chlamydia. Couples 
enrolled at STD clinic in Baltimore, USA. Infection associated with 
history of STD 
(Quinn, 
Gaydos et al. 
1996) 
  22% M - per sexual contact with 
infected females 
Urethral swab. Evaluated prevalence in hostesses in Philippine port 
(19.7%), 88 of 2191 men who had sex became infected. Median 3 acts, 
average 1.2 consorts, 2.5 contacts per consort.23% used condoms. 
Assumed random process of choosing hostess - but variable prevalence in 
different hostesses, e.g. up to 44.6% prevalence in highest activity.  
(Holmes, 
Johnson et al. 
1970) 
 Cohort study of venereal 
disease. Propsective design 
0.19 
0.53 
M, White 
M, Black 
Similar to Holmes 1970 study. Ethnic difference may be due to different 
prevalence in hostesses. Improved on Holmes methods. Tested men for 
asymptomatic gonorrhoea. Tested women at same time.  
(Hooper 
1978) 
47% 
45% 
36% 
22% 
28% 
26% 
F - CT from M (CT only) 
F - CT from M (CT +GC) 
F - CT + GC, M (CT+GC) 
M - CT from F (CT only) 
M - CT from F (CT +GC) 
M - CT + GC,  F (CT+GC) 
48% 
64% 
36% 
67% 
77% 
26% 
F - GC, from M (GC) 
F - GC, M (CT +GC) 
F - CT+GC, M (CT+GC) 
M -GC, F (GC only) 
M -GC, F (CT +GC) 
M -CT +GC, F (CT+GC) 
Culture method was used, so may have underestimated chlamydia 
transmission especially in men. Male partners more often infected with 
GC than CT. Of the female partners of men with GC only, 38% were 
found to have CT, compared with 14% of the male partners of women 
with GC only.  
(Lycke, 
Lowhagen et 
al. 1980b) 
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Chlamydia trachomatis Neisseria gonorrhoeae   
Estimate Comment Estimate Comment  Reference& 
type of study 
Recovery rate 
>61 
>21 
F No treatment (days) 
M no treatment (days) 
  
Review of data on duration of infection of chlamydia. Evidence quite poor 
for duration of untreated infection 
(Golden, 
Schillinger et 
al. 2000) 
  6 mo 
1.8 mo 
Untreated duration 
Treated duration 
(Brunham and 
Plummer 
1990) 
Proportion asymptomatic and symptomatic 
  33% 
40% 
GC in GU clinic, UK 
GC+CT  
(David, Wade 
et al. 1997) 
50% 
80% 
M 
F 
 
Most cases identified through 
contact tracing and screening. 
USA. 40% geographic overlap. 
(Zimmerman, 
Potterat et al. 
1990) 
43% 
79% 
M 
F 
 
STD clinic study in Baltimore, 
USA 
(Quinn, 
Gaydos et al. 
1996) 
11%  
6% 
M become symptomatic 
F become symptomatic 
45% 
14%  
M become symptomatic 
F become symptomatic 
Model of rural Ugandan setting. Sensitive to assumptions on relative 
duration of symptomatic/asymptomatic 
Symptoms are higher in men and more likely for GC than CT 
Calculated the proportion of infection that will become symptomatic, 
approx 1.5 times higher than point prevalence of symptomatic cases in 
cross sectional survey in rural Uganda 
(M, NG 33±9%;  M CT 7±3.6%; F NG 9±4% ; F CT 4±2.5%)  
(Korenromp, 
Sudaryo et al. 
2002) 
63% 
26% 
Symptomatic 
Abnormal Gram stain but no 
symptoms  
4.9% prevalence (474/9662 
tests done in male STD clinic 
attendees in NY USA by DNA 
test (urethral swab)  
 
 (Urban, 
Coury-
Doniger et al. 
1997) 
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Table 2.3 Parameter definitions used in the mathematical model of Chlamydia 
trachomatis and Neisseria gonorrhoeae 
Parameter Definition Default value Range of values 
used in the model 
µ Entry rate to maintain a constant 
population size, the entry and exit 
rates are assumed to be equal. 
0.02 per year n/a 
βNGxk, βCTxk Transmission probability of NG 
or CT to sex k per contact, where 
x=a denotes asymptomatic 
infection and x=s symptomatic 
infection 
0.5 per contact 0<β<1 
βDxk, βDxk Transmission probability of both 
infections to sex k per contact, 
where x=a denotes asymptomatic 
infection and x=s symptomatic 
infection 
0.5 per contact 0<β<1 
γNG, γCT Proportion of contacts with 
superinfected individuals, which 
result in transmission of NG or 
CT only. 
(If γΑ+ γΒ =0, then all contacts 
result in transmission of 
coinfection, if γΑ+ γΒ =1, then all 
contacts with coinfected 
individuals result in the 
transmission of a single strain. 
γΑ=γΒ=0.4 
Therefore 
proportion of 
contacts which 
result direct 
transmission 
of coinfection 
is: 1-
(γΑ+ γΒ)=0.2.  
0 ≤ γ ≥ 1  
γΑ+ γΒ ≤ 1 
ωΑ,ωΒ Proportion of those recovering 
from coinfection that remain 
infected with NG or CT. The 
extreme cases are when either all 
recovery is from mixed infection 
to the susceptible class (ωΑ=ωΒ = 
0); or all recovery is from single 
infections (ωΑ+ωΒ = 1). 
ωΑ=ωΒ =0.2,  0 ≤ ω ≥ 0.5 
ωΑ+ωΒ ≤ 1 
 
ρklm Mixing matrix, element klm is 
probability that individual of sex 
k in activity class l will form a 
partnership with a member of 
activity class m, sex k’ (opposite) 
See below n/a 
ckl Contact rate of individual of sex 
k, activity class l (see below) 
See below n/a 
ε Pattern of mixing (0=fully 
assortative, 1= random) 
1 (random) 0 ≤ ε ≥ 1 
 
θNG, θCT Percentage of infections with NG 
or CT which are symptomatic.  
θNG = 0.8 
θCT = 0.4  
n/a 
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Parameter Definition Default value Range of values 
used in the model 
σNGak, σ
CTa
k Recovery rate from 
asymptomatic infection with NG 
or CT per year 
(recovery rate = 1/duration) 
σNGsk, σ
CTs
k Recovery rate from symptomatic 
infection with NG or CT per year 
(recovery rate = 1/duration) 
σ = 2 per year, 
i.e. average 
duration of 6 
months 
without 
treatment, 
decreasing to  
10 per year, 
i.e. 1.2 months 
duration with 
treatment. 
With treatment, 
recovery depends 
on efficacy of 
treatment and the 
average time taken 
to seek treatment. 
Assumed to be the 
same for NG and 
CT.  
σDsk, σ
Da
k Recovery rate from dual infection Assumed to be 
faster than 
from single 
infections 
As above 
 
 
Table 2.4 Activity class definitions 
Activity class Rate of partner change 
(per year) 
Proportion of 
population in class 
1 10 0.05 
2 4.4 0.1 
3 2.2 0.2 
4 0.6 0.65 
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The mathematical equations describing the model are given below, along with further 
definitions of the parameters. Subscripts refer to the sex and activity class. In the case of 
sex, k=0 for men, k=1 for women while k' refers to the opposite sex to k and for activity 
l defines the class (from 1 to 4), according to average rate of partner change per year, 
ckl. The superscripts CT, NG associated with parameters identify the infecting organism 
and D a dual infection. Addition of a or s denotes asymptomatic and symptomatic 
infections, respectively.  
The subscripts stratify the state variables, which are as follows: 
Xkl.- population of susceptibles of sex k and activity class l 
NGakl -population of hosts infected with asymptomatic NG, of sex k, activity class l 
NGskl -population of hosts infected with symptomatic NG of sex k, activity class l 
CTakl -population of hosts infected with asymptomatic CT of sex k, activity class l 
CTskl - population of hosts infected with symptomatic CT of sex k, activity class l 
Dakl - population of hosts infected with asymptomatic NG and CT of sex k, activity 
class l 
Dskl - population of hosts infected with symptomatic NG and CT of sex k, activity class l 
Nkl- total population, sex k, activity class l 
In order to simplify the equations the force of infection is defined for symptomatic and 
asymptomatic infections of each strain independently (NG and CT) and for coinfection 
(D). The force of infection is the product of the transmissibility of the pathogen to each 
sex (β), the contact rate (partner change rate) (c) of the host population and the 
proportion of the total population infected with the strain, contacts with whom are 
determined by the elements (ρklm) of the mixing matrix (Ρklm). The force of infection 
here is the incidence per susceptible contributed by the type of infectious individuals. 
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Thus for an individual of sex k, activity class l, the forces of infection for strains NGa, 
NGs, CTa or CTs, or coinfection Da or Ds are: 
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The equations describing the model are as follows: 
( )
( )( )( )klDskklDakBAklCTskklCTakklNGsk
kl
NGa
k
Ds
kl
Da
kl
CTs
kl
CTa
kl
NGs
kl
NGa
klklklkl
kl
dt
d
DsDa1CTsCTaNGs
NGaXXN  X
σσωωσσσ
σλλλλλλµµ
++−++++
++++++−−=
 
( ) ( )( ) ( )( )( )
( ) ( ) klNGakklNGDDskNGklNGDDak
Ds
kl
Da
kl
NGCTs
kl
CTa
kl
NG
kl
Ds
kl
Da
kl
NGNGs
kl
NGa
klkl
NGkl
dt
d
NGaDs1Da
1NGaX1NGa
__ µσωσζωσ
λλγλλφλλγλλθ
+−−++
+−++−+++−=
 
( )( ) ( )( )( )
( )NGsDs
1NGsX
_ µσωσ
λλγλλφλλγλλθ
+−+
+−++−+++=
NGs
kkl
NGDDs
k
Ds
kl
Da
kl
NGCTs
kl
CTa
kl
NG
kl
Ds
kl
Da
kl
NGNGs
kl
NGa
klkl
NG
dt
dNGs
 
( ) ( )( ) ( )( )( )
( ) ( ) klCTakklCTDDskCTklCTDDak
Ds
kl
Da
kl
CTNGs
kl
NGa
kl
CT
kl
Ds
kl
Da
kl
CTCTs
kl
CTa
klkl
CTkl
dt
ad
CTaDs1Da
1CTaX1CT
__ µσωσζωσ
λλγλλφλλγλλθ
+−−++
+−++−+++−=
 
( )( ) ( )( )( )
( ) klCTskklCTDDsk
Ds
kl
Da
kl
CTNGs
kl
NGa
kl
CT
kl
Ds
kl
Da
kl
CTCTs
kl
CTa
klkl
CTkl
dt
d
CTsDs
1CTsX
CTs
_ µσωσ
λλγλλφλλγλλθ
+−+
+−++−+++=
 
( ) ( )( )( ) ( )
( ) ( )( )( )
( ) ( )( )( )DsklDaklNGCTsklCTaklklCTCTaD
Ds
kl
Da
kl
NGCTs
kl
CTa
klkl
NGNGaD
kl
Da
k
Ds
kl
Da
kl
CTNG
kl
Dkl
dt
ad
λλγλλφγ
λλγλλφγ
µσλλγγθ
+−++−+
+−++−+
+−+−−−=
1CTa1
1NGa1
Da1X1
D
_
_
 
( )( )( ) ( )
( ) ( )( )( )
( ) ( )( )( )DsklDaklNGCTsklCTaklklCTCTaD
Ds
kl
Da
kl
NGCTs
kl
CTa
klkl
NGNGaD
kl
Ds
k
Ds
kl
Da
kl
CTNG
kl
Dkl
dt
dDs
λλγλλφγ
λλγλλφγ
µσλλγγθ
+−+++
+−+++
+−+−−=
1CTs
1NGs
Ds1X
_
_
 
Katherine Turner 
Chapter 2 - Coinfection with gonorrhoea and chlamydia 
 64 
Ρlm is a mixing matrix, whose elements ρklm are the probability that an individual of sex 
k in activity class l will form a partnership with a member of activity class m of the 
opposite sex. The value of ρklm depends on the pattern of mixing and could vary from 
fully assortative, where partnerships only form within the same activity group to 
random, where partnerships form randomly between different activity classes. 
( )
∑
+−=
=
4
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''
'
'
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u
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mk
mklmklm
Nc
N
cεδερ  
δlm = 1 when l=m and δlm =0 when l≠m.  
It is necessary that the number of partnerships formed by sex k match those of the other 
sex. For the sake of simplicity in these models both sexes are divided into classes of 
identical size and activity levels. The models were solved numerically using a standard 
fourth order Runge-Kutta method. Parameters used in the model are defined in Table 
2.3. 
Results 
It was assumed that the only differences between gonorrhoea and chlamydia are in the 
duration of infection and the proportion of cases which become asymptomatic. The 
model was run under a variety of mixing patterns, which were varied from fully 
assortative (within activity class mixing only) to random (mixing proportional to the 
number of partnerships contributed by a class). 
In the absence of additional interventions, the prevalence and incidence of chlamydia, 
gonorrhoea and coinfection varied with mixing pattern. One fifth (20%) of dual 
infections are transmitted together, although this was chosen arbitrarily in the absence 
of data. The change in incidence is shown in Figure 2.3. The highest incidence is 
observed when mixing is fully assortative (left hand column) and infection is very 
rapidly passed around the highest activity group, but the overall prevalence is low. As 
the mixing becomes more random the effective population size increases which is 
mirrored by a corresponding increase in the number of infections, but the infection also 
becomes more diffuse. A turning point is observed and at higher levels of mixing 
between groups, the incidence begins to drop again. The effect of mixing pattern on the 
observed incidence follows a curve with some optimal level of mixing for incidence. 
This optimum value depends also on the biological parameters of the organism and the 
relative size of each activity group and may fall anywhere on the continuum of mixing 
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pattern (from assortative to random). The behaviour when mixing is fully assortative is 
a special case. One effect is that there may be two levels of mixing which produce the 
same combined incidence overall, however the pattern of coinfection will be different in 
each case. Coinfection is more frequent when mixing is relatively assortative and both 
infections are concentrated in a high activity part of the population. When mixing is 
close to assortative (like with like) 34% of those with gonorrhoea also have chlamydia, 
compared to proportionate (random) mixing, when 13% of those with gonorrhoea have 
chlamydia. Women with gonorrhoea are more likely to be coinfected than men, since 
women are more likely to be infected with chlamydia. The relative prevalence of the 
two infections is similar to that observed in the UK when mixing is slightly assortative.  
Different activity groups experience varying burden of infection (Figure 2.4). As the 
mixing pattern becomes more assortative, sexually transmitted infections become 
concentrated in the highest activity group and may saturate the group, preventing 
increases in prevalence. 
Impact of intervention strategies  
The intervention strategies for the control of gonorrhoea and chlamydia examined in 
this chapter are: 
Screening for chlamydia in women, men or both (5% coverage, 10 times per year) 
Routine cotreatment of chlamydia in gonorrhoea patients 
Under different mixing patterns, both screening and routine cotreatment of women 
and/or men reduce the prevalence of chlamydia (Figure 2.5). However, incident 
infections may actually increase due to replenishment and subsequent reinfection of 
susceptibles, especially when mixing is highly assortative due to the increased turnover 
of infections within the highest activity group. The impact of cotreatment on the 
prevalence of chlamydial infection declines over time, as coinfection decreases. As 
mixing becomes more random, screening is more effective, since it removes a certain 
proportion of the infected population at each time point, and reinfection is less rapid 
than when mixing is highly assortative.  
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Figure 2.3 Incident infections with chlamydia, gonorrhoea or both under 
different patterns of mixing (the infections are assumed to be independent but 
recovery from coinfection is faster than from a single infection) 
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Figure 2.5 Percentage change in prevalence of chlamydia seen under different 
control strategies and different patterns of mixing after 1 year 
Cotreatment – coinfected women recover from both infections rather than one on 
treatment.  
Screening – a percentage of those infected are identified at random and treated n times 
each year. (For whole population screening, 5% of those infected recover 10 times per 
year. When both males and females are screened the coverage is halfed such that the 
total fraction of those infected who are screened and treated is kept constant) 
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Discussion 
The model was used to investigate the patterns of infection with gonorrhoea, chlamydia 
and coinfection in a population stratified by gender and sexual activity. The mixing 
pattern between activity classes has a strong effect on the proportion of cases which are 
coinfections. When mixing is highly assortative, more people are infected with both 
bacteria than when mixing is more random. This is associated with increasing restriction 
of the infection to the highest activity group when mixing is highly assortative. Few 
dynamic models have attempted to parameterise the dynamic models for two infections. 
Interventions are shown to have different effects under different mixing patterns. In 
particular cotreatment is an effective strategy when coinfection is common and 
therefore a relatively high fraction of those people with chlamydia have gonorrhoea. In 
the USA, it was hoped that routine cotreatment could be monitored and relaxed when 
chlamydia prevalence declined due to screening programmes. However, Lyss et al, 
found a continuing high burden of chlamydia infection in patients diagnosed with 
gonorrhoea (Lyss, Kamb et al. 2003). This could be explained if chlamydia screening 
was systematically missing those at highest risk for STIs and particularly gonorrhoea, 
for example the poor, prison populations, sex workers or injection drug users. In this 
case one would expect that as screening continues to reduce the prevalence of 
chlamydia in the general population, the infection becomes more concentrated in high 
risk individuals who do not access screening and therefore the proportion coinfected 
remains high. This would imply that a combined approach is necessary: routine 
cotreatment of gonorrhoea patients who are likely to be at high risk even in the presence 
of good screening programmes, and screening of women and men to try to reduce the 
prevalence of the reservoir of asymptomatic infections.  
The stability of the relative incidence between chlamydia and gonorrhoea in women 
supports the notion that differences in the natural history of the organisms largely 
dictate the observed epidemiology and that differences in the level of sexual activity 
determine the overall extent of both diseases, with chlamydia being able to penetrate a 
larger (and therefore lower activity) part of the sexual network. Differences in host 
characteristics can therefore be explained by the ability of chlamydia to colonise a 
larger proportion of hosts, including those with lower partner change rates, due to a 
longer duration of infection and higher proportion of asymptomatic infection. 
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The impact of an intervention in this model is sensitive to the mixing pattern assumed 
and also to the transmission dynamics of coinfection, but the relationship is not 
straightforward. Coinfections are concentrated in the highest activity individuals. 
Therefore, cotreatment may prevent proportionately more infections in this group than 
in the population as a whole. However, without screening or partner notification, 
treatment is restricted to infections that are symptomatic, consequently treatment is 
limited in its impact. Furthermore there is very rapid reinfection in the highest activity 
group which means that treatment in this group is more rapidly undermined than 
treatment of those with a lower risk. The assumptions made regarding the pattern of 
recovery from coinfection are important in the results presented. 
Future work 
Further sensitivity analyses are required using contact rates derived from national 
survey data to try to assess the relative quality of the parameter estimates for gonorrhoea 
and chlamydia. Different parameter combinations can produce the same prevalence or 
incidence within a model. Therefore further investigating and validation of methods for 
measuring the fit of theoretical mathematical models and testing hypotheses with an 
internal control could potentially be very useful. However, due to the uncertainty of the 
parameter estimates a more extensive sensitivity analysis should be undertaken to test a 
broader range of scenarios. Better data on the natural history of coinfection with 
gonorrhoea and chlamydia is needed. 
Modelling of sexually transmitted diseases reported in the literature has been largely 
focused on single infections, most commonly gonorrhoea or HIV (Anderson, Gupta et 
al. 1991; Garnett and Anderson 1993a; Hethcote and Yorke 1984; Morris, Zavisca et al. 
1995). This chapter shows how integrating data from both gonorrhoea and chlamydia 
into a single model framework is possible. Such a model may provide a useful tool for 
investigating the impact of different potential control strategies such as routine 
cotreatment that rely on the relative prevalence of each infection for their success. The 
parameters required for model such as the duration of coinfection and potential 
interactions between infections highlight areas where knowledge of the natural history 
of both gonorrhoea and chlamydia is lacking. The pattern of mixing between activity 
classes has a strong influence on the distribution of disease. For a particular population 
being simulated, the pattern of mixing which accurately represents their behaviour of 
should produce comparable prevalence and incidence estimates for gonorrhoea, 
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chlamydia and coinfection. Parameter estimates for both infections can be tested within 
this framework. 
By modelling both infections together it may be possible to extract additional 
information about both diseases. For example, if realistic prevalence and incidence of 
infection can be obtained for both diseases, then one may have greater confidence that 
the model is representative. This approach is not straightforward because introducing 
the complexity of a second disease means the introduction of additional parameters, in 
particular to represent any interactions during coinfection which may affect the 
transmission or duration of infection of either pathogen. 
To what extent does the presence of both gonorrhoea and chlamydia predict that an 
individual of either gender is a transmitter? How much more likely are they to transmit 
at least one infection to a contact than someone with either infection singly? 
Identification of coinfected individuals may represent a useful measure of current and 
future risk and an opportunity for prevention efforts. Such individuals are likely to have 
contacts who are infected with either or both infections and the case-finding rate is 
potentially higher than with single infections, increasing the cost effectiveness of 
contact tracing based interventions. Quantifying such epidemiological parameters 
should be the subject of future work.  
Finally, the most valuable continuation of this work would be to use NATSAL 1990 and 
2000 data to parameterise the model of gonorrhoea and chlamydia and model the 
behaviour change during that time period. The model generated prevalence and 
incidence could then be fitted to the time series data (1990-2000), allowing a closer 
analysis of the biological parameters, and determine the scenarios of behaviour which 
could explain the observed changes in STI epidemiology in the UK. 
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Chapter 3  Sexual mixing patterns and the distribution of 
gonorrhoea in different subpopulations 
Summary 
This chapter explores the impact of sexual mixing patterns and sexual behaviour on the 
distribution of sexually transmitted infections in a community with high levels of 
infection. Empirical data from two cross-sectional studies of gonorrhoea in a South East 
London population inform model structure and relate theoretical model findings to 
practical intervention strategies. The ethical and practical difficulties of using ethnicity 
as a measure of sexual behaviour are discussed in detail. 
A simple deterministic, mathematical model of gonorrhoea transmission dynamics is 
used. This simulates a population stratified by gender, sexual activity (rate of partner 
change) and ethnic group (White, Black African and Black Caribbean). This model then 
provides the framework for investigating the impact of interventions. The literature on 
patterns of sexual mixing is reviewed, with particular emphasis on large studies of 
sexual behaviour and the results of other modelling approaches.  
Reported behaviours and mixing patterns are sufficient to generate major differences in 
the incidence of gonorrhoea experienced by each subpopulation in model simulations, 
with the Black Caribbean population bearing the greatest burden of disease. A variety of 
parameters are varied systematically to find, using maximum likelihood methods, the 
best fit to the observed data.  
The consistency between the model results and empirical data shows that large 
differences in gonorrhoea incidence between ethnic groups can be explained by modest 
differences in sexual behaviour and mixing patterns. Heterogeneity in sexual behaviour 
and partner choice interact through the dynamic feedback inherent in infectious disease 
epidemiology and cause large differences in disease incidence. Standard statistical 
methods exploring potential confounding variables such as socioeconomic status do not 
capture these dynamic effects. 
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Background 
Mixing patterns and disease spread 
To model the spread of an STI within a population, the pattern of choice of sexual 
partners must be understood. The way in which sexual partnerships form and dissolve is 
a determinant of an individual’s risk of disease, the pattern of mixing between groups 
and their consequent risk profile and describes the sexual network as a whole. One of 
the unanswered questions in sexually transmitted disease epidemiology is how best to 
characterise and describe the patterns of mixing within a population and how this relates 
to risk of infection for individuals, partnerships and the population. 
Various characteristics of individuals are markers of differential risk of STIs, including 
age, ethnicity, sexual activity level, location of residence, drug use and sex work (CDC 
2000b; Fenton, Korovessis et al. 2001; Hillis, Nakashima et al. 1994; HPA 2003a). 
These are therefore also the characteristics of epidemiological interest in determining 
the effect of mixing patterns on the epidemiology of STIs. Mixing within high risk 
groups provides a mechanism for the endemic maintenance of low prevalence infections 
such as gonorrhoea (Garnett and Anderson 1993a). Mixing between low and high risk 
groups has a strong influence on the overall distribution and prevalence of disease 
within a population and also on the potential impact of intervention strategies (Hethcote 
and Yorke 1984). 
Describing mixing patterns 
A key measure of mixing within populations is how likely individuals are to choose 
partners similar to, or different from themselves, according to a variety of measurable 
characteristics such as age, socioeconomic status, sexual activity, ethnicity or 
geographic location. This probability is defined by whether a sexual partnership is more 
or less likely than expected by random chance (in which mixing is simply proportionate 
to the number of partnerships contributed = group size * rate of partner change). Thus 
partnerships which form preferentially within a group are assortative (alternatively “like 
with like”, concordant or show “differential homophily”), whereas partnerships which 
form preferentially between different groups are disassortative (alternatively 
discordant). Random (proportionate) mixing occurs if the probability of partnership 
formation is the same as the proportion of partnerships contributed by that group 
(Anderson and May 1991).  
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In general most people choose their sex partners in an assortative manner i.e. young 
people mix with other young people, people choose partners who live near them and so 
forth (Johnson, Mercer et al. 2001; Johnson 1994; Laumann, Gagnon et al. 1994). 
However, evidence suggests that individuals with STI are more likely to form 
partnerships with people who differ from themselves, for example in age or social class, 
than those without STIs . It should also be noted that mixing patterns are not necessarily 
independent of group, so that a young female with a particular sexual partner change 
rate will not necessarily choose a partner in the same way as an older man with the same 
rate of partner change. This makes the formulation of mixing matrices for more 
stratified representations of populations increasingly difficult. 
Mixing patterns in people with STIs 
Directly measuring the pattern of mixing in a population is difficult, but efforts have 
been made to estimate parameters and validate models. Ideally information would be 
available from all partners in a network, but clearly this is difficult to achieve and the 
results from one setting cannot necessarily be applied in other settings. The results 
described below do indeed show different patterns in different settings. This emphasises 
the need for appropriate local knowledge when developing models in the process of 
formulating policy and making planning decisions. Ascertaining the difference between 
those with and those without STIs helps to understand the mechanisms for the spread of 
infection in a particular place. 
Interrelationship between determinants of mixing patterns 
Factors determining mixing patterns via partner choice are likely highly interrelated, 
making it difficult to analyse the influence of specific factors. Furthermore, the 
dynamics of infectious diseases are highly non-linear so even small differences in 
behaviour or choice of partner can be magnified into large differences in disease 
incidence, especially in small populations. A common theme of studies of individuals 
with STI and their patterns of partner choice or sexual mixing is the importance of 
discordant partnerships. In the USA, individuals with STI were likely to be involved in 
discordant partnerships (by a variety of criteria such as age, socioeconomic status, 
education etc) than those without STI (Aral, Garnett et al. 2000). 
Activity level 
The pattern of mixing between individuals with different rates of partner change can 
have a dramatic influence on the distribution of disease within a population and on the 
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overall prevalence of infection. Accurately determining the pattern of mixing between 
individuals of different activity levels is difficult to do on a large scale although 
methods such as snowball sampling could in theory be effective in obtaining network 
data on behaviour (Boily, Poulin et al. 2000; Ghani, Donnelly et al. 1998). Simply 
asking an index case about their partners’ behaviour is not satisfactory since an 
individual’s perception is a poor indicator of their partner’s behaviour and is not 
independent of disease status or index behaviour. Those with more partners are more 
likely to report that their partners have multiple partners (Aral, Garnett et al. 2000; 
Garnett, Hughes et al. 1996; Stoner, Whittington et al. 2003).  
A variety of patterns of mixing by activity level have been observed in practice. 
Laumann and Youm investigated the pattern of mixing by activity levels and ethnicity 
in the USA, and suggested that African Americans, who had higher incidence of STIs, 
were more likely to form “core-periphery” (high-low activity) type partnerships than 
whites, who had lower incidence of STIs (Laumann and Youm 1999). Using partner 
notification, Ramstedt et al constructed mixing matrices for young heterosexual women, 
based on socioeconomic status and activity. They concluded that mixing was not 
random, the assumption of which would cause an overestimation of the spread of 
disease (Ramstedt, Giesecke et al. 1991). A study of MSM in Iceland found 
disassortative mixing by activity level, which would lead to larger epidemics, but slower 
initial growth of an epidemic (Haraldsdottir, Gupta et al. 1992). 
Mathematical models can be used to estimate the likely pattern of mixing between 
different activity groups. Public health clinic attendees were interviewed in Seattle and 
their reported behaviour used to estimate the pattern of mixing by activity, which was 
found to be weakly assortative (Garnett, Hughes et al. 1996). In another study of 
gonorrhoea transmission in Newark, New Jersey, an almost random pattern of mixing 
by activity was initially inferred using a mathematical model (Garnett, Mertz et al. 
1999). Several studies have looked at the impact of mixing patterns on the course of the 
HIV epidemic (Anderson, Gupta et al. 1990; Boily, Lowndes et al. 2002; Garnett and 
Anderson 1993b; Garnett and Anderson 1994b; Gupta, Anderson et al. 1989; Kault 
1995; Sattenspiel, Koopman et al. 1990; Stigum, Falck et al. 1994). It has been 
demonstrated that assortative mixing by activity may lead to a more rapid initial growth 
but an ultimately restricted epidemic. However for HIV, which causes disease-induced 
mortality, the supply and demand of partnerships is unbalanced due to differential 
mortality by age, gender and activity. This needs to be accommodated in models 
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(Garnett and Anderson 1994b). A model which maintains consistency of partnership 
formation, to try to overcome this problem of partnership imbalance, shows that under 
certain conditions, bigger epidemics may be associated with increasingly assortative 
mixing (Kault 1995). This is not a consideration for uncomplicated gonorrhoea and 
chlamydia, since these do not cause excess mortality. A modelling study using the 
NATSAL 1990 data estimated the mixing matrix by activity level and provided some 
support for assortative mixing amongst the highest activity individuals (Renton, 
Whitaker et al. 1995). 
Age mixing 
One pattern of mixing by age which is well described occurs when younger women 
form partnerships with older men. In Africa men are on average 5-10 years older than 
their female partners and this pattern of mixing has been shown to influence the pattern 
of HIV infection, leading to more rapid rises in HIV incidence in young women 
(Garnett and Anderson 1994b; Gregson, Nyamukapa et al. 2002). Data from NATSAL 
1990 suggests that a similar pattern occurs in the UK, but that the average age 
difference is 1.5 years (Nigel Gay, personal communication 2004). A similar influence 
on disease amongst young MSM was seen due to their forming partnerships with older 
MSM in San Francisco (Service and Blower 1996). 
Geography 
Following early work in Colorado Springs, which found that 51% of cases of 
gonorrhoea disease incidence occurred in 4 census tracts, Potterat called gonorrhoea a 
“social disease” and coined the term “socio-geographic” space to describe the 
geographic clustering of gonorrhoea (Potterat, Rothenberg et al. 1985). Similar studies 
in the UK found that 66.5% of gonorrhoea and 41% of chlamydia cases occurred in 8 
adjacent wards in the city of Birmingham (Shahmanesh, Gayed et al. 2000). Geocoding 
or mapping infection has been a fertile topic of research recently, often using 
sophisticated mapping technology to show striking geographic and temporal trends in 
STI incidence (Krieger, Waterman et al. 2003; Law, Serre et al. 2003). The association 
between location and infection appears to be stable over time and provides a means of 
identifying “hotspots” which could be a target for interventions (Law, Serre et al. 2003).  
Most people tend to choose local partners. One estimate based on a survey in Baltimore, 
USA suggested that partners lived <100m away (Becker, Glass et al. 1998). Garnett and 
Anderson 1993 reviewed the degree of mixing between and within core and non-core 
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groups, based on the contact tracing and geographic residence. They found a high 
degree of mixing within core leading to within group transmission, which maintains 
gonorrhoea in the population (Garnett and Anderson 1993a). Kerani and colleagues 
define spatial bridgers as individuals with local and distant partners, although no 
distinction was made between people who travelled to their partner or who had distant 
partners travel to them (Kerani, Golden et al. 2003). Spatial bridgers were not typical 
high risk individuals; they had higher socioeconomic status and were older than other 
STI patients. Spatial bridgers therefore may be important especially in reintroducing 
infection to low prevalence populations and undermining targeted local interventions 
(Kerani, Golden et al. 2003).  
Ethnicity  
Ethnicity is an important factor in determining partner choice, and several studies have 
demonstrated that individuals preferentially choose partners from the same ethnic 
background (Aral, Hughes et al. 1999). Differences in disease incidence in ethnic 
groups persist, even when other confounding factors are accounted for, such as access to 
healthcare, behaviour, condom use or socioeconomic status. (Aral 2000) This may be in 
part due to sexual segregation. In the USA black women were found to mix more 
assortatively with black men than their male partners, whereas white men were more 
likely to have partners who are white women (Aral, Hughes et al. 1999). A similar 
pattern is observed in the UK (Low, Sterne et al. 2001). People strongly select partners 
on the basis of country of birth and even more so if parental country of birth is factored 
in (Barlow, Daker-White et al. 1997).  
Implications of different mixing patterns for disease control and policy 
decisions 
Mixing patterns have important implications for control interventions. In a highly 
assortative situation there is saturation of disease within the high activity class, so the 
threshold for an intervention within that group to have an impact on disease incidence 
may be higher than if mixing is random. Conversely, targeted interventions will be more 
effective if mixing is highly assortative, since those STIs will be more highly 
concentrated within the high risk group identified. Discordant partnerships represent 
sexual bridges, which in turn facilitate the spread of infection from one group to another 
(Anderson, May et al. 1991; Aral 2000). Two processes can therefore be identified: 
mixing within groups (assortativity) and mixing between groups (disassortativity). 
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Individuals who form both types of partnerships act as functional bridges, linking 
groups with different risk characteristics and extending the population available for a 
bacterium to infect. 
Inequality in disease burden 
The population under study in this chapter has several characteristics associated with a 
high risk of gonorrhoea infection. They are young (16-24 years old) and live in an urban 
area with high levels of poverty and deprivation, and associated high unemployment 
and low educational achievement. Over a quarter of the population is composed of 
ethnic minority groups.  
This uneven distribution of gonorrhoea is characteristic of the sexually transmitted 
infections. The overall prevalence in the UK and USA is low (although about 10 times 
higher in the USA), but this masks the much higher risks experienced by some groups 
(CDC 2000b; HPA 2003a). In both the UK and USA, gonorrhoea and chlamydia are 
more common amongst people from Black ethnic groups. These differences in STI 
incidence persist in statistical analyses even if socioeconomic status and behaviour are 
controlled for (CDC 2000b; HPA 2003a). Many studies of disease have described 
variations in prevalence or incidence in different ethnic groups, but have done little to 
explore the ultimate causes of the observed differences (Bhopal 1997).  
UK studies in Leeds (Lacey, Merrick et al. 1997), Birmingham (Shahmanesh, Gayed et 
al. 2000), Coventry (Winter, Sriskandabalan et al. 2000) and London (Low, Daker-
White et al. 1997) have shown higher incidence in Black ethnic groups compared to 
White or Asian groups for both gonorrhoea and chlamydia. Chlamydia appears to show 
less dramatic differences in incidence than gonorrhoea, which may be due to differences 
in prevalence. The difference in gonorrhoea incidence in urban areas in England is 10 to 
20-fold between Black and White populations (Lacey, Merrick et al. 1997; Low, Daker-
White et al. 1997) (Hickman, Judd et al. 1999). More detailed analyses showed that 
within the Black population, incidence of gonorrhoea among people from Black 
Caribbean backgrounds are higher than among Black Africans (Low, Sterne et al. 
2001), with similar incidence in White and Asian populations.  
In the United States as a whole, gonorrhoea incidence in 2000 were 30 times higher in 
non-Hispanic Blacks than in Whites (827 versus 28 cases per 100,000), despite 20 years 
of declining difference (CDC 2000b). A survey of US military recruits found that black 
women were over three times more likely to be infected with chlamydia than their white 
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counterparts, after controlling for state of origin, age and behaviour (Gaydos, Howell et 
al. 1998). In the USA, HIV is more common in African Americans, as is gonorrhoea. In 
the UK, HIV is more common in Black Africans, but gonorrhoea is less common than 
in Black Caribbeans (De Cock and Low 1997). Gonorrhoea is a co-factor for HIV 
transmission (CDC 2001). Therefore those groups with high gonorrhoea incidence are at 
increased risk of HIV, although the specific risk depends on the prevalence within the 
local network.  
Socioeconomic status and education play an important role in determining an 
individual’s ability to choose safer behaviours or partners as well as their ability to seek 
and obtain appropriate care following infection. Sexually transmitted infections are 
associated with low socioeconomic status, unemployment and poor education, which 
can overall be considered a measure of “social capital” (Holtgrave and Crosby 2003). 
Black Caribbean and Black African populations (although there are important 
differences, e.g. Black Africans have more education and lower risk of gonorrhoea) in 
the UK and African Americans in the US experience higher levels of poverty and lower 
levels of education than their white counterparts (Pfeffer 1998). This may lead to a 
social context in which STIs thrive (Adimora and Schoenbach 2002). There is little or 
no evidence for differences between ethnic groups in biological susceptibility to 
infection, although it is possible that differences in the relative prevalence of other STIs 
such as HSV-2 or chancroid may modify this somewhat (Fleming, McQuillan et al. 
1997). Population based studies in the US and UK have demonstrated that these groups 
remain sexually segregated (Laumann and Youm 1999) and others have shown that 
ethnic disparities in gonorrhoea incidence persist even after controlling statistically for 
measures of social and economic status (Ellen, Kohn et al. 1995; Hickman, Judd et al. 
1999) and sexual behaviour (Ellen, Aral et al. 1998). 
Other possible explanations for the observed differences in disease burden, include 
access to care, discrimination and age at sexual debut. Several authors have suggested 
that a major cause of the disparity is due to poorer access to care experienced by ethnic 
minorities with high disease incidence (Ellen, Aral et al. 1998; Moran, Aral et al. 1989). 
In the US there is differential use of public STD clinics, with black people more often 
attending public clinics, which report a higher proportion of cases and do more 
aetiological tests (Zenilman 2000). However in the UK health services are free to all. 
Discrimination and stigmatisation are also reasons why people from ethnic minorities 
may fear and distrust public health workers (Zenilman 2000). Other differences may 
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exist in sexual behaviour, such as age at sexual debut, which may modify the risk of 
different groups (Aral 2002b).  
In recent years, attention has turned to network-based explanations, involving social 
context and mixing patterns (Aral 1999; Aral 2002b; Ghani, Swinton et al. 1997; 
Laumann and Youm 1999; Rothenberg, Sterk et al. 1998; Stoner, Whittington et al. 
2000; Youm and Laumann 2002). An individual’s risk is determined by their sexual 
network, specifically the risk profile of their partner, in addition to their own individual 
characteristics. Sexual mixing patterns can act either to increase the risk of an individual 
by linking to a higher risk population or can protect a population from infection from 
external sources through sexual segregation (Aral 2000). High levels of undiagnosed 
asymptomatic infection within a segregated population could generate differences in 
incident infections (Winter, Sriskandabalan et al. 2000) and also in recurrent infections 
which have been found to be higher in ethnic minorities (Fortenberry, Brizendine et al. 
1999). An important research question is therefore how much influence can mixing 
patterns within a specific network structure have on modifying an individuals risk of 
infection above and beyond their own risk factors? 
Is ethnicity a valid epidemiological measure? 
Using race or ethnicity as an indicator for health issues, in particular for such socially 
stigmatised diseases such as STIs, is a sensitive issue. The subject of ethnic differences 
in STIs is politically sensitive and has been the subject of considerable debate over how 
it should be treated. Some would argue that ethnicity is at best a meaningless 
categorisation or at worst, further discriminates against minority populations (Osborne 
and Feit 1992). Historically, differences in disease incidence have been recognised since 
the second world war, but research has been plagued by racism (De Cock and Low 
1997; Zenilman 2000). Continuing inequality in health burden has lead to the UK 
government setting targets for improving the health of ethnic minorities (Adler 1997). 
To do this it is necessary to understand the proximate and ultimate causes of disease. 
Therefore Bhopal and others have called for a move from “black box” epidemiology, 
simply describing observed differences, to studies based on inequalities in care and 
provision of culturally sensitive, acceptable and accessible health care for all (Bhopal 
1997). 
A distinction should be drawn between ethnicity, which reflects social and ancestral 
identity and race, based on biological or genetic differences (Pfeffer 1998; Senior and 
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Bhopal 1994). There is very little, if any evidence to suggest that there are biological 
differences in susceptibility to infection with gonorrhoea or chlamydia between races 
(Fenton, Johnson et al. 1997).  
There are methodological concerns about using ethnicity in epidemiological research. 
What is the unit of measurement for ethnicity? Is it accurate and objective? The most 
objective approach is voluntary self report. The groups included in surveys may contain 
heterogeneous populations which may obscure significant differences within a group. 
Most attention has been given to diseases which impose a greater burden on a minority 
group. This may be misleading, since not all minority groups are at equal risk, some 
have a lower risk and some a higher risk than the general population. The “majority” 
group may also incorporate other disadvantaged groups e.g. the Irish in UK (Aral 
2002b) and may be too broad to be meaningful (Pfeffer 1998).  
Ethnicity can be an epidemiologically useful measure, but it must be used carefully 
(Aral 2002b; Bhopal 1997; Zenilman, Shahmanesh et al. 2001). Recommendations and 
actions taken as a result should be sensitive to social and cultural setting (Fenton, 
Johnson et al. 1997). Bhopal recommends that assumptions should be made fully 
explicit, the characteristics explored should be relevant to health, such as lifestyle, and 
differences observed should be used to generate testable causal hypotheses applicable to 
planning and delivery of healthcare (Bhopal 1997).  
In the study in South East London, Low et al distinguish specific ethnic groups and 
show that simply combining minority groups for convenience or to make statistically 
significant sample sizes is inadequate (Low, Daker-White et al. 1997). This may mask 
even greater differences in disease incidence or different causal factors for similar 
incidence of disease. The surveys of the population used voluntary self assessment 
(Low, Sterne et al. 2002). Despite the many demonstrations of ethnic differences in 
STIs, few attempts have been made to quantify the effects of mixing patterns, with 
mathematical models, parameterised by empirical data (Morris 1995). 
It is clear that many factors contribute to the variability in disease distribution across the 
total population, many of which are highly interrelated, making interpretation of 
observed data difficult. The effects of different indicators of risk may not simply add to 
increasing risk of disease; instead the risk to an individual or population is highly non-
linear as factors combine.  
Objectives 
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The objectives of the study described in this chapter are to define the extent to which 
sexual mixing patterns by ethnicity and rates of partner change affect gonorrhoea 
incidence, and to assess how preventive interventions might affect the endemic 
prevalence of disease. Empirical data were used from observational studies in South 
East London, which has a high proportion of black Caribbean and African residents and 
where gonorrhoea incidence is six to seven times higher than the national average (Low, 
Daker-White et al. 1997). This data was used, together with extensive investigation of 
model outputs under different parameter value combinations, to choose the most 
appropriate parameters for a simple deterministic model of gonorrhoea transmission in 
young people. 
In a modelling framework it is possible to vary individual parameters systematically and 
analyse the relative importance of different variables. After validating the mathematical 
model by comparing the outputs with observed incidence of disease, the impact of 
different intervention strategies in this simulated population are explored. 
Method 
Sources of data on sexual behaviour 
The data were obtained from a population-based cross-sectional survey of 16 to 25 year 
olds from three ethnic groups in the former Lambeth, Southwark and Lewisham Health 
Authority area in South East London. Here incidence of gonorrhoea is six to seven 
times higher than the national average (Low, Daker-White et al. 1997; Low, Sterne et 
al. 2001), as illustrated in Figure 3.1. These data were used to parameterise a simple 
deterministic model of gonorrhoea transmission to better define the extent to which 
observed mixing patterns by ethnicity might affect STI incidence and to assess how 
interventions focused on specific ethnic groups might affect the endemic prevalence of 
disease. The study area comprised the quintile of electoral wards with the highest 
gonorrhoea incidence, which formed a contiguous area in the west of the health 
authority (Low, Sterne et al. 2001). The survey was adapted from the National Survey 
of Sexual Attitudes and Lifestyles 2000 (Johnson, Mercer et al. 2001) and included 469 
participants (a response rate of 58%). 
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Mixing patterns 
Mixing by ethnicity 
Mixing matrices were constructed to show partner choice by ethnic group for 
heterosexual men and women from White, Black Caribbean and Black African ethnic 
groups. These are shown in Table 3.1 and were constructed from a question regarding 
the ethnicity of the last partner. Additional information could have been obtained about 
the variance in partner choice if additional information is used from details about the 
ethnicity of previous partners, but these questions were not fully completed. 
Mixing by activity and calculation of partner change rate 
Heterogeneity in rates of sexual partner change is crucial in determining the persistence 
of sexually transmitted diseases. As in the NATSAL survey, the distribution in 
behaviour was highly skewed, with most reporting few partners and a few reporting 
many partners (Johnson 1994; Low, Sterne et al. 2002). The behavioural data from 
South East London were used to calculate rates of partner change for each individual, 
illustrated in Figure 3.2. Table 3.2 shows summary measures of sexual activity for the 
study population. The variance in the average number of partners per year for Black 
Caribbean men and women was greater than for the other ethnic groups even though the 
median numbers of partners per year were similar. 
The study population was stratified by sexual activity to provide a basis for the activity 
of the theoretical model populations. There is no standard way in modelling to stratify 
the population according to risk behaviour. Therefore an objective, but arbitrary 
division was used, where each of the four groups contribute the same total number of 
partnerships (25%). The total number of partnerships formed per year across the whole 
population was calculated using the following formula: 
sex)first at  age-now (Age
partners lifetime ofnumber  Total
 
The total population was sorted by rates of partner change and assigned to an activity 
class accordingly. The highest activity class, 1, represented the lowest proportion of the 
population (4.6%) and the lowest activity class, 4, has the highest proportion (70.9%), 
with the intermediate classes (2 and 3) making up 8.7% and 15.8% of the population, 
respectively. These proportions were applied to each of 6 subgroups stratified by gender 
(male and female) and ethnic group (white, black Caribbean and black African). A 
group specific average rate of partner change was then calculated for each, giving a total 
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of 24 subgroups (2 genders x 3 ethnic groups x 4 activity levels) with differing rates of 
partner change (Table 3.3). 
In a closed population the numbers of partnerships formed by men and women must be 
equal. As has been found in many other studies (Johnson 1994; Wadsworth, Wellings et 
al. 1993), a discrepancy existed between the total number of partnerships reported by 
men and women, with men reporting approximately 1.5 times as many partners as 
women. A parameter (ν) was defined to control the extent that female rates of partner 
change are increased and male rates of partner change decreased so that the number of 
partnerships contributed by each sex balance. The outcome of balancing partnerships is 
complicated by this. In models of interacting populations, where partner numbers have 
to balance, the impact on adjusted contact matrices can be quite large, particularly in 
small populations. 
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Figure 3.1 Rates of gonorrhoea in South East London in different ethnic groups  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Low N, Sterne JAC, Barlow D. Inequalities in annual diagnoses of gonorrhoea 
and chlamydia between Black ethnic groups in South East London: Cross-sectional 
study. Sex Transm Inf 2001;77:15-20. Includes 934 episodes of gonorrhoea in 15-24 
year olds living anywhere in Lambeth, Southwark and Lewisham. 
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Table 3.1 Mixing matrix. Probabilities of sexual partner choice, by sex and 
ethnicity 
 
 
 
* Due to the small sample size of white men, there were no reported contacts with black 
women, which resulted in inconsistencies and an undefined probability of mixing 
between white men and black women, so a small probability was assigned to white 
males mixing with black females. 
 
 
Source: Improving Sexual Health Study, 16-25 year olds of Black Caribbean, Black 
African or White ethnicity living in 14 electoral wards with the highest gonorrhoea 
diagnoses in Lambeth, Southwark and Lewisham. Fieldwork by National Centre for 
Social Research, Jan 2000 to Jan 2001. 
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(1.2)1.0(1.0)0.7(2.6)1.3(1.7)1.2(3.7)1.4(5.9)2.2Partners per year, mean 
(variance)
(0-5)0.5(0-4)0.3(0-8.5)1(0-5)1.1(0-8.3)0.8(0-
12.5)
1.4Partners per year, median 
(range)
(30.4)4.9(11.4)2.2(47.0)4.7(38.0)5.3(104.4)5.3(151.8)10.1Lifetime partners, mean 
(variance)
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Figure 3.2 Rates of partner change calculated from reported data 
 
 
Source: Low N, Sterne JAC, Barlow D. Inequalities in diagnoses of gonorrhoea and 
chlamydia between Black ethnic groups in South East London: Cross-sectional study. 
Sex Transm Inf 2001;77:15-20. Includes 934 episodes of gonorrhoea in 15-24 year olds 
living anywhere in Lambeth, Southwark and Lewisham. 
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Table 3.3 Average rates of partner change per year of four activity classes 
calculated from sexual behaviour survey 
 
 
 
 
 
 
 
 
 
Notes: Rate of partner change calculated as the reported number of lifetime partners 
divided by the number of years since sexual debut. Those in their first year of sexual 
activity were assumed to have been sexually active for 6 months. 
Activity classes formed by splitting total number of partnerships formed into quartiles. 
% of population shows the proportion of population in each activity class.  
Due to the small sample size, a single individual (black African male) with very high 
rates of partner change (17.5 partners per year, compared with the next highest in his 
group of 8.5 partners per year) had a disproportionate effect on the diagnoses of 
infection predicted by the model. Recalculation of partner change rates excluding this 
individual generated incidence very close to those observed, so the rates excluding this 
individual were used in further analyses.  
 
Source: Low N, Sterne JAC, McKevitt C, Connell P. Investigating ethnic and 
geographic variations in sexual health in South East London. 463 heterosexual 16-25 
year olds of black Caribbean, black African or white ethnicity living in 14 electoral 
wards with the highest gonorrhoea diagnoses in the former Lambeth, Southwark and 
Lewisham Health Authority area. Fieldwork by National Centre for Social Research, 
Jan 2000 to Jan 2001. 
0.4 (0.4)0.2 (0.3)0.5 (0.5)0.6 (0.6)0.5 (0.6)1.0 (0.8)0.5 (0.5)70.94 (Low)
1.6 (0.4)1.3 (0.3)1.8 (0.4)2.2 (0.4)2.3 (0.4)3.8 (0.8)2.2 (0.4)15.83
2.8 (0.3)2.4 (0.5)3.4 (0.8)3.1 (0.1)4.5 (0.8)6.7 (0.9)3.9 (0.8)8.72
4.0 (1.4)3.6 (0.3)6.6 (1.2)5.0 (-)7.3 (1.2)9.9 (1.8)7.5 (1.7)4.61 (High)
WhiteBlack 
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WhiteBlack 
African
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Caribbean
Index FemaleIndex MaleMean 
rate of 
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change 
(sd)
% of
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Activity 
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Gonorrhoea diagnoses 
Data from previously published studies (Low, Daker-White et al. 1997; Low, Sterne et 
al. 2001) were used to calculate the rate of gonorrhoea in the study area for the age 
group 16 to 25 years in each ethnic group. Census data was used to estimate the 
population size. Figure 3.1 illustrates the diagnoses of gonorrhoea reported in South 
East London in 1997. 
Estimation of model parameters 
The estimation of the remaining parameters was largely informed by previous work on 
the transmission of gonorrhoea by Garnett et al in Newark New Jersey (Table 3.4) 
(Garnett, Mertz et al. 1999). The duration of infection was varied between 2 weeks and 
6 months for men and 1 month and 12 months women. Recovery rates were assumed to 
be identical for each ethnic group, as there is no evidence to suggest any biological 
differences. In practice, however there may be differences in treatment seeking 
behaviour and access to care. 
It is widely agreed that transmission of gonococci is less efficient from female to male, 
than vice versa, but the exact probabilities are not well established (Garnett, Mertz et al. 
1999). The transmission probability per sexual partnership was varied between 0.4 and 
0.6 for transmission from males to females and between 0.3 and 0.5 for transmission 
from females to males (Garnett, Mertz et al. 1999; Hook and Handsfield 1999). The 
exact values used for transmission and duration will affect the absolute magnitude of the 
epidemic but, since they are identical for the different ethnicities, the relative 
distribution of disease by ethnicity will not be altered.  
The rate of entry and exit into the population was determined by the average length of 
time that individuals remain in the model population, i.e. 10 years (from 15-24 years), 
giving an entry/exit rate to/from the sexually active population of 0.1 per year. 
Mathematical model 
Deterministic models must explicitly describe the probability of forming partnerships 
between groups and must balance partnership formation exactly. Network models deal 
implicitly with the problem of balancing partnerships, but the need to use algorithms to 
sensibly describe partner choice remains. 
A simple deterministic model of gonorrhoea was developed, based on previous work 
(Anderson and May 1991; Garnett, Mertz et al. 1999; Hethcote and Yorke 1984; Turner 
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and Garnett 2002). The model represents an exclusively heterosexual population aged 
16 to 25 years stratified according to gender, sexual activity (based on rate of partner 
change) and ethnicity. The model population was closed, assuming that all sexual 
contacts were chosen from within the specified age class and the study area where the 
survey was conducted. The mathematical equations describing the model are given 
below, along with further definitions of the parameters. 
Mixing matrices were used to describe the distribution of contacts of individuals of a 
particular activity class and ethnic group with individuals of the opposite sex according 
to ethnic groups and activity classes. An alternative method of describing the mixing 
pattern uses a single parameter to define the probabilities for each element of the mixing 
matrix, with reference to that predicted by random mixing. This parameter can vary the 
pattern of mixing from random to assortative. 
A quantitative measure of the pattern of mixing according to sexual activity group (ε2) 
was defined. This measure can be varied from random mixing (ε2 = 1), in which activity 
classes form partnerships at random based on numbers of partnerships supplied by the 
group, to assortative (ε2 = 0), in which individuals in a particular activity class only mix 
with individuals from the corresponding class of the opposite sex (although the partner 
may be of a different ethnicity). The value of this parameter has a significant effect on 
the epidemiology of gonorrhoea in the model. A range of values was used to assess the 
robustness of the results to the assumptions made. 
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Table 3.4 Parameter definitions used in model 
 
Parameter Definition Range of values used 
µ Entry rate. 
To maintain a constant population 
size, the entry and exit rates are 
assumed to be equal. 
0.1 per year (average length of 
stay in model population 10 
years) 
βk Transmission probability of 
infection to sex k 
Best fit 0.4 (female to male) 
Best fit 0.6 (male to female) 
δk, Recovery rate from infection Best fit for male and female 2 
months duration (recovery rate, 
6 per year) 
ρklmst Mixing matrix, element klmst is 
probability that, individual of sex k 
in activity class l, ethnicity s, when 
they form a partnership, it will be 
with a member of activity class m 
and ethnicity t, of the opposite sex, 
k’. 
See below 
ckls Partnership formation rate of 
individual of sex k, activity class l, 
ethnicity s (see below) 
See below 
Calculated from Table 3.3 
ε1, ε2 Pattern of mixing: ε1 by ethnicity; 
ε2 by activity. (0=fully assortative, 
1= random) 
Mixing according to activity 
varied from 0≤ ε2 ≤1 
Ethnicity mixing defined 
explicitly from reported 
behaviour – choice of last 
partner 
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Model details 
A deterministic, compartmental model of a bacterial STI, in a population stratified by 
sex, activity class (4) and ethnicity (3) was used.  
Subscripts k, l and s refer to sex, activity class and ethnicity, respectively. In the case of 
sex, k=0 for men, k=1 for women while k' refers to the opposite sex to k and for activity 
l defines the class (from 1 to 4), according to average rate of partner change per year, 
ckls. Ethnicity s defines the group (1 to 3) that an individual falls into. The letters m and t 
define the activity class and ethnicity, respectively of an individual of the opposite sex 
(k’) with whom a partnership is formed. The subscripts stratify the state variables, 
which are as follows: 
Xkls - population of susceptibles of sex k, activity class l and ethnicity s 
Ykls- population of hosts infected of sex k, activity class l and ethnicity s. 
The ordinary differential equations which define the model are: 
klsklskklsklsklskls XYXNX µδλµ −+−=
•
      1. 
klsklskklsklskls YYXY µδλ −−=
•
        2. 
The force of infection, λkls, the group specific incidence per susceptible, can be 
calculated from the transmission probability, βk; contact rate, ckls; the proportion of 
infected individuals and the mixing pattern klmstρ as follows: 
∑∑
==






=
4
1 '
'
3
1 m mtk
mtk
klmst
t
kklskls N
Y
c ρβλ        3. 
Other parameters used in the model are defined in Table 3.4. 
The average rate of partner change for each group is determined by the reported sexual 
activity levels obtained from the sexual behaviour survey (Table 3.3). 
The mixing matrix P has to take account of both ethnicity and activity, which 
complicates the calculation. ρklmst is an element of P, which defines the probability that, 
when an individual of sex k in activity class l and ethnic group s, forms a partnership, it 
will be with a member of activity class m, ethnicity t of the opposite sex, k’. The values 
of ρklmst depend on the overall pattern of mixing and can vary from fully assortative, to 
proportionate for both ethnicity (ε1) and activity (ε2). 
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The following equations describe the elements of the mixing matrix in this model in the 
absence of external information: 
   4. 
Where δst and δlm are identity matrices, such that  δij = 1 when i=j and δij =0 when i≠j. 
ε1 is the degree of assortativity by ethnicity and ε2 is the degree of assortativity by 
activity class (for fully assortative mixing, ε1 = 0; for random mixing, ε1 = 1). 
If any of the mixing patterns are known or can be estimated from data, the equations 
above can be simplified accordingly. A mixing matrix Mkls, was estimated from the 
behavioural data (NCSR 2001),
 
which defines the probability that a person of sex k, 
ethnicity s will choose a partner of ethnicity t. This was then input directly into the 
equation to calculate the overall mixing matrix:  
      5. 
Model constraints: Balancing the numbers of sexual partnerships in the model 
population 
In common with other behavioural surveys, the numbers of partnerships reported by 
heterosexual men exceeds that reported by women in South East London (by about 1.5 
times) (see Table 3.2). In a mathematical model of a closed population, it is necessary 
that the number of partnerships formed by sex k exactly match those of the other sex. 
Various constraints apply to ensure that the total number of partnerships between males 
and females in this closed population balance (Garnett and Anderson 1993b). There are 
various methods for balancing partnerships, as described elsewhere (Garnett and 
Anderson 1994a; Uche and Anderson 1996). For this fairly straightforward case, where 
there is no disease-induced mortality and the population falls within one age group 
(hence no significant sex difference in the average age of partner), several conditions 
are imposed by the model formulation to ensure that the numbers of partnerships 
formed by men and women in reciprocal groups are equal. Parameters are explicitly 
defined for both sexes, which enables the calculation of both of the mixing matrices. 
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The total numbers of partnership formed by one sex must equal those formed by the 
other, i.e. 
mtkmtkmltskklsklsklmst NcNc '''ρρ =         6. 
However, this may not hold true when empirical data are used to estimate the matrices. 
Therefore the discrepancy between the reported number of partnerships reported by men 
and women is calculated.  
The term for this discrepancy, Blmst is defined as: 
kltkltklmst
mtkmtkmltsk
lmst Nc
NcB
ρ
ρ
'''
=         7. 
(If the numbers of partnerships balanced, each element of B would equal unity.)  
A parameter ν is defined, which determines how each sex varies its activity levels to 
balance the total number of partnerships. If ν=0, sex k doesn’t change and k’ is forced 
to change activity levels and vice versa if ν=1. For ν=0.5, both sexes adjust equally. 
This then allows the adjusted contact rates for each sex to be calculated, such that the 
adjusted contact rate, cklmst is: 
v
lmstklsklmst Bcc =*          8. 
and for the opposite sex, k’: 
)1(
''
*
v
lmstmtkmltsk Bcc
−−
=          9. 
These adjusted values are then used in the model to define the contact rates for each sex 
which are used to determine the force of infection.  
This process was done twice, with male and then female reported behaviour used as the 
denominator in Equation 7. Since the size of the population and reported rate of partner 
change were different by gender and the balancing uses exponents rather than linear 
change, the adjusted contact rate matrices are slightly different. 
The model was developed to allow the introduction of various treatment or intervention 
strategies during the simulation. These could be targeted at specific groups or cover the 
whole population. For an intervention to have an effect on incidence of infection it must 
act to reduce the actual or effective reproductive number of infection by decreasing the 
transmission probability, β (e.g. using condoms), decreasing the contact rate, c, (e.g. 
changing sexual behaviour), or decreasing the duration D, of infection (e.g. screening 
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programmes, treatment of infection or contact tracing). Initially the impacts of 
interventions such as improved access to care, recognition of symptoms or risk 
behaviours, and screening, all of which decrease the duration of infection were 
investigated. The impacts of these interventions were investigated, both for a 
population-wide approach and high-risk approach, targeted to Black Caribbean males, 
females or both. An assumption was made that the interventions resulted in a decreased 
duration of infection of 40% in those targeted and that coverage of 25% of the target 
population was achieved. 
Fitting the model 
Τhe output from the model was compared with the observed incidence data, to obtain 
best fit estimates for these three parameters. Maximum likelihood analysis was used to 
quantify the fit of the model output to data and determine 95% confidence intervals. 
Incidence is binomially distributed (individuals either get infected or not during the 
year). The equation for the likelihood (Edwards 1972) is:  
( ) xnx pp
x
n
L −−





= 1           10. 
which gives a log likelihood of: 
)1ln()(lnlnln pxnpx
x
n
L −−++











=       11. 
where n is the population, x is the number of cases observed per year and p is the model 
probability of infection per year (incidence). 
A multivariate analysis was conducted by a systematic search of the parameter space to 
examine the effects of the parameter values on the model fit (the maximum likelihood 
was assessed by minimising: (-2)*ln L) . The following variables were varied whilst 
holding the other variables constant: transmission probability (from 0.4 to 0.6 for male 
to female transmission and from 0.3 to 0.5 for female to male transmission (Hook and 
Handsfield 1999) ), duration of infectiousness (one to 10 months for men and two to 12 
months for women (Garnett, Mertz et al. 1999; Hook and Handsfield 1999) ). 
For several parameters there were no estimates which could be made, either from the 
data or from published literature. The pattern of mixing by activity class (ε2), the degree 
to which males and females change rate of partner change to accommodate the reported 
behaviour of the opposite sex (ν) and the proportion of female cases of gonorrhoea not 
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reported (α) were all unknown. It is believed that, due to the high frequency of 
asymptomatic infection in females, that many cases remain unreported. Estimating the 
extent of this underreporting is therefore of interest. It is assumed that male cases are a 
more accurate reflection of incidence, therefore diagnoses of males are used to fit model 
incidence to. The values of ε2, ν and α were varied systematically. The pattern of 
mixing by activity group, ε2 was varied from 0 to 1, in steps of 0.1, from random to 
assortative. Balancing partnerships, ν  was varied from 0 to 1, in steps of 0.1, from 
assuming male reporting is accurate and increasing female partner change rates to 
balance, to the reciprocal situation. Finally the proportion of female cases which are 
reported α, was varied from 100% to 50%, in steps of 10%, assuming 100% reporting to 
50% reporting of female cases. 
Table 3.5 summarises the parameter combinations examined. A total of just over 1 
million parameter combinations were examined. The best fitting model provided the 
most likely values of these parameters, although there is a high degree of covariance in 
the combinations which gave fits close to the best fit due to the effect on prevalence and 
incidence. For example when the balancing parameter changes the average contact rate 
changes (when the male reported contact rate is favoured the average rate of partner 
change increases) and hence the incidence changes correspondingly. Similarly, the 
mixing pattern affected the incidence and prevalence. These effects meant that as one 
parameter changes towards increasing incidence, the best fit occurs when another 
favours a reduction in incidence. 
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Table 3.5 Parameter combinations tested for maximum likelihood analysis 
Parameter Values  
(displayed in order from 
lowest R0 to highest) 
Best fit 
Duration in men (δ) 0.5, 1, 2, 3, 4, 6 months 2 months 
Duration in women (δ) 1, 2, 4, 6, 8, 12 months 2 months 
Transmission from men to 
women (β) 
0.4, 0.45, 0.5, 0.55, 0.6 0.6 
Transmission from women to 
men (β) 
0.3 0.35, 0.4, 0.45, 0.5 0.4 
Mixing by activity (ε2) 0.001, 0.1, 0.2, 0.3….0.9, 1.0 0.2 
Balancing partnerships 
(starting from matching to 
male reporting behaviour, 
ν=0, male denominator in 
Equation 7) 
Balancing partnerships 
(starting from matching to 
male reporting behaviour, 
ν=1, female denominator in 
Equation 7) 
0, 0.1, 0.2…..0.9, 1.0 
 
 
 
 
1.0, 0.9……...0.1, 0.0 
0.2 
Underreporting of female 
cases (α) 
50%, 40%, 30%, 20%, 10%, 
0% 
20% 
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Results 
The model predictions were compared with observed diagnoses of gonorrhoea in the 
population of 15-24 year olds in South East London (Low, Daker-White et al. 1997; 
Low, Sterne et al. 2001). Model outcomes were qualitatively very similar to each other, 
with higher incidence in Black Caribbean and lower incidence in White and Black 
African groups. This result was robust across a wide range of parameters. The best fit 
scenario is illustrated by sex and ethnic group in Figure 3.3, together with the observed 
incidence of gonorrhoea in the study population and 95% confidence intervals, 
calculated as points. The left-hand column (of each set) shows the observed diagnoses 
of gonorrhoea and the right-hand column shows the model output for the best fitting set 
of parameters. The incidence predicted by the model for White and Black African 
groups were higher than those observed.  
Also in the best fitting scenario, mixing by activity class was assortative and balancing 
sexual partnerships was intermediate between male and female reported behaviour. The 
overall best fit was obtained when partnerships were adjusted with a bias towards male 
reported behaviour, when mixing was close to assortative and when 80% of female 
cases of gonorrhoea are reported. The parameter combination which gave the minimum 
likelihood was used to investigate the outcome of intervention strategies. 
Figure 3.4 shows the likelihood profiles for each parameter (where the lower values 
indicate a better fit), with the likelihood for each value of the parameter in question 
minimised across all other parameters (including using male or female as the 
denominator in equation 7). The method for balancing partners can give slightly 
different results when males or females are taken as the denominator (see Equation 7) 
and the discrepancy in behaviour calculated. This is because there are slightly different 
proportions of men and women in the different ethnic groups, who report different 
numbers of partners. Both alternatives were investigated to test for equivalence in the 
method of balancing partners. The horizontal line on each graph indicates points within 
the 95% confidence interval (assuming a χ2 distribution with 1 degree of freedom). 
The scenarios which gave the best fit to model data also produced model prevalence 
close to the limit of persistence, which fits with previous estimates of the R0 of 
gonorrhoea as being close to 1 and only above 1 in high activity groups (Brunham, 
Nagelkerke et al. 1994; Hethcote and Yorke 1984). There is also covariance of the 
parameters controlling the mixing by activity and how partnerships are balanced, shown 
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diagrammatically in Figure 3.5. As balancing sexual partnerships tends towards male 
reporting, the average contact rate of the population increases and consequently the 
prevalence of infection increases. As mixing by activity becomes more random, 
partnership formation has to be biased towards that reported by males to produce 
incidence closest to that observed. These two measures are closely correlated. 
Depending on the values of the other parameters chosen which control R0, i.e. duration 
of infection and transmission probability, the combination of mixing and balancing 
varies and the prevalence corresponding to the best fit incidence also varies.  
“Differential homophily”, i.e. the degree of preference for partners similar to oneself, is 
shown by both sexes of different ethnic groups in the study population. Table 3.6 shows 
the degree of differential homophily, i.e. the ratio between the numbers of reported 
partners of different ethnic groups and the expected partnerships if mixing was both 
proportional to numbers of partnerships contributed by each group. Black Caribbean 
and Black African women were more likely to form partnerships with those of the same 
ethnic group than their male counterparts. For white women, the pattern was closer to 
random mixing than for white men. 
Impact of intervention 
Having established that the model produces results consistent with the observed data, 
the impact of different intervention strategies was investigated. The total prevalence of 
disease predicted by the models is close to the limit of persistence, i.e. the reproductive 
number is close to unity. The parameters obtained from the sensitivity analysis as 
providing the closest fit were used for modelling interventions. Each strategy was 
assumed to achieve 25% coverage in the target population, and cause a decrease of 40% 
in the duration of infection. The results are illustrated in Figure 3.6.  
Unsurprisingly, the strategies that affect the whole population have the greatest impact 
on incidence. Implementing screening, thus reducing duration of infection, caused a 
reduction of 45% in annual incidence a year after the intervention is introduced. 
However, reaching the entire population is expensive, inefficient and difficult. By 
targeting the population at highest risk however i.e. Black Caribbeans (about 20% of the 
total population in this community), the total incidence can still be reduced by 35%. 
Even if only one sex is targeted, significant reductions in incidence can be achieved, e.g. 
decreasing the duration of infection in females reduces the overall incidence by 20%. 
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To evaluate the relative impact of the different interventions simulated, the number of 
individuals needed to treat (intervene in) in order to prevent one case of gonorrhoea was 
calculated for the different scenarios; interventions in the whole population or targeted 
interventions in the highest risk groups. The number needed to treat is shown in Figure 
3.7. Screening the whole population is much less effective than targeting the group (i.e. 
Black women) most at risk. 
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Figure 3.3 Model predictions compared with observed diagnoses of gonorrhoea 
 
 
Notes: Model output with the best fit to the observed data, using maximum likelihood 
methods. Estimated parameter values: transmission probability higher from male to 
female (0.6)  than from female to male (0.4), duration of infection 2 months in males 
and females, 20% underreporting in females, close to assortative mixing (by activity) (ε2 
=0.2) and partnerships balanced towards those reported by men (v=0.2). 
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Figure 3.4 Likelihood profilese from maximum likelihood analysis for unknown 
parameters 
Panel a) mixing by level of sexual activity: varies from ε2=0, assortative to ε2 =1, 
random. Panel b) balance between number of sexual partners per year reported by 
men and women: varies from v=0, male rate remains unchanged to v=1, male rate 
changes to balance that of women. Panel c) degree of underreporting of female cases: 
varies from 0%, all female cases reported to 50%, half of female cases not reported.  
The dotted line is the best fit maximum likelihood value + 3.814. Points below the 
line are statistically equivalent fits to the data, points above the line are worse, 
compared with the best fit value. Where no data point is shown, the maximum 
likelihood is too high to be shown on the y axis. 
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Figure 3.5 Model outputs which fit the observed data best are close to the limit 
of persistence 
 
The effect of shifting the balance of partnerships formation rates towards that reported 
by men effectively increases the average rate of contact in the population and thus 
increases the R0. Under assortative patterns of mixing the overall level of infection may 
be low, but a few people bear the brunt of disease.  
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Table 3.6 Differential homophily shown by both sexes and different ethnicities 
 
 
Male respondent Female respondent  
Partner 
ethnicity 
Black 
Caribbean 
Black 
African 
White Black 
Caribbean 
Black 
African 
White 
Black 
Caribbean 
0.63 0.34 0.0 (0.01)* 0.77 0.42 0.17 
Black African 0.06 0.43 0.0 (0.01)* 0.13 0.56 0.07 
White 0.31 0.23 1.00 (0.98)* 0.10 0.02 0.76 
 
 
* Figures for white men used the same estimated values for the distribution of 
partnerships as in Table 3.1. 
 
Notes: Table shows the ratio between the number of reported partnerships and the 
number expected if mixing was proportional to reported numbers of partnerships 
contributed by each group. For like with like mixing (along the diagonals), the higher 
the value, the greater the degree of homophily. 
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Figure 3.6 Impact of different treatment strategies on the epidemiology of 
disease 
Percentage of population in each ethnic group for each sex (Male; White (70.86), Black 
Caribbean (18.59), Black African (10.55): Female; White (69.85), Black Caribbean 
(19.73), Black African (10.42)) 
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Figure 3.7 The relative impact of interventions on the incidence of disease in the 
population  
 
 
 
 
 
 
Number of people needed to receive intervention to prevent one infection, assuming 
decrease in duration of infection by 40% and coverage of 25% in the population 
targeted. 
 
Percentage of population in each ethnic group for each sex (Male; White (70.86), Black 
Caribbean (18.59), Black African (10.55): Female; White (69.85), Black Caribbean 
(19.73), Black African (10.42)) 
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Discussion 
In this chapter previously published models of gonorrhoea transmission dynamics have 
been further developed to explore the details of a particular dataset. The focus of the 
study was ethnic disparities in gonorrhoea incidence and the results derived from the 
model show how such disparities can arise from small differences due to the feedback 
inherent in the system. Empirical data from South East London, where sexual behaviour 
and disease incidence was well described, was used to parameterise the model as far as 
possible. This, coupled with extensive analysis of the effect of varying different 
parameters provided insight into the reasons for the observed disparities in disease 
incidence in this population. 
The outcomes from the mathematical model are consistent with the observed data across 
a range of parameters. A large proportion of the ethnic difference in diagnoses of 
gonorrhoea in this South London population could be accounted for using a limited 
number of simple parameters. By using a mathematical model of the dynamics of 
gonorrhoea transmission it was possible to incorporate the effects of sexual mixing and 
illustrate their role in contributing to ethnic disparities in diagnoses of infection.  
The model illustrates how small differences in behaviour i.e. the variance in activity or 
in attending clinics can become magnified by the feedback found within an infection 
transmission system. More data are needed on the patterns of mixing by activity and 
how this relates to other mixing patterns, such as age or ethnicity. Differences in 
recovery rate or transmission probability, for example, due to poor access to healthcare 
or behavioural differences, are often postulated to explain differences in disease burden. 
In the model including these largely unquantified effects would exacerbate the 
differences in disease burden and strengthen the effects of targeted therapy, whilst 
obscuring the effects of sexual behaviour and partner choice in determining disease 
epidemiology. Socioeconomic factors may influence the incidence of STIs through 
behaviour, but standard statistical techniques will not identify the influence of this 
behaviour. The model can be used to explore interactive effects which might otherwise 
stay hidden. The consistency of the model predictions with the observed data, suggests 
that additional differences may be less obvious than might be expected.  
In all scenarios the prevalence corresponding to the best fit is close to the limit of 
persistence. This suggests that the R0 of gonorrhoea is close to 1. In the best fitting 
scenario in terms of duration and transmissibility, the values taken by mixing by activity 
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and balancing partnerships are towards the extremes of assortativity and match reported 
male behaviour. The overall prevalence of disease is determined by the reproductive 
number of the organism, which in turn depends upon the mixing patterns of the 
population. When different values for the mixing between activity classes (ε2) are used, 
the distribution of infection within the different activity classes will be altered. If the 
parameter estimates are reasonable, the model suggests that the disease is close to not 
persisting. The best fitting model is in a sensitive region of the parameter space, 
therefore slight changes in parameters which determine the reproductive number (R0) of 
the infection can have a substantial impact. A low R0 means that, in a deterministic 
scenario, the model is sensitive to small changes in parameter values. Therefore whilst 
the results are robust across a range of parameters, additional analysis is necessary to 
determine whether the parameters chosen are close to those which actually occur in the 
study population. 
The investigation of the relative impact of different potential interventions to reduce the 
levels of gonorrhoea showed that interventions targeted at the group at highest risk, i.e. 
Black Caribbeans would be nearly three times as effective as those implemented in the 
whole population (Figure 3.7). This is due to the dynamic feedback effects which help 
to maintain an STI in a population. Targeted interventions can have large effects both 
within the target group and in the overall population. Inequities in access to healthcare 
can be evened out, as well as the whole population benefiting from the intervention 
directly or indirectly. To ignore the differences in disease burden on the grounds of 
political correctness is to do disservice to those populations most at risk. Community-
based action which empowers minority groups in matters of their health is urgently 
needed (Fenton 2001; Hughes, Brady et al. 2001; Low and FitzGerald 1998). 
Two factors were crucial in determining the distribution of disease within the 
population: heterogeneity in the rate of partner change (which was greater in Black 
Caribbeans than in other groups) and partner choice (which was dependent on the 
choices of the whole population). Overall prevalence is determined by variety of factors 
which influence the reproductive number. When the average contact rate among the 
whole population is quite low, as seems to be the case for this population, it acts as a 
limiting factor on the persistence of disease and the prevalence is determined by the 
degree of mixing between activity groups (if all other factors are kept constant). 
Average behaviours do not explain the distribution of gonorrhoea in this highly 
heterogeneous population. Instead, the behaviour of a few individuals within a minority 
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population, combined with the pattern of partner choice by the whole population, had a 
disproportionate effect on the overall burden of disease experienced by that group.  
The model used was an approximation of the interactions of the whole population. For 
simplicity a closed population was assumed. The reality is more complex. External 
partnerships are possible, e.g. between young women and older men or partnerships 
outside the geographic region. Ignoring age mixing would overestimate the prevalence 
of gonorrhoea in young men compared to young women. Disease incidence in girls 
occurs primarily within this age group, but for men the distribution of disease is more 
evenly spread up to older ages. Intervention programmes should take account of this and 
may need to involve older men as well. However, the sexual behaviour survey showed 
that only 15% of women had older male partners so the effect of this on predicted 
incidence would be small. There were no data from which to estimate the rate of 
partnership formation with individuals outside the geographic region. Studies from 
Baltimore however, show that the average linear distance between the residences of 
non-cohabiting sexual partners was only 100m (Becker, Glass et al. 1998). 
The sample sizes for some of the behavioural data, especially for white men and women 
were small. In future work it would be important to include other sources of behavioural 
data. The ethnicity of the last partner alone was used to determine the mixing matrix in 
the model, possibly increasing the likelihood of choosing a regular/long-term partner in 
the same ethnic group and thereby biasing the matrix used towards assortativity.  
Incidence figures in the cross-sectional surveys were based on attendance at sexually 
transmitted diseases clinics. Differences in healthcare facility use by different ethnic 
groups might influence the distribution of disease observed. For simplicity, no measure 
of concurrent sexual partnerships was included in the model, although this has been 
shown to be important in theoretical studies (Morris and Kretzschmar 1997). The survey 
data suggested that concurrency was more common in the Black Caribbean population, 
which would further exacerbate the ethnic disparity seen in this population.  
The pattern of mixing between individuals in different activity classes also varies 
according to ethnicity (Aral, Hughes et al. 1999; Laumann and Youm 1999). In the 
general population in the United States of America, African Americans with low risk 
sexual behaviour have been shown to be more likely than whites to have partners with 
high risk behaviour (Laumann and Youm 1999). In studies in Seattle amongst 
individuals with gonorrhoea, the direct links between high and low prevalence groups 
were most common between African American men and low prevalence women (Aral, 
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Hughes et al. 1999). In mixing matrices obtained from the model some evidence was 
found to support this hypothesis, with the probability of women in the lowest activity 
group having a male partner from the highest activity group being slightly higher for 
black Caribbean than white women. However the possibility of large differences by 
ethnicity in the probability of forming partnerships with other activity classes was not 
explored explicitly.  
The best fit to the observed data occurred when sexual mixing between activity classes 
was assortative, but this was sensitive to assumptions about the average rate of partner 
change. Modelling studies in sexually transmitted diseases clinic attenders as well as the 
USA general population study by Laumann (Laumann, Gagnon et al. 1994) and these 
have found near random or weakly assortative mixing (Garnett, Hughes et al. 1996; 
Garnett, Mertz et al. 1999). This may be as a result of biases in reporting, under 
representing high risk behaviours in those infected. Alternatively stochastic effects may 
be important in restricting contacts with the core group, for example due to spatial 
segregation. Thus, in the model presented here, assortative mixing may be required to 
restrict the spread of gonorrhoea, whereas in a stochastic network simulation mixing 
which is less assortative might provide a better fit.  
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Chapter 4  Epidemiology of reinfection with gonorrhoea 
Summary 
In this chapter the importance of reinfection to the epidemiology of bacterial sexually 
transmitted infections is investigated. Both chlamydia and gonorrhoea often occur 
repeatedly in the same individual. This has implications for the health of the patient, 
since reinfection is associated with an increased risk of future complications. 
Reinfection also impacts on the wider epidemiology of infection, because the 
prevalence at which infection saturates in a high risk groups is increased compared to 
the case when reinfection is not possible and troughs in incidence which could lead to 
fade out of infection are minimised. 
Using data collected in London, the frequency of reinfection is calculated. A 
mathematical model of reinfection is developed to compare with the observed data and 
obtain insights into the natural history of reinfection. Usually, reinfection occurs a short 
time after initial infection, but does sometimes occur many years afterwards. A few 
individuals were diagnosed multiple times within the five year timeframe of the data 
collection. 
This study aims to use mathematical models, together with observed rates of reinfection, 
to analyse the effect of different network structures as described by mixing patterns on 
rates of reinfection. 
Two mathematical models of gonococcal reinfection were developed. An analysis of the 
effect of varying the degree of assortative mixing (i.e. like with like) on the rate of 
reinfection was carried out to determine whether this difficult to measure parameter can 
be estimated using other epidemiological characteristics of the disease, in this case the 
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Introduction 
Patients diagnosed with bacterial STIs, especially gonorrhoea and chlamydia, are often 
infected multiple times. Patients with gonorrhoea or chlamydia may re-attend a clinic 
with the same diagnosis due to transmission from an untreated partner (either existing or 
new) or treatment failure, due to resistant infection or relapse. In this chapter reinfection 
is considered a repeat infection acquired from another person, as illustrated in Figure 
4.1. Infection due to treatment failure, persistent or resistant infection will be termed 
relapse. 
A proportion of cases of STIs occur in those who have previously had an STI and these 
may make up a significant fraction of the case load of a GUM clinic. Reinfections with 
chlamydia and gonorrhoea represent approximately one third of cases of these 
infections diagnosed at GUM clinics in the UK (HPA 2003a). In the USA in 2000, 47% 
of patients with gonorrhoea reported a history of infection (CDC 2002b). The risk of 
suffering long term effects of infection, such as PID and infertility, increases with the 
number of reinfections (Hughes, Brady et al. 2001). An interesting approach was taken 
by Fortenberry et al who considered all STIs and found that over 40% of adolescent 
women at an STD clinic reattended within a year with the same or a different infection 
(Fortenberry, Brizendine et al. 1999). 
Multiple diagnoses can be used to identify those at risk of complications in the future. 
Patients who are infected repeatedly are likely those participating in current high risk 
behaviour and are potentially members of the “core group” (Hughes, Brady et al. 2001). 
Identifying individuals with repeat infections provides a point of contact for 
interventions and a group likely to obtain the most benefit from prevention efforts. 
Finally, reinfection is a biologically meaningful measure of the impact of control 
strategies. As such, reinfection is an endpoint which can be used to quantify and test the 
relative success of different arms of randomised controlled trials (Golden, Whittington 
et al. 2001; Schillinger, Kissinger et al. 2003). Those infected once tend to be 
reinfected, so their incidence is higher than others. They can therefore provide a smaller 
sample size for trials than a random selection of the population. Alternatively, a trial 
may be specifically designed to prevent reinfection itself. If more general interventions 
reduce the overall incidence then infections may become more concentrated in the core, 
and reinfections may become relatively more common, whilst decreasing in absolute 
numbers.  
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Figure 4.1 Mechanisms of reinfection 
A - Reinfection from existing, untreated partner. 
B – Reinfection from a new, infected partner. 
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Rates of reinfection with gonorrhoea and chlamydia 
Studies of rates of reinfection are difficult to compare since many are conducted over 
different time periods, with different study populations. However it is clear that 
reinfection is common and constitutes a significant fraction of cases of STIs. In the UK, 
of those attending STI clinics, approximately one third of those diagnosed with 
gonorrhoea had a previous gonorrhoea diagnosis (HPA 2003a).  
In the US and UK, projects to survey gonorrhoea isolates (GISP and GRASP, 
respectively) are underway, which are primarily used to track trends in antimicrobial 
resistance, but also collect other valuable data, including past history of infection (CDC 
2000a; Paine, Fenton et al. 2001). In the US, GISP 2001 reported that approximately 
48% (Range: 45% - 50%) of participants (who are comprised of the first 25 men with 
urethral gonorrhoea reporting to STD clinics in 26 cities each month) had ever 
previously had gonorrhoea. Approximately 20% of these (Range: 17.2% - 23.6%) had a 
diagnosis within the previous 12 months (CDC 2002b). These proportions were quite 
stable from 1991 – 2001. The GRASP survey in the UK 2002 (which collects 
consecutive isolates from sentinel surveillance sites in the UK from both men and 
women) showed somewhat lower proportions ever infected, with 27% of patients 
reporting a previous gonorrhoea diagnosis in 2002. Women were least likely to report a 
history of gonorrhoea (22%), followed by heterosexual men (27%) with homosexual 
men the most likely to have a history of infection (36%) (GRASP 2002). 
Various different study designs have been used to examine the likelihood of reinfection 
following treatment for chlamydia. Retrospective or prospective cohort studies analyse 
historical data and identify repeat infections or reported history. For example Hughes et 
al conducted a retrospective cohort study and showed that 14% of patients with an acute 
STI attended again within a year. (Hughes, Brady et al. 2001). Prospective studies enrol 
a cohort and can arrange testing at intervals after initial treatment and may identify a 
higher proportion of asymptomatic infections especially in females. For example, 
Whittington et al followed young women treated for chlamydia, and tested one and four 
months after the initial diagnosis. Overall they found 13% were infected by the second 
test (Whittington, Kent et al. 2001). A passive prospective study would identify 
symptomatic reinfections when they attend again. 
These different approaches have different strengths and weaknesses. Retrospective 
studies can investigate large datasets, but are restricted with respect to the questions that 
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can be addressed. Cohort studies are time-consuming and expensive, and therefore 
usually only involve small numbers of people. They are sometimes able to quantify the 
time to reinfection, but more commonly are able to determine a time interval for 
reinfection to have occurred. Cohort studies can assess the probability of reinfection 
more accurately by retesting a known cohort at specific time intervals. Clinic based 
calculations of reinfection may underestimate rates of reinfection if patients do not 
return to the same clinic for subsequent diagnoses. Only 36% of women with repeat 
chlamydia diagnoses in a US study were diagnosed in the same health care setting and 
only half of those were diagnosed in the same type of clinic (Xu, Schillinger et al. 
2000a). In the same study young girls were the least consistent in their clinic use (Xu, 
Schillinger et al. 2000b). Conversely, in prospective studies of reinfection, compliance 
may be biased by those with symptomatic reinfections or known risk behaviour who 
may be more likely to attend follow-up appointments, compared with those without 
symptoms and who don’t perceive themselves to be at risk, leading to overestimates of 
the rate of reinfection. In the prospective cohort study of chlamydia reinfection by 
Whittington et al, less than 70% of those enrolled attended at least one follow-up 
appointment. (Whittington, Kent et al. 2001)  
As well as the proportion of people who are likely to get reinfected at some stage, it is 
also important to know the timing of reinfection events and their distribution. Burstein 
and colleagues followed 3000 inner city adolescents treated in a variety of clinic 
settings for an average of 33 months. For those initially infected, the median time to 
reinfection was 6 months and slightly longer (7 months) for those initially tested 
negative for chlamydia (Burstein, Zenilman et al. 2001). 
Risk factors for reinfection 
Several studies have identified risk factors for reinfection with gonorrhoea or 
chlamydia. For gonorrhoea, Hughes et al, found that in UK GUM clinic attendees, 
young age, Black Caribbean ethnicity, female gender, previous diagnosis of STI and 
high rates of partner change were important determinants of repeat infection (Hughes, 
Brady et al. 2001). Similarly, in the US, risk factors for reinfection were young age, 
female gender and Black ethnic group. Not surprisingly these variables are risk factors 
for any infection as well as for repeat infection. Gunn et al found that the strongest 
predictor of subsequent infection was recent or current infection with gonorrhoea or 
chlamydia and an increased number of past episodes increased the future risk (Gunn, 
Fitzgerald et al. 2000). 
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A large study in Washington State followed 32,000 women after their treatment for 
chlamydia. It was found that 15% had at least one reinfection within 3 years. For those 
less than 20 years old, 17% were reinfected within 2 years. Hughes et al also report that 
teenage females are more likely to have repeated infections; 20 - 30% of this group are 
diagnosed with an acute STI within 18 months of initial diagnosis (Hughes, Brady et al. 
2001) and that 12-15 year olds re-attend soonest. Many studies have demonstrated that 
adolescents have a higher rate of reinfection than older patients but few have provided 
evidence to explain this observation. Possible reasons for a higher probability of 
reinfection in young people are biological factors e.g. greater susceptibility to infection; 
social factors, e.g. poorer adherence to therapy, lower ability or power to inform 
partners and ensure their treatment and sexual network factors e.g. young people may be 
involved in densely connected networks, with a high turnover of partners and relatively 
high prevalence. 
Reinfection with gonorrhoea 
In gonorrhoea, resistance to antimicrobials may lead to treatment failure. Risk factors 
for resistant infection depend on the stage of the epidemic of antimicrobial resistance. 
Ciprofloxacin was recommended as first line therapy in the UK in 1989. In the next few 
years, when most strains were sensitive, risk factors for resistance included acquiring 
infection abroad, since resistance to ciprofloxacin was already very high in other 
countries, especially in the Pacific rim and Asia (CDSC 2003; Ison, Woodford et al. 
1998). More recently ciprofloxacin resistance has spread endemically in the UK and 
therefore risk factors are less clearly defined (HPA 2003a). Gonococcal isolates have 
been reported with resistance to a wide variety of antimicrobials and are increasing in 
frequency (Chapter 1, Table 1.2). Persistent gonococcal infection i.e. infection which 
apparently clears but remains in a latent form and can reactivate at a later date, does not 
appear to occur. 
The evidence for acquisition of immunity to gonorrhoea is equivocal. Recent human 
challenge studies suggest complex mechanisms. There may be some strain specific 
immunity, but this is unlikely to provide cross protection (Plummer, Simonsen et al. 
1989; Schmidt, Schneider et al. 2001). Ross et al found no evidence of strain specific 
immunity, when they compared circulating strain types with strains isolates from first 
and subsequent infections (Ross, Moyes et al. 1995). In general, individuals remain 
susceptible to future infections following successful treatment. The production of 
antibodies in response to gonorrhoea infection is limited and no higher in those with a 
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history of infection (Russell, Hedges et al. 1999). The same study notes that the origin 
of immune cells in the genital tract is obscure and a better understanding will be 
necessary if therapies are to be developed which support the natural immune response 
(Russell, Hedges et al. 1999). 
Reinfection with chlamydia 
Persistent chlamydial infection has been reported to occur in some people, potentially 
for many years (Dean, Suchland et al. 2000). The exact proportion of treated infections 
which are not cleared through standard therapy is thought to be small, although few 
studies have carefully followed individuals treated for more than a few weeks. In one 
study, patients treated with doxycycline for 7 days were followed up for 20 weeks and 
no recurrent infections were detected by PCR (after one week) or by culture methods 
(except one woman who was reinfected) (Workowski, Lampe et al. 1993). Stamm 
suggests that similar studies could be carried out with single dose azithromycin therapy, 
to see if a single dose therapy permits persistence (Stamm 2001).  
Reinfection with a different strain can be taken as definitive evidence of a new 
infection, if infections with more than one strain do not occur or will always result in 
the same strain being cultured. However, many true reinfections are likely to occur with 
the same strain, through repeated contact with the original source or due to infection 
with the most common strain in circulation in the local community (Stamm 2001). It is 
not known whether persistent infections have any particular characteristics in terms of 
human or pathogen biology and epidemiology. (Dean, Suchland et al. 2000; Suchland, 
Eckert et al. 2003). 
Antimicrobial therapy may promote persistence in C. trachomatis (Dreses-Werringloer, 
Padubrin et al. 2000). In contrast to N. gonorrhoeae, there as yet appears to be very 
little, if any, clinically significant antimicrobial resistance of C. trachomatis. Somani 
and colleagues recently reported clinically significant chlamydia resistance (Somani, 
Bhullar et al. 2000). Given the increasing intensity of chlamydia case-finding through 
screening over the last 10 years, perhaps this recent emergence of resistance is not 
surprising. The evolutionary aspects of the emergence of drug resistance are considered 
in Chapter 5.  
There is some evidence for acquisition of immunity to chlamydia, although the 
biological mechanism is not well understood (Schachter, Cles et al. 1983). In guinea 
pigs, experimental studies showed that treatment with doxycycline inhibits the 
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development of an effective immune response and may reduce acquired immunity (Su, 
Morrison et al. 1999). 
Comparison of gonorrhoea and chlamydia reinfection 
Reinfection with chlamydia has features which differ from reinfection with gonorrhoea, 
but also many similarities. A patient with gonorrhoea is more likely to fail therapy due 
to drug resistance than someone with chlamydia, but a patient with chlamydia is more 
likely to relapse due to persistent infection. For both pathogens there is some evidence 
for the acquisition of strain-specific immunity, but there is better evidence regarding 
immunity to chlamydia than to gonorrhoea and the protection against future infection 
with the same strain is greater for chlamydia (Ross, Moyes et al. 1995; Schachter 1999; 
Schachter, Cles et al. 1983; Sparling 1999). 
In a recent study of network characteristics of those with chlamydia and gonorrhoea 
infections, those with coinfections and repeat infections were disproportionately 
represented in the large (i.e. more densely connected) components of the network 
(Potterat, Muth et al. 2002). Nearly 75% of repeat and 60% of coinfections occurred in 
medium to large networks.  
Two randomised controlled trials have investigated interventions designed to reduce the 
rate of reinfection, through patient delivered therapy (PDT). Index patients are given 
treatments to give to their partner or facilities are put in place for their partner to collect 
treatment from a pharmacy (Golden, Whittington et al. 2001; Schillinger, Kissinger et 
al. 2003). The rationale for this approach is that providing treatment for partners will 
increase the proportion of partners who get treated or reduce the delay in obtaining their 
treatment. Treating both partners within a short space of time should reduce the 
probability of reinfection from an untreated partner. Thus, reinfection rates in index 
cases can be used to measure the success of the intervention.  
To date two groups have reported the results from such randomised controlled trials. 
The first (Schillinger, Kissinger et al. 2003) reported a lower proportion of women 
reinfected with chlamydia 4 months after initial diagnosis. A total of 12% were 
reinfected in the PDT arm compared with 15% in the control arm, in which patients 
referred their partners for treatment. However this difference was not statistically 
significant. The second trial (Golden 2003; Golden, Whittington et al. 2001) 
investigated the impact of PDT for the partners of patients (men and women) with 
gonorrhoea and/or chlamydia. Overall they found a statistically significant reduction in 
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the rate of reinfection of index patients (9.9% PDT vs. 13% standard care), but the 
intervention was more successful in preventing gonorrhoea reinfections (3.4% PDT vs. 
10.6%) than chlamydia (13.2 vs. 10.6%) (Golden 2003; Golden, Whittington et al. 
2001). Of those reporting no sexual intercourse between tests, the rate of apparent 
reinfection for women with chlamydia was 6%, only one woman was reinfected with 
gonorrhoea and no men were reinfected with either pathogen. This suggests that 
persistent chlamydial infection may affect the ability of an RCT to detect a significant 
change in the rate of reinfection. In addition, patients with chlamydia are more likely to 
refer their partners without additional interventions than are gonorrhoea patients, so the 
margin for improvement may be greater with gonorrhoea. 
Estimation of parameters 
The crucial parameters for determining the role of reinfection in the epidemiology of 
infection cannot be derived from routine data. It is important to know whether 
reinfection has any impact on the parameters which determine the effective reproductive 
number (Rt) of the organism. These parameters include the transmission probability of 
an infection which may be reduced due to incomplete immunity, the duration of 
subsequent infections, which may be shortened due to better recognition of symptoms 
and awareness of the possibility of infection and the contact rate of the individual which 
may be modified transiently or permanently following infection. There is some evidence 
for a degree of acquired immunity as discussed but the extent of immunity or the level 
of cross protection from other strains has not been quantified. There is also a possibility 
that previous infection may have caused cellular damage and rendered the individual 
more susceptible to future infection, i.e. an enhancement effect.  
Most studies of reinfection have considered repeat attendances at the same clinic, with 
the attendant difficulties of loss to follow-up when cases reattend elsewhere. It is not 
known if the clinical profile of infection changes with repeated episodes of infection or 
if this has an effect on the timing or likelihood of a patient seeking treatment. 
The characteristics of those who become reinfected have been well defined and a 
mathematical model should be able to incorporate an epidemiologically meaningful 
measure of the profile of those at risk for reinfection or not. 
In contrast, the timing of reinfection is not well described. For the purposes of designing 
new interventions or trials, the timing of reinfection in relation to the method of follow-
up is important. 
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Various studies have estimated the time to reinfection for chlamydia or gonorrhoea but 
most have been over a relatively short period of time (Javanbakht, Smith et al. 2003; 
Jolly and Wylie 2002; Orr, Johnston et al. 2001; Whittington, Kent et al. 2001), 
although a few have been conducted for 2 or more years (Burstein, Zenilman et al. 
2001; Mehta, Erbelding et al. 2003; Rietmeijer, Van Bemmelen et al. 2002; Xu, 
Schillinger et al. 2000a). The findings presented here indicate that reinfection may still 
occur many years after the initial infection although at what point, if ever, risk becomes 
equivalent to the general population is not clear. 
Method 
This chapter uses two deterministic mathematical models, together with observed rates, 
in an analysis of rates of reinfection.  
Empirical data 
The empirical data presented consists of gonococcal isolates collected at St Mary’s 
Hospital, in London between 1995 and 2001 by Prof Cathy Ison and Dr Iona Martin 
(Imperial College London). 
In order to distinguish epidemiologically meaningful reinfection (i.e. reinfection from 
an infected, untreated partner) from treatment failure or infection at multiple sites, 
reinfection is defined as a second infection occurring more than one month following 
treatment for an initial infection. The same patient may be listed more than once on the 
same day or soon after with infection at different anatomical sites, so these are 
considered as a single event.  
Overall, nearly a quarter (23.6%) of infections diagnosed at St Mary’s occurred in 
women. This proportion did not change during the data collection (Figure 4.2). Between 
1995 and 2001 the number of isolates collected at St Mary’s increased in line with 
London-wide increases. In Figure 4.2 the number of isolates collected at Mary’s are 
compared with London overall (shown on different scales). In 2001 there were 809 
isolates collected at St Mary’s, in London there were 9378 diagnoses of gonorrhoea 
reported to the Health Protection Agency from KC60 data which are lab confirmed 
diagnoses (HPA 2003b). 
Mathematical model of reinfection 
Two deterministic mathematical models of gonorrhoea reinfection were developed, a 
simple model of reinfection and a modified version, incorporating a refractory period 
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when treated individuals cannot transmit or acquire infection. An analysis of the effect 
of varying the degree of assortative mixing (i.e. like with like) on the rate of reinfection 
was carried out to determine whether it can be estimated using other epidemiological 
characteristics of the disease, in this case the rate of reinfection.  
These two models describing reinfection with gonorrhoea are presented and illustrated 
as flow diagrams in Figure 4.4 and Figure 4.5. They are based on a simple one pathogen 
susceptible-infected-susceptible (SIS) and a susceptible-infected-recovered-susceptible 
(SIRS) deterministic model. The model structures make it possible to track infections 
over time to calculate the proportion of the population who get reinfected. Within an 
activity class exposure is the same across individuals and is a function of the pattern of 
sexual partner change and mixing. 
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Figure 4.2 Proportion of gonorrhoea diagnosed in females.
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Figure 4.4 Flow diagram of reinfection model 1
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Figure 4.5 Flow diagram of reinfection model 2 with refractory period
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Mathematical model 1 – simple reinfection 
The model describes a population stratified by gender and partner change rate and 
whether an infection is the first, second or third (or greater) time an infection has 
occurred. Individuals enter the susceptible population at a rate µ and can then acquire 
infection repeatedly. Recovery from infection occurs at a rate σ and once an individual 
recovers they are assumed to be immediately susceptible to reinfection. The flow 
diagram for this model is given in Figure 4.4. 
The state variables are as follows: 
X0kl - population of naïve susceptibles of sex k, activity class l  
Y1kl - population of hosts infected for the first time of sex k, activity class l 
X1kl - population of susceptibles (previously infected once) of sex k, activity class l  
Y2kl - population of hosts infected for the second time of sex k, activity class l 
X2kl - population of susceptibles (previously infected twice) of sex k, activity class l  
Y3kl - population of hosts infected for the third or greater time of sex k, activity class l 
X3kl - population of susceptibles (previously infected three or more times) of sex k, 
activity class l 
In order that the model system is closed, the last two compartments, corresponding to 
infection and recovery three or more times, cycle between infected and susceptible. 
Subscripts k and l refer to sex and activity class, respectively. k=0 for men, k=1 for 
women. The subscript l defines the activity class (from 1 to 4), according to average rate 
of partner change per year, ckl.  
The ordinary differential equations which define the model are: 
klklklklkl XXNX 000 µλµ −−=
•
        1.1 
ikliklkliklikl YYXY µσλ −−= −
•
)1(     (for i = 1, 2)   1.2 
ikliklkliklikl XXYX µλσ −−=
•
    (for i = 1, 2, 3)  1.3 
( ) ( ) klklklklkl YXXY 3323 µσλ +−+=
•
       1.4 
The force of infection, λkl, (the group specific incidence per susceptible) can be 
calculated from the transmission probability from sex k’ to sex k (βk), contact rate (ckl) 
the proportion of infected individuals (ΣYik’m/Nk’m, where ΣYik’m  is the sum of those 
infected i = 1,2 or 3 and Nk’m is the total population of sex k’, activity class m) and the 
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mixing pattern between different activity groups klmρ  (where letter m defines the activity 
class of an individual of the opposite sex (k’) with whom a partnership is formed) as 
follows: 
∑
∑
=
=






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




=
4
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m mk
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mikklm
kklkl N
Y
c
ρ
βλ         1.8 
Parameters used in the model are further defined in Table 4.1. 
ρklm is an element of P, which defines the probability that, when an individual of sex k in 
activity class l, forms a partnership, it will be with a member of activity class m of the 
opposite sex, k’. The values of ρklm depend on the overall pattern of mixing by partner 
change rate, and can vary from fully assortative (ε1=0) to proportionate (ε1=1). 
The following equation describes the mixing matrix: 
( )












−+=Ρ
∑
=
lm
u
uuk
mkmk
klm
cN
cN δεε 14
1
'
''
1 1        1.9 
where δ is the identity matrix, such that  δlm = 1 when l=m and  δlm  =0 when l≠m. 
Katherine Turner 
Chapter 4 - Reinfection with gonorrhoea 
 129 
Table 4.1 Table of parameters used in mathematical models 1 and 2 of 
reinfection 
Parameter Definition Values used 
µ Entry rate. 
To maintain a constant population 
size, the entry and exit rates are 
assumed to be equal. 
0.1 per year (average length of 
stay in model population 10 
years) 
βk Transmission probability of infection 
to sex k per contact  
Probability per contact  
0.5 (Male to Female) 
0.35 (Female to Male)  
σk, Recovery rate from infection 1.5 per year (female) – mean 
duration 8 months. 
2 per year (male) – mean 
duration 6 months.  
Ρklm Mixing matrix, element ρklm  is the 
probability that, when an individual of 
sex k in activity class l forms a 
partnership, it will be with a member 
of activity class m of the opposite sex, 
k’. 
See below 
ckl Partnership formation rate of 
individual of sex k, activity class l (see 
below) 
See below 
ε
 
Pattern of mixing: ε
 
by activity 
(0=fully assortative, 1= random) 
Mixing according to activity 
varied from 0≤ ε ≤1 
Katherine Turner 
Chapter 4 - Reinfection with gonorrhoea 
 130 
Mathematical model 2 – including a refractory period 
In the second model, a third state is introduced, the refractory period (Zikl), which 
represents the period following diagnosis and treatment of an infection, in which 
individuals are not infectious or susceptible to infection with gonorrhoea and therefore 
do not contribute to the force of infection. This could be due either to a lasting benefit 
effect of antibiotic therapy or abstention from sex or complete condom use during for a 
week, as recommended. Protection from reinfection is assumed to be complete during 
this period. The flow diagram for this model is given in Figure 4.5.  
The state variables for the modified model are as follows: 
X0kl - population of naïve susceptibles of sex k, activity class l  
Y1kl - population of hosts infected for the first time of sex k, activity class l 
Z1kl - population of hosts refractory following first infection, sex k, activity class l 
X1kl - population of susceptibles (previously infected once) of sex k, activity class l  
Y2kl - population of hosts infected for the second time of sex k, activity class l 
Z2kl - population of hosts refractory following second infection, sex k, activity class l 
X2kl - population of susceptibles (previously infected twice) of sex k, activity class l  
Y3kl - population of hosts infected for the third or greater time of sex k, activity class l 
Z3kl - population of hosts, refractory following third (or more) infection(s), sex k, 
activity class l 
X3kl - population of susceptibles (previously infected three or more times) of sex k, 
activity class l 
As in the previous model, the requirement for closure means, after the third infection 
individuals in the population cycle between the final three compartments, corresponding 
to infection, recovery and refraction three or more times. 
In the equations describing model 2, subscripts k and l refer to sex and activity class, 
respectively. In the case of sex, k=0 for men, k=1 for women while k' refers to the 
opposite sex to k and for activity l defines the class (from 1 to 4), according to average 
rate of partner change per year, cklr. The letter m defines the activity class of an 
individual of the opposite sex (k’) with whom a partnership is formed by a person of sex 
k, activity class l. 
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Two additional parameters are included to control movement to and from the refractory 
period in model 2. These are a relapse rate, (γ) which accounts for treatment failure 
(resistance or persistence) not counted as reinfection and the duration of stay in the 
refractory period (α) i.e. the time following diagnosis when a patient is not infectious or 
susceptible to further infection. They continue to form sexual partnerships but are 
assumed to have short term immunity and use condoms or refrain from intercourse 
during the refractory period. 
The ordinary differential equations which define the model are: 
klklklklkl XXNX 000 µλµ −−=
•
        2.1 
( ) ikliklkliklikl ZYXY γµσλ ++−= −
•
)1(    (for i = 1, 2)   2.2 
( ) ikliklikl ZYZ γµασ ++−=
•
    (for i = 1, 2, 3)  2.3 
( ) iklkliklikl XZX µλα +−=
•
    (for i = 1, 2, 3)  2.4 
( ) ( ) klklklklkl YXXY 3323 γµσλ ++−+=
•
      2.8 
The force of infection, λkl, and the mixing matrix, ρklm, are as defined for model 1. 
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Results 
Between 1995 and 2001 a total of 3911 infections were diagnosed in 2860 individuals. 
The gender was known for 2670 of whom, 24% (631) were female. This proportion has 
stayed roughly constant since 1995. During the study, on average of 5.0% (Male, 5.3%, 
Female 3.8%) of patients diagnosed with GC in a London GUM clinic were diagnosed 
two or more times, and 0.4% (0.4% Male, 0.4% Female) three or more times within 
each year. Cumulatively over the seven years of the study, 11.5% of patients were 
diagnosed two or more times, and 2.5% diagnosed three or more times. The number of 
people diagnosed with 1, 2, 3 or more infections over the course of the study is given in 
Table 4.2 
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Table 4.2 Number of people reinfected and diagnosed at St Mary’s, 
London between 1995 and 2001 
Number of infections Number of individuals 
≥1 3256 
≥2 447  
≥3 23  
≥4 
15  
Initial infection 1995-1999 (median = 
1997) 
Earliest diagnosis July 1995 
Last diagnosis July 1999 
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The mean and median times to reinfection were calculated crudely for each year. This 
was taken as the time between the most recent diagnosis and the previous diagnosis and 
in an alternative calculation, between the most recent diagnosis and the first ever 
diagnosis. This is illustrated in Figure 4.6. The left hand column for each year shows the 
time since the most recent occurrence, the right hand column the time since first 
diagnosed. The lower shaded section of the column indicates the median time to 
reinfection and the whole column the mean. Error bars indicate the maximum and 
minimum time to reinfection in each year. 
The time to reinfection was calculated for the first reinfection to create a survival curve 
for time remaining without reinfection. Figure 4.7 shows the fraction becoming 
reinfected following index infection as a survival curve. The median time to reinfection 
amongst those who were reinfected was 15 months. The longest time to first reinfection 
observed within the study was 70 months. However given that isolates were only 
collected for 72 months and that half of observed infections were documented more 
than 15 months after the first isolate was collected, those diagnosed with gonorrhoea 
may remain at elevated risk for several years afterwards. In general, most reinfections 
observed occurred soon after, with 25% occurring within 6 months. This is shown more 
clearly as a hazard function in Figure 4.8, where there is a high hazard initially, which 
drops and levels off to a fairly constant low risk after approximately 1 year. In 
calculating the hazard only those infections included sufficiently early to be able to 
acquire an infection at the particular time are included in the denominator. Thus as time 
progresses, fewer individuals are included and confidence in the hazard decreases. 
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Figure 4.6 Mean and median time to reinfection since first occurrence and most 
recent occurrence for those who have previously been infected in each year of the 
study 
(Error bars indicate the range)
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Model 1 - simple reinfection scenario 
Model 1 fails to capture the pattern of reinfection, primarily because reinfection occurs 
too rapidly. Reinfection is overestimated in the deterministic model but because of the 
difficulties identifying a repeat infection, is likely to be underestimated in observed 
data. Figure 4.9 illustrates the effect of changing the mixing pattern on the proportion of 
reinfections which occur. Model simulations show that as mixing becomes more 
random, the frequency of reinfection decreases. Those who become reinfected have a 
higher average rate of partner change than those who are singly infected.  
Model 2 – with refractory period 
Because of the overestimate of reinfection a second model is introduced to examine the 
effect of a refractory phase due to treatment of infections. It is assumed that those 
treated change their behaviour or gain benefit from antimicrobial therapy for 4 weeks 
following diagnosis of an STI that renders them not susceptible to infection for the 
duration of the refractory period. Introducing this stage also allows the introduction of a 
rate of treatment failure or relapse to investigate. 
With this scenario, more realistic proportions of the yearly incidence of repeat 
infections are obtained, as shown in Figure 4.10. 
The results suggest that reduced susceptibility to reinfection has to be present for a time 
following treatment. This is without allowing in the model for reinfection from the 
initial partner. However, chance may slow down reinfection in a sexual partner network. 
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Discussion 
Reinfection represents an important component of the epidemiology of gonorrhoea and 
of chlamydia, but gaps remain in knowledge of the extent of reinfection and timing of 
reinfection events. This chapter presents new data and a mathematical modelling 
approach to improve understanding of the population level factors including mixing 
patterns and rates of partner change which can affect the risk of reinfection. There 
remains a lack of knowledge on the natural history of reinfection with gonorrhoea. 
Mathematical models can be used to investigate the expected outcome of different rates 
of relapse and acquired immunity which may allow these parameters to be quantified 
with more accuracy. 
In this chapter the frequency and timing of reinfection in St Mary’s clinic, London from 
was calculated and the implications for models of gonorrhoea investigated. Reinfection 
with gonorrhoea occurs frequently, and about 5% of people return within a year of 
diagnosis, overall 20% of those diagnosed at St Mary’s will be reinfected. Multiple 
reinfections were also quite common. Fifteen people returned four or more times during 
the course of the data collection at intervals greater than one month. The average time to 
reinfection was 15 months. These values are comparable with rates of reinfection 
obtained in studies in similar settings (Mehta, Erbelding et al. 2003).  
The pattern of reinfection observed is complex. The risk of reinfection is highest soon 
after treated infection, as is anticipated if most reinfection events occur due to 
reinfection from untreated partners. However, reinfections were also observed several 
years after initial infection which implies that some individuals who have been infected 
with gonorrhoea remain at elevated risk for a substantial period. Infections occurring 
several years later are unlikely to be acquired from the original source of infection. This 
implies that these infections represent a new source, either from a newly infected 
existing partner (which would indicate overlapping partnerships) or from a new partner 
who is infected. Both scenarios suggest continued high risk and potential membership 
of a core group. Since Hethcote and Yorke’s seminal work on gonorrhoea transmission 
dynamics and even before it has been recognised that members of core groups are prime 
targets for intervention efforts. 
Limitations of method 
Empirical data from one clinic will tend to underestimate the proportion of reinfection 
due to the availability of other sources of care, including other clinics or GPs and 
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movement of people away from the area. Many of the parameters required for a model 
or reinfection with gonorrhoea remain poorly characterised, for example the variation in 
time before seeking care, variability in the incubation period and the effect of contact 
tracing and treatment of partners on the probability of future infections. At present it is 
difficult to determine whether a reinfection is due to failure of treatment, contact with 
an untreated partner or due to a contact with a new infected partner. Patients who have 
acquired an STI from one sexual partner are more likely to be in higher risk networks 
and may therefore be more likely to form future partnerships with infected or high risk 
partners. 
It is difficult to quantify how many reinfection events are missed in the empirical study, 
due to a proportion of people seeking treatment elsewhere. The rates of reinfection 
reported are likely to be an underestimate. In the USA, people seeking care in public 
STI clinics comprise higher risk demographic groups than the general population at risk 
for STIs and reinfection rates based on this population may overestimate reinfection. In 
the UK, where free care is available to all this may not be true to the same extent. 
However, there are other sources of care which may be utilised, in particular men who 
reported having had an STI diagnosis were more likely to report attending a GUM clinic 
than women (Johnson, Mercer et al. 2001). There may be some gender differences in 
the risk of reinfection, and further analysis should be undertaken to evaluate these and 
the effect of sexual orientation on the rate of reinfection.  
This analysis did not incorporate age, but this would be useful additional work, as most 
studies of reinfection have found that age correlates strongly with risk of reinfection 
with both gonorrhoea and chlamydia, which occurs more often and more rapidly among 
young people. Burstein and colleagues found in a study of chlamydia in 12-18 year olds 
that 14 year olds had the highest rate and, in a later study in a wider age range of women 
12-60, showed the same pattern of higher risk in younger women (Burstein, Gaydos et 
al. 1998; Burstein, Zenilman et al. 2001). Similarly for gonorrhoea, rates are high in 
young people (Orr, Johnston et al. 2001).  
More data are needed for model parameterisation, for example in the rate of treatment 
failure due to resistant infection may change over time and under different treatment 
guidelines. If treatment does not clear the infection but does resolve symptoms, then 
infections may last for much longer than anticipated. There is some evidence that 
treatment of chlamydia may lead to asymptomatic infection, (Dreses-Werringloer, 
Padubrin et al. 2000) and that it is possible that a similar effect may occur if gonorrhoea 
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is treated sub-optimally. Modelling can help to predict the effects of different outcomes 
of treatment and the effects of resistant or persistent infection. This theoretical aspect is 
explored further in Chapter 5. 
Using a standard susceptible-infected-susceptible model of gonorrhoea, it was initially 
found that reinfection occurred much more rapidly than was suggested by empirical 
data. It is reasonable to assume that, following successful treatment, people to do not 
become immediately exposed and susceptible to infection. To mimic the definition of 
reinfection as occurring more than one month after initial diagnosis, this protected 
period was set to one month. During this time, individuals are not susceptible to 
infection. This has the effect of reducing the pool of susceptibles (especially in the 
highest activity groups) which therefore results in a reduction in the effective R0 of 
gonorrhoea and a reduction in the prevalence and rate of reinfection. This effect brought 
the rate of reinfection down to a more realistic level. The evidence suggests that 
individuals change their behaviour at least temporarily following diagnosis with an STI 
(Fortenberry, Brizendine et al. 2002). Treatment may induce a benefit for some days 
afterwards, depending on the pharmacokinetics and pharmacodynamics of the drug used 
and dosing regime. 
If reinfection could be modelled accurately with good parameter estimates, then by 
fitting rates of first, second and greater infections per year the mixing patterns within 
the population could be estimated. This has not been possible as yet, since too many of 
the parameters are poorly quantified. However, it does represent a novel approach 
which could be taken, together with data on coinfection to characterise populations at 
risk who would benefit from targeted interventions and also to monitor the 
epidemiology of STIs and indirectly measure changes in sexual behaviour for example 
in mixing patterns or the distribution of sexual activity. 
The model of reinfection has not been explicitly fitted to data due to the uncertainty in 
the parameter estimates made. However, additional sensitivity analyses could be carried 
out to determine the relative effect of varying parameters which are not well quantified, 
such as resistance, proportions of asymptomatic infections, protective acquired 
immunity. There is some evidence that there is incomplete strain-specific immunity 
(Plummer, Simonsen et al. 1989), two or more strain models such as that developed in 
Chapter 2 (gonorrhoea and chlamydia) and Chapter 5 (2 strains of gonorrhoea) as well 
as other work on strain structure in viral and bacterial populations (Castillo-Chavez, 
Hethcote et al. 1989; Ferguson, Anderson et al. 1999; Gupta and Galvani 1999) could 
Katherine Turner 
Chapter 4 - Reinfection with gonorrhoea 
 144 
be extended to investigate the specific properties of gonorrhoea strain structure and 
immunity. Risk of reinfection is intimately linked with partnerships and infection status 
of partners, so the next stage in this work is to explore individual based models with 
explicit partnerships. This will enable different mechanisms of reinfection to be 
determined as well as the effect of novel intervention approaches, such as partner 
delivered therapy.  
Molecular typing provides another empirical approach to understanding the source of 
reinfections and more generally the epidemiology of gonorrhoea. (Ghani, Ison et al. 
1996; Ward, Ison et al. 2000) Genetic typing could also be used to identify sources of 
reinfections, either new infections, resistant infections or reinfections from untreated 
partners (Martin and Ison 2003).  
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Chapter 5  Evolution of gonorrhoea and chlamydia 
Summary 
The evolution of any sexually transmitted organism will be influenced by prevailing 
epidemiological interactions. The level of competition between organisms and the 
selective pressures imposed on the pathogens are determined by the prevalence of 
infection and the use of interventions. 
A deterministic, compartmental mathematical model of two strains of gonorrhoea with a 
range of properties is used to illustrate some of the key relationships between 
epidemiology and evolution. The epidemiology of an STD can be categorised according 
to a series of ‘phases’ which provide a framework within which to discuss its influence 
on evolution. 
The basic reproductive number is a measure of fitness which, within constraints 
imposed by what is biologically possible, will be optimised by selection. Additionally, 
if there is strong interference between infections the speed of replication as measured by 
transmissibility can be an important component of fitness. When treatment is introduced 
it imposes an enormous selective cost. The optimum strategy for an organism to 
overcome treatment, either through drug resistance or cryptic infections, depends upon 
whether the method for identifying patients is passive (treating symptoms alone favours 
asymptomatic organisms) or active (screening favours resistant organisms). 
The use of mathematical models of competing strains of infection allows theoretical 
predictions for the outcome of evolution under a range of assumptions about potential 
phenotypes. The course of pathogen evolution has implications for the success of 
interventions, but the predictions presented need to be tested at the level of the 
community in carefully monitored interventions. 
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Introduction 
The current diversity of sexually transmitted infections is the consequence of evolution. 
For any infectious organism this evolution is profoundly influenced by the 
epidemiological factors which constrain its environment. The organisms within an 
infection interact with one another and with the individual host. Likewise, within the 
host population, infections compete, altering their reproductive success. 
For any organism, evolution is shaped by the mechanisms that introduce variation into 
the genome, the ways in which genes spread through populations and the challenges 
which limit populations and thereby the success of different genes. The sequence of 
bases in DNA and RNA encoding the regulation and synthesis of enzymes and 
structural molecules is the raw material for evolution. On replication, molecular 
mechanisms of base substitution and deletion, or recombination and re-assortment, 
configure this genetic raw material. Then selection and neutral drift act to determine the 
distribution of different sequences in future generations. Chances for genetic 
recombination, genetic drift and natural selection are a function of the population 
dynamics of organisms and, for infectious diseases, population dynamics is the main 
focus of epidemiology.  The phase of an epidemic plays many roles in controlling 
evolutionary pressures, which will be explored here in the context of sexually 
transmitted infections (STIs).  
As described elsewhere, an epidemic can be divided into five phases characterising 
growth and decline of a population of infectious organisms (Garnett 2002; Wasserheit 
1992). These are:  
Phase I – The growth period, as the invasion of host population occurs;  
Phase II – The peak of the epidemic and hyper-endemic phase when no controls have 
yet been imposed;  
Phase III – A decline phase as controls are introduced and take effect;  
Phase IV – A new endemic phase i.e. the steady state prevalence and incidence when 
controls are acting;  
Phase V – Elimination, and potentially eradication. These phases could be applied to the 
global or local spread of an infectious organism. 
By definition, STIs are caused by pathogens, whose evolution is intimately tied up with 
the disease they induce, their ability to spread in new hosts and their response to 
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immunity and treatment. It is inevitable that when the relationship between the 
evolution and epidemiology of STIs is considered, the concern will be with the 
phenotypes of the organisms (the actual expression of the characteristics encoded gene 
which is influenced by both genes and the environment) and how these phenotypes 
influence their reproductive success. The pressures imposed on the sexually transmitted 
infection can be considered at each epidemiological phase in turn.  
The founder effect will be important in phase I when an infection enters a host 
population and spreads with little competition (Anderson and May 1991). The founder 
effect is defined as the establishment of a new population by a few original founders, 
which carry only a fraction of the genotypes of the parental population (Mayr 1963). 
Particular genotypes will become common because they were present when the STI was 
introduced into the population. With small local outbreaks, as are currently observed in 
industrialised countries for bacterial STIs, there will be repeated episodes where founder 
infections become common in particular locations causing fluctuations in the common 
genotypes within a community, country or region. Likewise, for infections within the 
host those organisms present in the infecting dose may be a limited subset of the 
infectious population allowing for random shifts in the genes represented in the 
pathogen population.  
At a hyper-endemic steady state (Phase II), saturation of the infection in the population 
has occurred, when pre-emptive infection, or acquired immunity, reduces the 
reproductive success of each infection. It is in this phase that the transmissibility of the 
infection and the ability to persist in the individual host, avoiding acquired or innate 
immunity, would be optimised. This will generate and hone mechanisms to avoid the 
immune defences of the individual host and the host population. Examples of these 
mechanisms are antigenic variation as observed in gonorrhoea, chlamydia and HIV 
(Ward, Ison et al. 2000) (Nowak 1991; Stephens, Wagar et al. 1988), low levels of 
exposed antigens as appears to be the case for syphilis (Schouls 1992), latent state in an 
immune privileged site with continual reactivation as in the case of HSV-2 (Corey 
1999) or minimal contact with systemic immunity as appears to be the case with 
minimally invasive infections like HPV (Galloway 1999). Competition at this endemic 
prevalence may be particularly intense, especially if there is a group with a high risk of 
acquiring and transmitting infection, as is often the case for STIs where continual re-
exposure can occur for some individuals. The ability to invade an already infected host 
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becomes a selective advantage in such circumstances, but concomitantly it becomes an 
advantage for the original infection to prevent further infection. 
The key measure for evolutionary fitness is the reproductive success of the organism, 
i.e. its representation in future generations. Normally the reproductive success (the 
number of viable offspring) of the individual organism or gene is measured. However, 
in infectious disease epidemiology one can also think in terms of the reproductive 
success of the infection, a colony of related individuals, and the reproductive number 
(R0) (Anderson and May 1991).  
The basic reproductive number (R0) is defined as the average number of new infections 
arising from one index case in an entirely susceptible population. The value of the 
reproductive number at a given time t (Rt) determines whether the related organisms are 
increasing (Rt > 1) or decreasing (Rt < 1) their representation at that time. The basic 
reproductive number R0 applies only in the absence of density dependent constraints, in 
Phase I, the invasion of a susceptible population. The influences on the reproductive 
number, in addition to the proportion of the host population susceptible, consist of three 
main elements: the duration of infectiousness, the pattern of contact within the host 
population and the likelihood of transmission on contact. An increase in duration of 
infectiousness or transmissibility would increase the fitness of a pathogen. 
While it is possible to hypothesise about optimum evolutionary strategies, the early 
academic consensus, that parasites should evolve to become benign, illustrates the 
potential pitfalls of such speculation.  It was assumed that increasing the longevity of 
the host would also improve the fitness of parasites by maximising the parasites own 
survival (McKeown 1988). However, this fails to take into account the potential 
correlation between pathogenesis and virulence1.  
A trade off is likely between the duration of infection and infectiousness, which may be 
associated with severity of disease (Anderson and & May 1982; Bull 1994; Lipsitch 
2001). Biological explanations for the link between virulence and pathogenicity have 
been explored and may include increased replication, which increases pathogenicity but 
also increases fitness in terms of ability to withstand host immune defences and 
increased probability of transmission (Lipsitch and Moxon 1997; Lipsitch and Nowak 
                                                 
1
 Virulence has been defined differently across disciplines. To the clinical microbiologist virulence is the 
ability to invade the host causing disease, whereas to the evolutionary biologist  virulence is a measure of 
an organisms ability to replicate and be transmitted to new hosts. The latter definition is used here.  
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1995). The level of disease associated with an infection will depend upon this trade off 
and the biological mechanisms damaging the host.  
Support for the earlier view was invoked from the severe symptoms and high mortality 
observed for many emerging infections are seen, which then decline as the epidemic 
progresses. The first recorded outbreaks of syphilis, caused by Treponema pallidum, in 
the fifteenth century involved severe symptoms and rapid progression to death (Quetel 
1990). Subsequently, disease progression has slowed and symptoms reduced in intensity 
(Garnett, Aral et al. 1997). The myxoma virus strains, which cause myxomatosis in 
rabbits, were released in Australia in 1950. The initial virus was associated with a 90% 
fatality rate, but was soon supplanted by strains with a lower level of virulence 
(Anderson and & May 1982; Fenner 1965). In both cases an intermediate level of 
virulence was maintained as the optimum in the trade of between transmission and 
survival.  
In the later phases of an epidemic (III, IV and V) following the introduction of 
interventions, very different selective pressures will apply. The characteristics of an 
infection that allow it to be targeted by an intervention become more significant, and 
will be selected against. In the case of treatment, this selective pressure could be for 
drug resistance or to avoid being identified (i.e. selection against the characteristics that 
identify cases for treatment). Under the selective pressures of an intervention new 
optimum characteristics are selected for, and the most successful organisms are likely to 
have a different phenotype from those most successful in Phase II.  
Selection of traits such as drug resistance or asymptomatic infections could compromise 
the organism’s ability to exploit its host, avoid immunity or be transmitted. For 
example, in several organisms, including HIV, Escherichia coli and Salmonella 
typhimurium drug resistance is associated with a reduced rate of replication for some 
mutations, however, compensatory mechanisms have been shown to evolve rapidly in 
antimicrobial resistant viral and bacterial strains (Gillespie 2001; Levin, Perrot et al. 
2000).  
If the new organisms can compensate for the costs associated with resistance or 
asymptomatic infection then they will re-establish the Phase II prevalence, causing the 
failure of the intervention. However, it is likely that resistant or asymptomatic infections 
are less transmissible and the new steady state prevalence will be lower than that of 
Phase II. If the selection imposed by the intervention is sufficiently strong it will drive 
the population of pathogens to extinction. This is the ‘cost of selection’ defined by 
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Haldane (Haldane 1957), which limits the rate of change imposed by natural selection. 
The greater this cost the faster a sensitive gene will be eliminated and a resistant gene 
will dominate, but also the greater the chances of the entire population being eliminated. 
In the last phase, Phase V, small, isolated populations of organisms are likely to be 
selected by the main traits related to their niche as pathogens and the interventions 
against them, but are also more likely to be susceptible to the fixation or loss of genes 
through genetic drift. Genetic or neutral drift is where there are random shifts in the 
frequency of genes and alterations to gene sequences that are selectively neutral (e.g. 
synonymous changes in bases which do not alter the amino acids coded for) spread 
through populations (Kimura 1983). 
To illustrate the influence of phase of epidemic on STI evolution a mathematical model 
of two interacting strains is used. The model is that used by Hethcote and Yorke 
(Hethcote and Yorke 1984) to study gonorrhoea epidemiology, with the additional 
complexity derived from including two strains. First the ability of a genotype to invade 
a naive population (Phase I) is explored, and then its ability to invade a population 
where infection is hyper-endemic (Phase II). The importance of both the basic 
reproductive number, which determines the relative success of strains in a naive 
population and also the importance of causing new infections rapidly, thus out-
competing rivals are highlighted. The ability of organisms to coexist and compete when 
they are able to exclude one another and when there is restricted cross immunity are 
compared. In the extreme case of no cross immunity, the two strains are entirely 
independent and play no role in one another’s evolutionary success. Then the changed 
situation in Phases III, IV and V is explored when interventions have been included. In 
particular, the relative merits of drug resistance and asymptomatic infection as 
evolutionary strategies are illustrated. 
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Method 
Two versions of a two-strain deterministic model of gonorrhoea in a heterosexual 
population divided into four activity classes are used. Partnerships in this type of model 
occur instantaneously. A small proportion of the population (2%) are in the highest 
activity class, the majority (60%) are in the lowest. For simplicity in balancing the 
supply and demand for sexual partnerships, both sexes are assumed to have the same 
distribution of activity. The values of the transmission probability per sex partnership or 
the duration of infection for each strain are varied, to represent different phenotypes. 
For example, resistance to antimicrobial therapy would generate a longer duration of 
infection compared to sensitive infections, when treatment is used. For all infections it 
is assumed that there is no acquired immunity, so recovery is to the susceptible class. In 
the case of dual infection, recovery may be from either or both strains.  
Both models allow the parameter values describing the characteristics of strains to 
change during the course of the simulation. This could be to add a new strain or to 
represent the introduction of a treatment strategy. The impact of treatment is modelled 
by assigning new values for the duration of infections of the strains. The new values 
depend on the assumed sensitivity of the particular strain to treatment and whether the 
infection can be detected and treated (e.g. asymptomatic infections may go untreated for 
a long period of time). The impact of these changes can then be seen in the context of 
different phases of the epidemic, depending when the switch is made.  
The models are illustrated in Figure 5.1 where the flow of people between categories is 
shown. In the first model, model 1, (Figure 5.1a) ‘super-infection’ is possible and the 
host population falls into four categories: susceptible; infected with strain A; infected 
with strain B; and infected with both strains. Infection with one strain may confer some 
immunity to infection against the other, with the strength of this cross protection 
varying from absolute (no super infection) to negligible where the strains are 
independent. Different strains could vary in their ability to inhibit rival strains, e.g. by 
faster growth in vivo, but in the following examples cross protection is assumed to be 
symmetrical.  
The second model, model 2, is a special case, with total cross-immunity, which includes 
the additional complexity of asymptomatic and symptomatic infections being separately 
represented and strains having an associated propensity to generate symptoms (Figure 
5.1b). Asymptomatic infections are widely assumed to be less transmissible than 
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symptomatic infections, e.g. due to a lower intensity of infection or lower replication 
rate. However it may also be the case that symptomatic infections are transmitted less 
frequently due to increases in treatment seeking behaviour, decreases in sexual contacts 
or increases in condom use. There is no good quantitative evidence to indicate which of 
these factors is most important and the balance between the two conflicting assumptions 
is likely to vary in different populations with differing access to education and 
healthcare. A term has been included in the model to allow the transmissibility of 
asymptomatic infections to be modified (either increased or decreased) relative to 
symptomatic infections, depending on available empirical evidence, but this term is not 
utilised in the examples given here.  
Model 2 has five categories: susceptible (X); asymptomatic infections with strain A 
(Aa); symptomatic infections with strain A (As); asymptomatic infections with strain B 
(Ba); and symptomatic infections with strain B (Bs). The probability that when an 
infection occurs it remains asymptomatic differs between the strains (strain A: 80% 
asymptomatic and 20% symptomatic; strain B: 40% asymptomatic and 60% 
symptomatic infections. Mathematical descriptions of the models and the parameters 
used are presented. 
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Figure 5.1 Flow diagrams describing the categorisation of infections in two 
strain models of gonorrhoea 
(a) model 1 – a two strain model with superinfection. (b) Model 2 – a two strain model 
incorporating asymptomatic and symptomatic infection. 
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Mathematical models 
Model 1 - Two-strain model, including superinfection 
Model incorporates two strains, two sexes and four activity classes with the possibility 
of super-infection.  
Subscripts refer to the sex and activity class. In the case of sex, k=0 for men, k=1 for 
women while k' refers to the opposite sex to k and for activity l defines the class (from 1 
to 4), according to average rate of partner change per year, ckl. The superscripts A, B 
associated with parameters identify the strain of the infection and C a dual infection. 
The subscripts stratify the state variables, which are as follows: 
Xkl.- population of susceptibles of sex k and activity class l 
Akl - population of hosts infected with strain A of sex k, activity class l 
Bkl - population of hosts infected with strain B of sex k, activity class l 
Ckl - population of hosts infected with strains A and B of sex k, activity class l 
Nk l- total population, sex k, activity class l 
In order to simplify the equations first define the force of infection (λ) is defined for 
each strain (A and B) and for coinfection. The force of infection is the product of the 
transmissibility of the strain (β), the contact rate (c) and the proportion of the total 
population infected with the strain, contacts with whom are determined by the mixing 
matrix (Ρklm). The force of infection is equivalent to the incidence rate per susceptible. 
Thus for an individual of sex k, activity class l, the forces of infection for strains A or B, 
or coinfection C are: 
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The equations describing the model are as follows: 
( ) ( )( ) klklBACkklBkklAkCklBklAklklklkl XCBAXNdt
dX µωωσσσλλλµ −+−+++++−= 1   
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( ) ( )( ) ( ) klAkklCkCklABklAklCklAAklklkl ACAXdt
dA
A µσωσλγλφλγλ +−+−+−+= 1  
( ) ( )( ) ( ) klBkklBCkCklBAklBklCklBBklklkl BCBXdt
dB µσωσλγλφλγλ +−++−+−+= 1  
( )( ) ( )( ) ( )( ) ( ) klCkCklBAklBkklCklABklAkklCklBAklkl CBAXdt
dC µσλγλφλγλφλγγ +−−++−+++−= 111
 
Parameter definitions used in models (for two general strains, A and B).are given in 
Table 5.1. 
Ρklm is a mixing matrix, whose elements ρklm are the probability that an individual of sex 
k in activity class l will form a partnership with a member of activity class m of the 
opposite sex. The value of ρklm depends on the pattern of mixing and could vary from 
fully assortative, where partnerships only form within the same activity group to 
random, where partnerships form randomly between different activity classes. 
( )
∑
=
−+= 4
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mklmklm
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δ
 lm = 1 when l=m and δlm =0 when l≠m.  
It is necessary that the number of partnerships formed by sex k match those of the other 
sex. For the sake of simplicity in these models both sexes are divided into classes of 
identical size and activity levels. The models can include a range of mixing patterns 
between activity classes (from fully assortative to random). 
The rate of partner change for each activity class is given in (Table 5.2). 
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Table 5.1 Table of parameters used in the mathematical models 
Parameter Definition Default value Range of values 
used in the model 
µ Entry rate to maintain a constant 
population size, the entry and 
exit rates are assumed to be 
equal. 
0.02 per year n/a 
βAk, βBk Transmission rate of strain A or 
strain B to sex k per contact  
0.5 per contact 0<β<1 
σAk, σ
B
k Recovery rate from 
asymptomatic infection with A 
or B per year 
(recovery rate = 1/duration) 
σ = 2 per year, i.e. average 
duration of 6 months without 
treatment, decreasing to  
10 per year, i.e. 1.2 months 
duration with treatment. 
σ = 2 per year 
without 
treatment, 
increasing to 
10 per year, 
with 
treatment. 
With treatment, 
recovery depends on 
efficacy of treatment 
and the average time 
taken to seek 
treatment.  
γA, γB Proportion of contacts with 
superinfected individuals, which 
result in transmission of A or B 
only. 
(If γΑ+ γΒ =0, then all contacts 
result in transmission of 
superinfection, if γΑ+ γΒ =1, then 
all contacts with coinfected 
individuals result in the 
transmission of a single strain. 
γΑ=γΒ=0.4 
Therefore 
proportion of 
contacts which 
result direct 
transmission 
of coinfection 
is: 1-
(γΑ+ γΒ)=0.2.  
0 ≤ γ ≥ 1  
γΑ+ γΒ ≤ 1 
ωΑ,ωΒ Proportion of those recovering 
from superinfection that remain 
infected with strain A or B. The 
extreme cases are when either all 
recovery is from mixed infection 
to the susceptible class (ωΑ=ωΒ = 
0); or all recovery is from single 
infections (ωΑ+ωΒ = 1). 
In the examples given in the text, 
40% of recovery from 
coinfection is from a single strain 
(equally split between the two 
strains), and 60% is recovery to 
the susceptible class directly, e.g. 
due to treatment. 
ωΑ=ωΒ =0.2,  0 ≤ ω ≥ 0.5 
ωΑ+ωΒ ≤ 1 
Katherine Turner 
Chapter 5 - Evolution of gonorrhoea and chlamydia 
 157 
Parameter Definition Default value Range of values 
used in the model 
φA,φB Protective effect of infection 
with strain A, or strain B on 
likelihood of transmission of 
different strains (total protective 
effect, no coinfection (φΑ=φΒ =0) 
to no protective effect (φΑ=φΒ 
==1)). An enhancing effect of 
transmission due to prior 
infection could also be given by 
φΑ or φΒ > 1.   
φA= φB =0.5 0 ≤ φ≤ 1 for 
protective effect, or 
φ > 1 for enhancing 
effect. 
 
Ρklm Mixing matrix, element ρklm is 
probability that individual of sex 
k in activity class l will form a 
partnership with a member of 
activity class m of the opposite 
sex. 
See below n/a 
ckl Contact rate of individual of sex 
k, activity class l (see below) 
See below n/a 
ε Pattern of mixing (0=fully 
assortative, 1= random) 
1 (random) 0 ≤ ε ≥ 1 
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Table 5.2 Contact rates of hypothetical population in mathematical model 
Activity class 
Rate of partner change 
(per year) 
Proportion of population 
in class 
1 40 0.02 
2 10 0.08 
3 2 0.3 
4 0.5 0.6 
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Relation between R0 and recovery rate and transmissibility 
When varying the transmissibility or recovery rate, the following formula is used to for 
calculations to keep R0 constant: 
υµ
β
+
=
cR0  
R0 is the reproductive number (defined as the average number of new infections caused 
by an index case), β is the transmission coefficient, c is the contact rate, µ is the entry 
rate into the population and υ is the recovery rate, which is related to the duration of 
infection as follows: 
µ
υ
+
=
D
1
 
Model 2 - Two strain model, including asymptomatic and symptomatic 
infections 
Model incorporates two strains, two sexes, four activity classes with asymptomatic and 
symptomatic infection. 
Formulae to accompany two-strain model incorporating asymptomatic and symptomatic 
infections with no superinfection. Superscript 'a' or 's' denotes asymptomatic and 
symptomatically infected populations respectively, e.g. Aakl is the population infected 
with strain E who are asymptomatic. Capital superscripts indicate the strain as before. 
The force of infection (λ) is again defined, for strains A and B, assuming no 
coinfection: 
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The equations describing the model are as follows: 
( ) klSklBskaklBakSklAskaklAakBklAklklkl XBBAAXNdtkl
dX
µσσσσλλµ −+++++−=   
a
kl
a
kl
Aa
k
A
klkl
A
a
kl AAX
dt
dA µσλθ −−=   
( ) sklsklAskAklklAskl AAXdt
dA µσλθ −−= -1   
a
kl
a
kl
Ba
k
B
klkl
B
a
kl BBX
dt
dB µσλθ −−=   
( ) sklsklBskBklklBskl BBXdt
dB µσλθ −−= -1   
The models were solved numerically using a standard fourth order Runge-Kutta 
method. 
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Table 5.3 Additional parameters for model 2, including asymptomatic 
infection 
Parameter Definition Default value Range of 
values used 
in the model 
θA,θB Percentage of infections with A or 
B which are asymptomatic.  
θA = 0.8 
θB = 0.4  
n/a 
ψA, ψB Transmissibility of asymptomatic 
infections as a percentage of 
symptomatic infections 
transmissibility. 
(If ψ=0, then only symptomatic 
infections are transmitted, if  
ψ=0.5, the transmissibility of 
asymptomatic infections is 50% 
that of symptomatic, for ψ=1, 
transmissibility of both infections 
is the same. Potentially there could 
be an increase in the relative 
transmissibility of asymptomatic 
infections, due to lack of awareness 
of infections, and therefore no 
change in sexual behaviour (e.g. 
condom use or abstention). 
1 (No 
difference 
between 
asymptomatic 
and 
symptomatic 
infections)  
n/a 
σAak, σ
Ba
k Recovery rate from asymptomatic 
infection with A or B per year 
(recovery rate = 1/duration) 
σAsk, σ
Bs
k Recovery rate from symptomatic 
infection with A or B per year 
(recovery rate = 1/duration) 
σ = 2 per year, 
i.e. average 
duration of 6 
months 
without 
treatment, 
decreasing to 
10 per year, 
i.e. 1.2 months 
duration with 
treatment. 
With 
treatment, 
recovery 
depends on 
efficacy of 
treatment and 
the average 
time taken to 
seek 
treatment. 
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Results 
Competition between strains during phases I and II 
Phase I and II describe the Initial spread of infection in a naïve population and the early 
endemic situation. The outcome of competition between strains is investigated in the 
presence and absence of superinfection (model 1). 
Theory is used, as illustrated by model results, to predict the result of competition 
between strains during the initial spread and saturation of infection (Phase I and II). 
First, if there is cross protection the outcome of competition between strains will be 
determined by their relative R0. The strain with the higher R0 will dominate and drive 
other strains to extinction. Recent studies of HIV, for example, suggest that HIV-1 will 
eventually competitively exclude HIV-2 (Anderson and May 1996).  
This general rule of competitive exclusion with a higher R0 applies for a deterministic 
large population approximation, when there is total cross immunity. However, it is 
possible that despite a lower basic reproductive number a strain with a higher 
transmissibility (and by implication shorter duration of infectiousness) could spread 
first, only to eventually be overtaken by the strain with a higher basic reproductive 
number associated with a lower transmissibility but longer duration, which could persist 
at an extremely low prevalence early in the epidemic (Lipsitch and Nowak, 1995). In 
smaller populations the first strain drives another strain to extinction before the overall 
reproductive number is made to count. If two strains have the same basic reproductive 
number, which is likely if they are genetically very similar, they will coexist. However, 
a strain introduced when another is already endemic can only invade if it has a higher R0 
than the existing strain.  
Figure 5.2 illustrates the importance of transmissibility (in model 1), during the initial 
phase of the epidemic (total cross immunity), with the course of epidemics illustrated in 
Figure 5.2a, and the equilibrium prevalence in Figure 5.2b. Both strains have the same 
R0 (to permit coexistence) but different transmission parameters. The transmissibility of 
strain B is increased and, in compensation, its duration of infection decreased, while 
parameters for strain A were held constant. When the strains are identical in 
transmissibility and reproductive number they cause similar numbers of cases. When B 
is less transmissible the initial increase of strain B is slower and it ultimately causes 
fewer cases. This is reversed as the transmissibility of B exceeds that of A. The total 
number of infections is the same in each case since the R0 of both strains is constant. 
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High transmissibility in the growth phase enables a strain to establish itself in the 
available ecological niche quickly and is a selective advantage. 
The results described above apply to mutually exclusive strains, but it is quite possible 
that multiple strains coexist within infections. The simplest case, with two strains, is 
explored first and ‘superinfection’ is defined as infection with more than one strain. The 
evolutionary outcome of superinfection will depend upon which organisms are 
transmitted to contacts and when recovery occurs.  
Superinfection can occur in two ways; by serial acquisition i.e. acquisition of one strain 
followed by the separate acquisition of another strain, or by the concurrent transmission 
of both strains from a superinfected individual. Both are biologically feasible and may 
lead to different outcomes in terms of competition between the two strains. Serial 
transmission may present more difficulties for the invading pathogen, since it not only 
has to overcome the host defences, but also has to establish itself in the face of 
competition from the resident strain. To transmit to a pre-infected individual a strain 
may need to have a higher replication rate
 
or occupy a different ecological niche which 
avoids direct competition in the host. Alternatively pre-infection may actually aid 
further infections, by altering the host environment to be more hospitable to invading 
bacteria e.g. by changing the pH or causing inflammation. Different strains could 
conceivably have differing success in male and female hosts, which could allow both to 
persist. The order of serial infection may be important, with a hierarchy of invasiveness 
of different strains. However, in the current model this level of complexity is not 
explored. 
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Figure 5.2  Competition between strains 
 
The outcome of spread of 2 strains in the absence of superinfection with the same basic 
reproductive number for each strain but variation in the transmission coefficient of 
Strain B. Graph a – the time course of the epidemic as a whole and the epidemic of 
strain B. The bars show the equilibrium prevalence of the two strains. Graph b – The 
equilibrium percentage of strains that are B as a function of its transmission probability. 
(βA = 0.5, σA = 2; βB =0.1,..,0.9,  σB = 0.3,..,3.62)  
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The timescale over which multiple infecting organisms coexist is important. If a strain 
can out-compete a rival before the next opportunity for transmission, then 
superinfections will be less important in the overall prevalence of infections. Instead 
there would be a hierarchy of replacement and direct competition between strains, 
where ability to dislodge a rival from a host would play a role in the success of 
competing strains. Assuming that superinfection lasts long enough to be transmitted 
directly to another individual, what actually happens within the next infected individual 
will be the result of competition between the strains for resources. Another important 
interaction, which gonococci in particular are capable of, is the exchange of genetic 
material, potentially resulting in the evolution of novel strains in a short space of time. 
N. gonorrhoeae are competent for gene transfer or plasmid exchange all the time, so it 
seems highly likely that this is an important mechanism for this organism. In these 
models, however it is assumed that strains remain distinct during superinfection. 
Recovery from superinfection may be faster than from single infections, e.g. due to a 
greater host immune response or increased likelihood of symptoms and hence treatment 
seeking behaviour. Alternatively, superinfections may be more difficult for the host to 
clear, e.g. due to increased replication by the competing strains. Recovery from 
superinfection may be to the susceptible class, e.g. if effective treatment is obtained, or 
to single infection with either strain, e.g. if competition between strains removes one 
strain, or if strains have different sensitivities to antimicrobial treatment. The recovery 
rate from superinfection may be faster or slower than for single infections and may be 
dependent on the recovery rates of the individual strains present.  
If cross immunity is relaxed and superinfection can occur, various outcomes are 
possible, depending on the selective pressures acting on the system and the 
characteristics of the two competing strains (Anderson 1994; Anderson and May 1996). 
The equilibrium prevalence of the two strains is explored in Figure 5.3 where there is 
only a moderate level of cross protection so that coexistence of strains in the population 
will be frequent. Three sets of possibilities are explored: (1) both strains are transmitted 
concomitantly from a superinfection and recovery is from both strains simultaneously, 
e.g. all recovery is due to treatment and both strains are equally susceptible. In this case 
superinfection becomes the sole form of infection despite cross protection unless it 
causes more rapid recovery, giving an advantage to single strain infections. (2) Both 
strains are transmitted together but recovery from superinfection involves the removal 
of one strain before recovery from the other strain becomes possible. For example, this 
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could be due to within-host competition, where one strain rapidly drives the other to 
extinction and there is some kind of hierarchy of invasiveness, or alternatively there is a 
differential response to treatment. Here superinfection can increase the average duration 
of infections and the relative recovery rates of single and dual infections determines 
their relative frequency with a longer duration of infection for a strain providing a 
greater advantage than a comparable higher transmissibility. (3) Transmission from a 
superinfected host always generates a single infection. This could be due to stochastic 
effects or differences in transmissibility of the two strains. Here superinfection is much 
less common. 
Stronger cross protection decreases the overall prevalence of infection (with no cross 
protection, no potential infections are prevented). With no superinfection, an invading 
strain may only invade if its R0 is higher than the existing strain. Superinfection relaxes 
the impact of phase of an epidemic on the outcome of competition between strains, as 
the timing of a strain entering the population no longer determines its relative success. 
Additionally, a strain with a lower R0 may invade and coexist with the more infectious 
strain. The relative proportions are determined by the R0 of the two strains and with 
some cross protection the relative duration of infection is critical because long 
infections prevent proportionately more infections with the opposite strain than short 
ones. 
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Figure 5.3 The equilibrium prevalence of individual infections and coinfection 
with two strains 
Using model 2, for a range of assumptions about the biology of superinfection. 
Intermediate cross immunity φA=φB=0.5 throughout. Transmission: either βA=βB=0.5 or 
βA>βB (βA =0.5, βB=0.2), and βC= βA or βC=βB. Recovery: either σA=σB=0.5 or σA>σB 
(σA=2, σB=0.788) (greater recovery rate implies shorter duration). Transmission of both 
strains from superinfection: (γA =0), except last two columns (γA=0.5) 
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Competition between strains during Phases III, IV and V – Model 1 
In phases III and IV, controls take effect resulting in declining incidence and 
prevalence. The impact of the introduction of a resistance phenotype is investigated 
(model 1). 
The implementation of effective treatments or changes in host behaviour imposes new 
selective pressures in the ongoing competition between host and parasite. This may 
select for novel traits, such as resistance, or for increases in the likelihood of 
asymptomatic infection. The success of different evolutionary strategies for the 
pathogen depends upon a trade-off between the costs and benefits of the phenotypic 
change. Possible evolutionary strategies are constrained by the mechanisms available to 
the organism from within its own gene pool or drawn from other organisms through 
recombination or the transfer of plasmids (Condit 1990). Because of rapid replication 
and various genetic mechanisms e.g. DNA transfer, the evolution of bacteria can be 
extremely rapid. If competition between strains for hosts is intense, small advantages in 
reproductive fitness can quickly translate to large changes in frequency distributions of 
different strains (Levin and Bergstrom 2000; Lipsitch 2001). Frequent population 
bottlenecks, e.g. during transmission to a new host and bacterial population expansion 
in a host provide fertile conditions for the rapid evolution and distribution of new 
strains. 
In Phases III/IV of an epidemic, the implementation of controls can therefore exert a 
strong selective pressure on the bacterial populations resulting the in the evolution of 
novel strains. Treatment of symptomatic gonorrhoea infections has led to the evolution 
of resistant strains. E.g. Neisseria gonorrhoea strains resistant to penicillin were 
isolated 30 years after the introduction of the drug (Phillips 1976). Following the 
introduction of other antimicrobial compounds new resistant strains have appeared, e.g. 
to tetracycline (MMWR 1985) and fluoroquinolones (Fox, Knapp et al. 1997). There 
has been general theoretical work modelling the evolution and spread of resistance in 
bacteria which has concentrated on non-specific consumption of antibiotics and 
nosocomial infection (Austin 1999; Lipsitch and Levin 1997; Stewart, Antia et al. 
1998). Here the impact of treatment on two competing strains is modelled. 
Figure 5.4 illustrates the impact of treatment on two competing strains, with no 
superinfection. In Figure 5.4a before treatment, both strain A and B have the same 
parameters and so each contributes 50% of total prevalence. Strain A is sensitive and 
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strain B resistant to treatment. When treatment is implemented, the recovery rate of the 
susceptible strain A is greatly increased, lowering its effective reproductive number. 
Strain B rapidly outcompetes A, and drives it to extinction. If treatment reduces the 
reproductive number of A to less than one it will become extinct, whether or not there is 
competition from another strain. Even if the basic reproductive number (R0) has not 
been reduced to less than one, competition between strains can drive the sensitive strain 
A from the population when there is complete cross protection. Despite the reduction in 
prevalence of the sensitive strain the total prevalence of gonorrhoea is eventually 
restored because the resistant strain is released from competition. 
The effect of resistant infection being introduced rather than being common at the outset 
is illustrated in Figure 5.4b. Again the reproductive numbers of A and B are identical in 
the absence of treatment but A is sensitive to treatment and B resistant. In the absence 
of treatment, strain B would not be able to invade. Two alternatives are illustrated, first, 
when treatment has no effect on B it invades and rapidly spread, replacing A, and re-
establishing prevalence. Second, treatment has some effect on strain B, e.g. due to re-
treatment after initial treatment failure. Here B is still able to invade, but somewhat 
more slowly and with a lower final prevalence, due to a lower effective reproductive 
number. Which alternative is most likely depends upon the mechanism of resistance, the 
other costs it imposes and the availability of second line drugs. 
Resistant strains are able to rapidly out-compete sensitive strains when there is no 
superinfection due to the introduction of a significant difference in the effective 
reproductive number. Without superinfection, two strains can only coexist if they have 
the same R0. When superinfection is permitted, the situation becomes more complicated 
and is discussed in detail elsewhere (Anderson 1994; Anderson and May 1996). 
Competition between strains is no longer absolute and strains with different basic 
reproductive numbers can coexist in a host population.  
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Figure 5.4 Impact of treatment on resistant and susceptible strains during 
Phases III and IV of an epidemic in the absence of superinfection (i.e. total cross 
immunity) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph a – the resistant stain is present when infection is introduced. Before treatment: 
R0A=R0B; transmissibility (per contact) βA=βB =0.5; recovery (individuals per  year) 
σA =σB =2; After treatment: transmissibility βA=βB =0.5; recovery σA =10, σB =2.  
Graph b – resistant strain (strain B) introduced with 1 infected individual of each sex at 
the same time as treatment. Before treatment: R0A=R0B; transmissibility (per contact) 
βA=βB=0.5; recovery (individuals per  year) σA=σB=2. After treatment, transmissibility 
βA=0.5, βB=0.5; recovery σA=10, σB1=2, σB2=4 
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Competition between strains during Phases III, IV and V – Model 2 
During phases III, IV and V controls take effect. The model used includes resistance 
phenotypes and asymptomatic infections (model 2). 
During Phases III, IV and V, in the presence of treatment asymptomatic infections may 
play an extremely important role in determining the success of a strain. The effect of 
different treatment strategies is investigated, on competition between strains with 
different asymptomatic and resistant phenotypes using model 2. 
In Figure 5.5 both strains have the same basic reproductive number prior to treatment 
and the same transmission/duration parameters, but strain A generates a higher 
proportion of asymptomatic infections (80:20 asymptomatic: symptomatic) compared to 
B (40:60). For the purposes of this discussion, it is assumed that the recovery rates, for a 
particular strain, of both asymptomatic and symptomatic infections are the same in the 
absence of treatment. The effect of treatment is incorporated in the model by decreasing 
the duration of infection of those treated, according to whether the strain is susceptible 
or resistant. Outcomes are shown 2 years after treatment, when levels have largely 
stabilised i.e. in Phase IV of the epidemic, the endemic situation after controls are 
introduced. 
Column (a) shows the distribution of infections by strain and by asymptomatic or 
symptomatic infection before treatment. As expected, each strain accounts for 50% of 
the total infections and infections are asymptomatic and symptomatic according to the 
ratios above. If symptomatic infections are treated and both strains are sensitive to drug 
(column b) there is a modest decrease in the overall prevalence. While symptomatic 
infections decrease quite dramatically prevalence is maintained by asymptomatic 
infections. The proportion of prevalent infections that are asymptomatic increases for 
strain A to 95% and for strain B to 83%. Strain A has a higher probability of causing 
asymptomatic infection and consequently a greater proportion of those infected are 
untreated and the proportion of all infections caused by A increases to over 90%.
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The impact of the introduction of a screening programme, or comparable strategy e.g. 
contact tracing and partner notification, which results in the treatment of both 
asymptomatic and symptomatic infections is illustrated in column (c). If treatment 
decreases the basic reproductive number of strains A and B to less than one, both will 
become extinct. If however the basic reproductive number for each strain remains above 
one, both infections can persist, retaining the same proportions of A to B and 
asymptomatic to symptomatic infections, but at a much lower overall prevalence.  
A similar scenario is illustrated in column (d) where both types of infection can be 
detected and treated, but strain A is sensitive and B resistant. Competition between A 
and B will quickly drive strain A to extinction due to a lower effective number. The 
recovery rate of the resistant strain B is still increased due to re-treatment with second 
line options so its prevalence falls.  
In column (e), as in column (b), symptomatic infections alone are treated, and strain A 
is sensitive and B resistant, but strain A is more likely to lead to asymptomatic 
infections. Both strains persist for at least two years, but the propensity to cause 
asymptomatic infections is a greater advantage than resistance, illustrating the impact 
that failure to identify and treat asymptomatic infections may have. Unless there is an 
effective screening program to identify asymptomatic cases, surveillance data on the 
incidence of symptomatic gonorrhoea might show a dramatic decrease masking the 
continued high levels of asymptomatic infections. For columns (e) and (b) the incidence 
of symptomatic infections of both strains declines and eventually reaches a new 
equilibrium point, when strain A outcompetes B. The time taken to reach the new 
equilibrium is determined by the relative difference between the R0 of A and B after 
treatment. For these particular parameters, strain A has a higher R0 than B after 
treatment and will eventually dominate, but for different proportions of asymptomatic 
infections for the strains or different responses to treatment, strain B would dominate. If 
the benefit conferred by resistance is equivalent to the benefit gained from avoiding 
treatment due to a higher proportion of asymptomatic infections, i.e. if the effective 
reproductive numbers after treatment is introduced are the same, both strains can coexist 
indefinitely. If the reproductive numbers are similar, then both strains may coexist for 
many years before one or other dominates.  
Empirical evidence of asymptomatic strains gaining a selective advantage is scarce 
probably because it has not been sought. In the case of gonorrhoea, where asymptomatic 
infections are common, particular strains may be associated with asymptomatic, or very 
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mild infection e.g. the AHU auxotype (Crawford, Knapp et al. 1977). In Washington, 
the prevalence of the AHU auxotype has declined steadily from 52% in 1971 to 1074 to 
0% in 1994 to 1996. This was believed to be due to increased screening efforts, 
resulting in treatment of more asymptomatic infections. More recently (1996 - 1997), 
the CU auxotype, which is also associated with asymptomatic infection, has increased in 
prevalence in this region, despite an overall decline in gonorrhoea rates of 80% 
(Whittington and Holmes 2000). The exact reasons for the changes in subtype 
distribution of gonorrhoea are not well understood. This CU auxotype is more likely 
than other auxotypes to be misdiagnosed as nongonococcal urethritis (NGU), which 
may account for part of the increase. Other possible explanations include: decreased 
screening, decreased competition between strains, or genetic drift resulting from purely 
stochastic events facilitated by the lower population size and the random introduction 
and disappearance of subtypes. 
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Discussion 
The ecology and evolution of an infectious disease are influenced by both the natural 
dynamics of epidemics and the interventions used to control them. An extension of a 
mathematical model which includes two competing strains, with the possibility of 
superinfection or asymptomatic infections is used to explore the outcome of 
competition. The results illustrate the conditions that lead to coexistence and the 
optimum phenotypes of organisms according to the phase of epidemic. In the early 
phases of an epidemic, where the majority of contacts are with susceptible hosts, the 
simplest models of competition suggest that transmissibility is a key attribute. If strains 
can coexist within a host, the impact of transmissibility on the success of competing 
strains is reduced and instead, the duration of infection becomes paramount. Founder 
effects are also important at this stage, as once a strain is established in the population, 
only strains with a higher basic reproductive number (R0) can invade. 
The biological mechanisms allowing coinfection and its clinical consequences are 
poorly specified. To generate testable predictions from models including superinfection, 
assumptions need to be based on the biology of specific organisms. For example, there 
is convincing evidence (Martin and Ison 2003) that mixed infections of gonococci do 
occur and that two strains can be transmitted simultaneously, depending on the 
relationship between the course of infection and sexual exposure. However, competition 
between strains within the host is intense and it seems likely that one of the strains or a 
novel, composite descendant, resulting from gene exchange between different lineages 
will rapidly come to dominate in a particular host and be transmitted onwards. It is 
likely that intense competition between strains in high risk (core) individuals may be 
important in driving the evolution of novel strains.  
The impact of different treatment strategies on the evolution of STIs like gonorrhoea 
may differ at different phases of an epidemic. Early interventions, during the growth 
phase, are likely to have more impact than those made once a strain is endemic. The 
need for identifying and treating asymptomatic infections is highlighted. Treatment of 
symptomatic infections only has a small effect on the total prevalence of infections 
(depending on the proportion of asymptomatic infections), but reduces the number of 
symptomatic infections. The increase in the proportion of infections that are 
asymptomatic may result not from genetic changes in the population of organisms, but 
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simply be a product of the asymptomatic infections not being curtailed in comparison to 
symptomatic infections.  
A decrease and subsequent stabilisation in the incidence of symptomatic cases is seen in 
the model when only symptomatic infections are treated, therefore, the observed 
decline, and subsequent levelling off of reported cases, e.g. USA (CDC 1999), could be 
in part explained by this effect. There will be a selective advantage to organisms that are 
prone to cause asymptomatic infections, which could well further increase the 
proportion of infections without obvious symptoms. A major concern would be that 
such infections still have serious long-term sequelae. In the example shown, strains with 
a high proportion of asymptomatic infections could compete well, even against strains 
resistant to antimicrobial therapy. For all cases it is clear that treatment will act as a 
strong selective force for novel strains. Advantages in resisting or avoiding treatment 
will result in the rapid spread of a strain through the population and elimination of 
competitors.  
In the simulations presented in this thesis, extreme levels of competition between strains 
are assumed, which in reality may not exist, due to heterogeneities in hosts or more 
subtle differences in the biological properties of the strains and their ability to colonise 
different hosts. The deterministic model assumes that partnerships are instantaneous and 
there is no concurrency. Therefore two features of real partnerships e.g. duration of 
partnership and concurrency, which have been shown to affect the epidemiology of 
STIs (Ghani, Swinton et al. 1997; Morris and Kretzschmar 1997) are not captured in 
these models. Models that include more detail and have been validated are necessary to 
predict the outcome of treatment strategies and informing decision-makers.  
Only through careful monitoring of the genotype of organisms, the link between the 
genotype and the in vivo phenotype and the relationship to epidemic phase will it be 
possible to gain a full understanding of STD evolution. Such an understanding would 
underpin the construction of the detailed and well validated models necessary to predict 
the outcome of treatment strategies. 
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Chapter 6  Discussion 
This chapter draws together the findings of the thesis. Several themes have emerged 
from the results presented and a variety of important issues in sexually transmitted 
disease epidemiology raised. These can be considered in terms of biology, behaviour 
and interventions. The future directions of research on mathematical models of STIs are 
discussed. 
Gonorrhoea and chlamydia are an important public health problem in the developed 
world. Despite readily available treatment and a commitment from the UK government 
to control STIs, there has been a sustained increase in gonorrhoea and chlamydia 
diagnoses. There remains a need for better control. A better understanding of the 
epidemiology of these infections is necessary to allow appropriately targeted control 
interventions. The mathematical models presented in Chapter 2, 3 and 4 allow 
interventions to be compared.  
There are various unique features of STI epidemiology to consider when developing 
mathematical models (Anderson 1999). For STIs, the course of an epidemic is 
determined by the rate of partner change and not population density as for other 
infections such as influenza or measles. There is also much more heterogeneity in 
individual risk than for airborne or community-acquired infections. High rates of partner 
change increase the effective size of the sexual network available for infection. In 
addition, the importance of mixing patterns (i.e. partner choice) has been recognised as 
a factor influencing the epidemiology of an STI (Garnett & Anderson, 1993 and Ghani, 
1997). 
Accurate parameter estimates are essential for realistically parameterising mathematical 
models, but also for determining the impact of interventions. There are ethical and 
practical difficulties associated with conducting experiments on human infection, 
although a small number of investigations are ongoing for male gonococcal infection.  
Extensive parameter analysis was conducted in Chapter 3 to choose the model scenario 
which provided the best fit to the data. Whilst this study highlights the need for much 
more information for several parameters, this approach can indicate the extent to which 
parameter uncertainty is likely to impact on qualitative model results. In addition, this 
highlights areas where additional empirical research could be undertaken. 
The epidemiology of sexually transmitted infections is characterised by heterogeneity. 
In terms of the natural history of infection, strains circulating in the population may 
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differ in their susceptibility to antibiotics, their ability to survive in particular 
anatomical sites, their ability to colonise men or women, their likelihood of causing 
serious disease and their chances of being detected by diagnostic tests. The emergence 
and spread of novel strains is the subject of Chapter 5. Maintaining surveillance and 
knowledge of the biology of these organisms to identify the emergence of new strains 
which could subvert current interventions is crucial for the future treatment and 
management of infections.  
Probably the most interesting and most studied but least well quantified aspect of STI 
epidemiology is human sexual behaviour. Risk of acquiring an STI is complex. Human 
sexual behaviour is highly variable across a population and within an individual’s 
lifetime. Not all humans are at equal risk of acquiring an STI. Also not all humans with 
the same contact rate with new sexual partners are at the same risk. Whilst most markers 
of risk concentrate on individual behaviour, studies such as those by Low presented in 
Chapter 3 show the importance of an individual’s position in the sexual network in 
raising or lowering their risk of acquiring infection relative to the general population. 
This heterogeneity in risk also plays a role in ensuring the continued transmission of 
STIs. Both gonorrhoea and chlamydia occur more often in those who are difficult to 
reach through standard health care programmes, due to social exclusion. The challenge 
for health care providers is therefore to provide appropriate interventions and to 
maintain those interventions to include new cohorts of young people as they become 
sexually active. Alongside interventions, maintaining surveillance is essential to be able 
to assess the efficacy of interventions.  
The models presented here have attempted to incorporate some of the complexity and 
heterogeneity in novel frameworks and to use available data in new ways. In Chapter 2 
a model including both gonorrhoea and chlamydia is presented. The aim was to 
investigate the possible mixing patterns by activity in the population which would give 
rise to the observed proportion of coinfections with both gonorrhoea and chlamydia. 
This proved to be difficult due to the number of poorly quantified parameters. However 
this approach could be pursued, validated and tested with more specific data.  
The advantage of the data presented in chapter 3 was that both behavioural and 
epidemiological parameters were estimated for a well defined population in South East 
London. Extensive analysis of the impact of the parameter choices on the model outputs 
made the results more robust. The parameter values obtained for the duration of 
infection and the transmission probability are well within reasonable limits, which is 
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reassuring. Even a simple deterministic model may perform reasonably well in this type 
of analysis, given appropriate choices of complexity to be included. In this instance, the 
inclusion of ethnic specific choices of partner ethnicity captured some of the most 
relevant aspects of gonorrhoea in this population.  
Another novel source of information about the epidemiology of gonorrhoea, or 
chlamydia is the number of people who become reinfected and the length of time 
between infections. As discussed in chapter 4 reinfection and the lack of a significant 
sustained immunological response to these infections, presence of asymptomatic 
infections and the concentration of disease within high risk individuals, means that 
reinfection is common. Reinfection also represents a potentially useful measure of the 
success of an intervention, which is relevant to the health of those in whom reinfection 
is prevented.  
Asymptomatic infection is an important component of the epidemiology of infection 
with gonorrhoea and chlamydia. Unrecognised or asymptomatic infections represent a 
reservoir of infection which may go untreated for a substantial period of time; this may 
increase the probability that the infected person will develop complications. In addition, 
individuals without symptoms are unlikely to modify their behaviour whilst infectious, 
so the potential for onwards transmission of infection remains while they are infectious. 
Little is known about the relation between symptoms and transmissibility for either 
gonorrhoea or chlamydia but modelling approaches can investigate a range of scenarios. 
In Chapter 5, a theoretical analysis of the different selective pressures which are exerted 
on populations of bacteria was undertaken. The interplay between asymptomatic and 
symptomatic infections and resistant and susceptible infections was explored. In general 
treatment selects for drug resistance and treatment of symptomatic infections selects for 
asymptomatic infections. Depending on the effect of treatment on the R0 of a strain, 
either outcome may be selected for. For example treatment of only symptomatic 
infections may favour a predominantly asymptomatic, drug sensitive strain over a 
resistant but predominantly symptomatic one. Screening and contact tracing which 
identify and treat asymptomatic cases will tip the balance in favour of the evolution of 
drug resistance. Understanding these selective pressures requires constant monitoring 
the changes in the natural history of bacterial infections and an appreciation of the 
expected effects of an intervention.  
Throughout this thesis, deterministic transmission models have been used to investigate 
the epidemiology of gonorrhoea and chlamydia. Recent interest has centred on network 
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formulations. Both types of modelling approach have their advantages. Deterministic 
models are, by definition well-defined and for a given set of parameters produce 
identical outputs. Individual-based network models give a range of outputs for any 
given set of input parameters and therefore require more analysis to interpret. In both 
cases the form of the model itself has unpredictable elements, such as the impact that 
the choice of partner matching algorithm has on the overall structure of the sexual 
network and whether this is true to the formation of partnerships in reality.  
All models involve simplification and abstraction of the complexities that make up the 
sexual behaviour and transmission of STIs in a population. Whilst it may seem that 
there is a debate of which model is the “right” model to use, in fact the appropriateness 
of a model depends very much on the question one wishes to answer. A robust 
comparison of different methods of analysing model performance for different tasks is 
needed. Several authors are attempting to do this with respect to STI epidemiology and 
a few have compared their results to empirical data (Eames and Keeling 2002; Ghani 
and Garnett 2000; Morris 1997), but most have simply shown how different models 
perform consistently in different ways. The future of mathematical modelling of 
sexually transmitted infections should be characterised by close collaboration between 
clinical scientists and epidemiologist who collect and understand the context of data and 
theoreticians who can build an accurate picture.  
Future directions 
Modelling of STIs in the future will require continuation of the process of parameter 
estimation and model validation using good quality data. Only in this way can the field 
progress. Other model structures, in particular individual based network models, are 
emerging as important tools for understanding the social component of STI transmission 
and as the tools for interpreting and analysing these models continue to improve, they 
will surely produce fascinating, new insights into the epidemiology of STIs. An 
interesting feature is the apparent robustness of STIs to interventions, which is not 
predicted by most current models. The properties of human sexual networks hold the 
key to a fuller understanding of sexually transmitted disease. Further work is needed to 
improve the realism of such models or at least more fully validate the findings from 
more abstract models with real life data.  
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Conclusions 
As outlined in chapter 1, infections with gonorrhoea and chlamydia represent a 
significant public health threat. However, in large part due to the difficulty in reaching 
those at highest risk, neither infection is well controlled. The modelling studies outlined 
demonstrate the need for accurate data to define the parameters which determine the 
reproductive number of the infection, namely, the transmission probability, the duration 
of infectiousness and the contact rate in the population. This thesis has used some new 
data and reanalysed existing data in novel ways to investigate the epidemiology of 
gonorrhoea and chlamydia. The main results are that realistic outputs can be achieved 
when empirical data are used to parameterise mathematical models. The sexual 
behaviour of the general population is difficult to quantify, since it is highly 
heterogeneous and therefore simulations based on smaller populations, such as those in 
Chapter 3 and 4 are useful for validating and testing hypotheses. Data were used in new 
ways to enable improved parameter estimation and incorporation of relevant complexity 
in simple models. A recurring theme in the studies presented here is the absence of good 
estimates of many of the parameters needed in a mathematical model. This absence of 
accurate information highlights what is needed from empirical studies and should 
promote caution in interpreting model results. 
Appendix 
Antibiotics used in treatment of gonorrhoea and chlamydia 
This list is not intended to be exhaustive, but to illustrate the differences between the 
major classes of antibiotics used in the treatment of gonorrhoea and chlamydia, as 
described in USA and UK treatment guidelines (MMWR 1998; MMWR 2002a; 
Radcliffe, Ahmed-Jushuf et al. 1999). Antibiotics are either bacteriostatic, i.e. prevent 
reproduction and growth or bactericidal, i.e. cause death. Table 1.2 notes the first 
reports of clinically significant drug resistance in N. gonorrhoeae to various antibiotics. 
The MEDSCAPE drug directory was searched for the major classes of antibiotics used 
for treatment of gonorrhoea and chlamydia in the UK (Table A.1) and USA (Table A.2) 
(Medscape 2001). The chemical structures are illustrated in Table A.3. 
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Penicillins 
Natural penicillins (penicillin G, penicillin V) 
Semisynthetic penicillins, e.g. aminopenicillins (ampicillin, amoxycillin), pipericillin 
Extended spectrum penicillins. 
Mechanism of action 
The same mechanism of action applies to natural and semisynthetic penicillins. 
Bactericidal, β-lactam antibiotics act by inhibition of mucopeptide synthesis in the 
bacterial cell wall. Penicillins are hypothesised to act as analogues of acyl-d-alanyl-d-
alanine, binding reversibly to various enzymes (penicillin binding proteins or PBPs), 
and thereby disrupting mucopeptide synthesis. This results in osmotically unstable 
organisms, which normally lyse. β-lactam antibiotics are most active when cells are 
actively dividing and synthesising new cell walls. 
Natural penicillins are normally active against non-penicillinase producing strains of 
Neisseria gonorrhoeae, but due to increasing prevalence of resistant strains CDC 
changed guidelines in 1989 and no longer recommends penicillins as first line therapy 
(MMWR 1989). Penicillin is not effective against chlamydial infections.  
Structures (Table A.3)  
Chemistry 
Natural penicillins 
Natural penicillins are produced by the fermentation of mutant strains of Penicillium 
chrysogenum. Various forms, with different side chains can be produced by the addition 
of specific chemicals to the culture media. Of these, penicillin V (phenylacetic acid) and 
penicillin G (phenoxyacetic acid) are of clinical interest. The alternative side chains 
(phenoxymethyl or phenyl, respectively) result in different pharmacological properties: 
penicillin V has more acid stability but decreased antibacterial activity compared to 
penicillin G. 
Aminopenicillins 
Aminopenicillins are semisynthetic penicillin derivatives produced by acylation of 6-
aminopenicillanic acid (6-APA). They are characterised by a free amino group at the 
alpha position R group on penicillin nucleus. This increases the activity of 
aminopenicillins against gram-negative bacteria compared with natural penicillins by 
improving the penetration of the drug across the cell wall.  
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Ampicillin is the prototype aminopenicillin and is composed of penicillin G with an 
amino group at the alpha position on benzene ring at R on the penicillin nucleus. 
Amoxycillin is the p-hydroxyl analogue of ampicillin. 
Piperacillin is a semisynthetic acylaminopenicillin and is the piperazine derivative of 
ampicillin, may be active against some strains of gonorrhoea resistant to natural 
penicillins.  
Resistance 
The two possible mechanisms of resistance to penicillins are: production of β-lactamase 
(inactivates β-lactam drugs) and intrinsic resistance (presence of permeability barrier or 
alterations in the target enzymes, PBPs). 
Both complete and relative resistance have been reported for N. gonorrhoeae (Table 
1.2). PPNG strains are resistant to penicillin and are usually also resistant to 
aminopenicillins, but may be inhibited by spectinomycin, cefotixin, cefuroxime or third 
generation cephalosporins. Relative resistance is due to either alterations in PBP or 
presence of a permeability barrier. Strains may also be resistant to aminopenicillins, 
tetracyclines, erythromycin and chloramphenicol, but may be susceptible to 
spectinomycin, cefoxitin or third generation cephalosporins. Some strain of Neisseria 
gonorrhoeae resistant to natural penicillins (including some PPNG) may be inhibited by 
acylaminopenicillins e.g. piperacillin. 
Cephalosporins 
First generation cephalosporins e.g. cefadoxil 
Second generation cephalosporin, e.g. cefaclor, cefoxitin 
Third generation cephalosporins e.g. cefotaxime, ceftizoxime, ceftriaxone 
Forth generation cephalosporins e.g. cefepime. 
Mechanism of action 
Cephalosporins are β-lactam antibiotics, and are usually bactericidal. Thought to act as 
substrate analogues of acyl-d-alanyl-d-alanine in the same way as penicillins and 
therefore also only act on actively divided cells. Cephalosporins are structurally and 
pharmacologically related to penicillins.  
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Structures (Table A.3) 
Chemistry 
Cephalosporins are semisynthetic β-lactam antibiotic derivatives of cephalosporin C, 
which is produced by the fungus Cephalosporium acremonium. Cephalosporins in 
clinical use all contain 7-aminocephalosporanic acid (7-ACA) nucleus, which is 
composed of a β-lactam ring fused with a six-membered thiazolidine ring of penicillins. 
Aminothiazolyl methoxyimino cephalosporins (3rd generation, broad spectrum), e.g. 
cefixime, cefdinir, cefodoxime proxetil, ceftibuten, ceftraxime, ceftrazidone, 
ceftizoxime, contain an aminothiazolyl side chain at position 7 of the cephalosporin 
nucleus, which enhances their antibiotic activity and confers a high degree of β-
lactamase stability. 
Resistance 
Although they remain effective, strains with reduced susceptibility to 3rd generation 
cephalosporins have been reported in the Western Pacific region (WHO 2002). 99.9% 
of isolates in USA in 1994 were susceptible to broad-spectrum cephalosporins (Fox, 
Knapp et al. 1997). Cefixime is not hydrolysed by beta-lactamases classified as 
Richmond-Sykes types Ia (P99), III (TEM-1, TEM-2, SHV-1), IV (K-1), and V (OXA-
2, OXA-3, PSE-1, PSE-4, PSE-4), which includes those produced by Neisseria 
gonorrhoeae. Some authorities recommend that third generation oral cephalosporins are 
discouraged as this will lead to self-medication, which in turn can increase the 
development of resistance (van de Laar, van Duynhoven et al. 1997).  
Resistance to earlier cephalosporins (first and second generation) may occur through 
several mechanisms: either the drug cannot permeate the bacterial cell wall, or the drug 
does not inhibit the metabolic pathways of the bacterium. Additionally resistance can 
occur by direct action of the bacteria on the drug, breaking it down into harmless 
metabolites. Production of β-lactamase is a common example of this form of resistance. 
The bacteria produce this enzyme, which inactivates the cephalosporin by hydrolysing 
the β-lactam ring. However, in practice resistance usually results from both production 
of β -lactamases and presence of permeability barriers.  
Spectinomycin 
Spectinomycin is obtained from cultures of Streptomyces spectabilis. 
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Mechanism of action 
Spectinomycin is usually bactericidal in action. Appears to inhibit protein synthesis by 
binding to 30S ribosomal subunit. 
Structures (Table A.3) 
Tetracyclines 
Mechanism of action 
Usually bacteriostatic, but may be bactericidal in high concentrations or against highly 
susceptible organisms. Appear to inhibit protein synthesis by binding reversibly to 30S 
ribosomal subunit and inhibiting binding of aminoacyl transfer RNA to the ribosome. 
Additionally it appears to bind to the 50S ribosomal subunit. There is early evidence to 
suggest that tetracycline also alters the cytoplasmic membrane of susceptible organisms, 
causing leakage of nucleotides and other cellular components. 
Structures (Table A.3) 
Chemistry 
Tetracyclines are natural and semisynthetic antibiotics derived from cultures of 
Streptomyces. The tetracycline nucleus (Table A.3) forms the basis of all tetracyclines 
currently available. Different drugs can be formed by addition of different side groups at 
R5, R6 and R7  
Resistance 
Resistance may be natural or acquired and the mechanism of resistance is usually 
decreased permeability of the cell surface. This may be due either to mutations or the 
presence of an inducible plasmid-mediated resistance factor acquired by conjugation. 
Plasmids carrying resistance factors may be transferred between species and may code 
for resistance to more than one type of antibiotic. 
N. gonorrhoeae strains resistant to tetracyclines were first reported in the USA 1985 
(MMWR 1985) and subsequently increased (MMWR 1987). Tetracycline resistance 
was reported in UK at around the same time (Beattie, Moyes et al. 1999; Ison, Gedney 
et al. 1987) and followed the same increasing trend. In the USA and UK treatment 
guidelines have been changed and tetracycline is no longer recommended as a first line 
therapy (MMWR 1998; Radcliffe, Ahmed-Jushuf et al. 1999).  
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In the Netherlands, there has been an increase in the prevalence of tetracycline resistant 
strains of N. gonorrhoeae (TRNG), even though this drug is not used to treat 
gonorrhoea (van de Laar, van Duynhoven et al. 1997). It is possible that treatment of 
chlamydia with tetracycline has contributed to the development and spread of 
tetracycline resistant gonococci. The evolution of resistant strains of gonorrhoea 
therefore must be seen within a wider context of treatment of associated infections such 
as chlamydia and other STDs, and antibiotic use in general (Austin, Kakehashi et al. 
1997; Bonhoeffer, Lipsitch et al. 1997) 
High level resistance to tetracycline is conferred by a 25.2MDa plasmid, derived from 
the 24.5MDa conjugative plasmid with an additional tetM determinant. (Morse, Johnson 
et al. 1986)  Some strains with TRNG may be susceptible to other antibiotic agents, 
such as penicillins or cephalosporins (e.g. ceftriaxone). Strains which are also PPNG 
have been reported in the US and elsewhere. Testing for TRNG is more difficult and 
expensive than for PPNG, which slowed the early detection of such strains. 
Chromosomally mediated resistance to tetracycline also occurs and many of these 
strains also possess chromosomally mediated resistance to penicillin (CMRNG). 
Macrolide antibiotics 
Erythromycins.  
Azalides e.g. azithromycin 
Mechanism of action 
Macrolide antibiotics are usually bacteriostatic (sometimes bactericidal, but not against 
N. gonorrhoeae). Act on the 50S RNA subunit to inhibit translocation of aminoacyl 
transfer RNA and thus inhibit protein synthesis. This class of drugs are only effective 
against multiplying organisms. Penetrates gram-positive bacteria better than gram-
negative bacteria. Activity decreases at low pH. Accumulates in phagocytes, which is 
necessary for activity against intracellular pathogens such as Chlamydia trachomatis.  
Erythromycins 
Erythromycin is a macrolide antibiotic produced by Streptomyces erythreus. 
Erythromycin is a weak base and readily forms salts and esters with organic acids. 
Erythromycin penetration is better in gram positive than gram-negative bacteria.  
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Azalides  
A subclass of macrolides, azalides have a nitrogen atom at position 9a of the lactone 
ring compared with other macrolides. The semisynthetic azalide, azithromycin, contains 
a methyl-substituted N atom at the 9a position of the macrolide ring, which 
distinguishes it from erythromycin. Azithromycin has an extended spectrum of activity 
compared to erythromycin and is more active in vitro against gram-negative bacteria, 
due to better penetration of the cell wall. It is also less prone to acid degradation. 
Resistance to macrolide antibiotics (NB no specific mention of gonorrhoea/chlamydia 
on the website) 
• This can be natural or acquired and may occur via several mechanisms:  
Decreased permeability of cell envelope to antibiotic 
• Plasmid-mediated active efflux of antibiotic  
• Enzymatic inactivation of antibiotic by plasmid-mediated esterases or 
phosphotransferases 
• Chromosomally mediated alteration of a single 50S ribosomal protein at receptor 
site, resulting in decreased macrolide affinity 
• Alteration of 23S ribosomal RNA of 50S ribosomal subunit by methylation of 
adenine to decrease macrolide affinity 
Quinolones 
Fluoroquinolones e.g. ciprofloxacin, enoxacin, ofloxacin 
Mechanism of action 
Fluoroquinolones are bactericidal and act by inhibiting the enzymes DNA gyrase and 
DNA topoisomerase IV, both of which are involved in DNA replication. Disruption of 
DNA replication leads to cell death (Hooper 2000). 
Structures (Table A.3) 
Resistance 
Resistance to ciprofloxacin has increased substantially in the UK and USA in the last 5 
years. In the UK resistance to ciprofloxacin reached nearly 10% in 2002, with wide 
local variations. The national guidelines have been changed to reflect this and 
ciprofloxacin is no longer recommended as first line therapy (Fenton 2003; GRASP 
2003)(CDSC 2003). 
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Table A.1 Treatment guidelines 1. Current recommendations for treatment of chlamydia and gonorrhoea from the UK national guidelines 
(CEG and Bignell 2002; CEG, Horner et al. 2002) 
Disease R/A§ Agent Dose (g) 
Method of 
administration 
Number 
of doses 
per day 
Course 
(days) 
Comments relating to specific 
regimens 
 
Follow-up and general 
comments 
Doxycycline (Tet) 0.1 Oral 2 7 
Cheaper than Azi 
Contraindicated in pregnancy 
Retest not necessary R 
Azithromycin (M) 1 Oral 
Single dose (1 hr 
before food or 2 hrs 
after food) 
Dosing regimen improves 
compliance 
Retest not necessary 
Erythromycin (M) 0.5 Oral 4  2 
7 
14 
GI side effects in 20-25% 
sufficient to cause 
discontinuation of treatment.  
Decreased efficacy compared 
with doxycycline or 
azithromycin 
Retest may be considered after 3 
weeks 
Deteclo (Tet) 0.3 Oral 2 7  
0.2 2 7 
Ofloxacin (Q) 
0.4 
Oral 
1 7 
Similar efficacy, better side 
effect profile, but more 
expensive than doxycycline 
Chlamydial 
infection - 
uncomplicated 
A 
Tetracycline (Tet) 0.5 Oral 4 7 Contraindicated in pregnancy 
Both recommended regimes 
have equal efficacy 
Treat partners  
Refer contacts to GUM 
0.5 4 7 Erythromycin (M) 
0.5 
Oral 
2 14 
<95% effective. Side effects 
significant  
Chlamydial 
infection in 
pregnant 
women 
R 
 
Amoxycillin (P) 0.5 Oral 3 7 
Similar cure rate to erythromycin 
and better side effect profile. Has 
been shown to induce latency in 
vitro, so may not be reliable.  
Quinolones and tetracyclines 
are contraindicated in 
pregnancy. 
Partner notification should be 
discussed and documented. 
  
 
Azithromycin (M)  
Not Recommended 1 Oral Single dose  
Recent data suggest Azi might be 
safe and effective, but 
insufficient to recommend as 
routine therapy for pregnant or 
lactating mothers. 
Ciprofloxacin 0.5 Oral Single dose  
Ofloxacin 0.4 Oral Single dose  
R 
Ampicillin + 
Probenecid 
2 or 3 
1 Oral Single dose 
Applicable in areas where 
regional prevalence of penicillin 
resistant N gonorrhoeae  <5%  
At least one follow up 
assessment recommended for 
all gonococcal infections. 
Sexual partners of 
symptomatic males should be 
traced from previous 2 
weeks. Asymptomatic 
infections should trace 
partners from preceding 3 
months. 
Ceftriaxone 0.25 i.m. Single dose 
Cefotaxime 0.5 i.m. Single dose 
Uncomplicated 
gonococcal 
infection of 
cervix, urethra 
and rectum in 
the adult/ 
adolescent 
A 
Spectinomycin 2 i.m. Single dose 
All three are highly active 
against penicillin and quinolone 
resistant strains of N 
gonorrhoeae (Ia). 
Not usually used as first line 
therapy in United Kingdom, 
but valuable against imported 
infection from South East 
Asia, and/or when special 
considerations apply. 
Ceftriaxone  0.25 i.m. Single dose  
Ciprofloxacin (Q) 0.5 Oral Single dose  Uncomplicated gonococcal 
infection of the 
pharynx 
R 
Ofloxacin (Q) 0.4 Oral Single dose  
Single dose treatments using 
ampicillin or spectinomycin 
have a poor efficacy in 
eradicating gonococcal 
infection of the pharynx. 
Ceftriaxone 0.25 i.m. Single dose  
Cefotaxime 0.5 i.m. Single dose  
Ampicillin +  
Probenecid 
2 or 3 
1 oral Single dose 
Where regional prevalence of 
penicillin resistant N. gonorrhoea  
<5% 
Gonococcal 
infection in 
pregnant 
women 
R 
Spectinomycin 2 g i.m. Single dose  
Quinolones and tetracyclines 
are contraindicated in 
pregnant women 
§R = Recommended therapy; A = Alternative therapy -S = Cephalosporins; M = Macrolides, including the erythomycins and azalides; P = penicillins; Q = Quinolones; Tet = 
Tetracyclines
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Table A.2 Treatment guidelines USA. Current recommendations for treatment of chlamydia and gonorrhoea from CDC guidelines 1998 
(MMWR 1989) 
Disease R/A§ Agent Dose (g) 
Method of 
administration 
Number 
of doses 
per day 
Length 
of course 
(days) 
Comments relating to specific 
regimens 
 
Follow-up and general 
comments 
Azithromycin (M) 1 Oral Single dose 
 
Dosing regimen improves 
compliance 
Retest not necessary R 
 
Doxycycline (Tet) 0.1 Oral 2 7 
Cheaper than Azi 
Contraindicated in pregnancy 
Retest not necessary 
Erythromycin base 
(M) 0.5 Oral 4 7 
Erythromycin 
ethylsuccinate (M) 0.8 Oral 4 7 
GI side effects 
Decreased efficacy compared 
with Azi, Dox and Ofl 
Retest may be considered after 3 
weeks 
Chlamydial 
infection 
A 
Ofloxacin (Q) 0.3 Oral 2 7 
Expensive 
Equivalent efficacy to Azi and 
Doxy 
Contraindicated in pregnancy 
Erythromycin base 
(M) 0.5 Oral 4 7 R 
 
Amoxycillin (P) 0.5 Oral 3 7 
Erythromycin base 
(M) 0.25 Oral 1 14 
Erythromycin 
ethylsuccinate (M) 0.8 Oral 4 7 
Erythromycin 
ethylsuccinate (M) 0.4 Oral 4 14 
Repeat testing recommended 3 
weeks after completion, none of 
these regimens is highly 
efficacious. 
Side effects of erythromycin 
compounds might result in 
patient non-compliance 
Chlamydial 
infection in 
pregnant 
women A 
Azithromycin (M) 1 Oral Single dose  
Recent data suggest Azi might be 
safe and effective, but 
insufficient to recommend as 
routine therapy 
Refer patients sexual partners 
from past 60 days for 
treatment 
Return visit if symptoms 
persist or recur 
Recommend abstention from 
sex for 7 days and/or until the 
end of the course of treatment 
and/or until all partners 
treated 
Patients infected with HIV 
should receive same 
treatment 
Quinolones and tetracyclines 
contraindicated in pregnancy. 
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Disease R/A Agent Dose (g) 
Method of 
administration 
Number 
of doses 
per day 
Length 
of 
course 
(days) 
Comments relating to specific 
regimens 
 
Follow-up and general 
comments 
Cefixime  
(C-S) 0.4 Oral Single dose 
97.1% efficacy 
Similar spectrum to cefixime, but 
not as high or sustained a 
bactericidal level 
Ceftriaxone 
(C-S) 0.125 i.m. Single dose 
99.1% efficacy 
Safe and effective for gonorrhoea 
at all sites including 
rectal/pharyngeal 
Ciprofloxacin 
(Q) 0.5 Oral Single dose 
99.8% efficacy in urogenital and 
anorectal infections 
Safe and relatively inexpensive 
Contraindicated in pregnancy 
One 
of: 
Ofloxacin  
(Q) 0.4 Oral Single dose 
98.4% efficacy 
Urogenital and anorectal 
infections 
Contraindicated in pregnancy 
Azithromycin 
(M) 1 Oral Single dose 
Also effective for chlamydial 
infection 
R 
Plus 
one 
of: Doxycycline (Tet) 0.1 Oral 2 7  
No need for retest 
If symptoms persist isolate 
should be cultured and tested 
for antibiotic susceptibility 
Partner referral important as 
most recurrent infections are 
due to reinfection rather than 
treatment failure 
Persistent urethritis, cervicitis 
or proctitis also may be 
caused by C. trachomatis or 
other organisms 
Patients should avoid sex 
until therapy in completed 
Patients infected with HIV 
should receive same 
treatment 
Pregnant women (see 
separate section) 
Uncomplicated 
gonococcal 
infection of 
cervix, urethra 
and rectum in 
the adult/ 
adolescent 
Spectinomycin (Spc) 2 i.m. Single dose 
98.2% efficacy in urogenital and 
anorectal infections 
Expensive 
Useful for patients intolerant 
to cephalosporins and 
quinolones, but if patients 
have pharyngeal infection, 
should be tested 3-5 weeks 
after therapy as Spc is only 
52% effective 
 
Ceftizoxime (C-S) + 
Probenecid 0.5 i.m. Single dose 
 
A 
Cefotaxime (C-S) + 
Probenecid 0.5 i.m. Single dose 
None offer any advantage over 
ceftriaxone. Limited clinical 
experience for gonorrhoea 
treatment 
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Cefotetan (C-S) + 
Probenecid 1 i.m. Single dose 
  
Cefoxitin (C-S) + 
Probenecid 
2 
1 
i.m. 
Oral Single dose 
  Enoxacin (Q) 0.4 Oral Single dose 
Limited data on these alternative 
quinolones, none seems to offer 
any advantage over ciprofloxacin 
or ofloxacin 
  Lomefloxacin (Q) 0.4 Oral Single dose Contraindicated in pregnancy 
  Norfloxacin (Q) 0.8 Oral Single dose  
 
 Many other antimicrobials are effective against N. gonorrhoea but this is not exhaustive list but simply a guideline. Azithromycin 2 g orally is effective, 
but expensive and too often causes GI side effects to be recommended. At 1 g it is insufficiently effective (93%). 
Cefixime  
(C-S) 0.125 i.m. Single dose   
Ciprofloxacin 
(Q) 0.5 Oral Single dose   
One 
of: 
Ofloxacin (Q) 0.4 Oral Single dose   
Azithromycin 
(M) 1 Oral Single dose   
Uncomplicated 
gonococcal 
infection of the 
pharynx 
R 
Plus 
one 
of: Doxycycline (Tet) 0.1 Oral 2 7   
Gonococcal 
infection in 
pregnant 
women 
R 
Treatment with recommended or alternate cephalosporin 
Cephalosporin intolerant women should be prescribed a single dose of 2 g spectinomycin i.m. 
If C. trachomatis infection is diagnosed or presumed, treatment with erythromycin or amoxycillin is 
recommended. 
Quinolones and tetracyclines 
are contraindicated in 
pregnant women 
§R = Recommended therapy; A = Alternative therapy 
C-S = Cephalosporins; M = Macrolides, including the erythomycins and azalides; P = penicillins; Q = Quinolones; Tet = Tetracycline
192
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Table A.3 Structure of antibiotics (http://www.medscape.com.) 
Penicillins 
 
 
 
Penicillin G potassium Penicillin V 
Cephalosporins 
 
 
Cefixime Cefoperazone sodium 
 
 
Cefpodoxime proxetil oral Ceftiaxone 
Aminocyclitol 
 
Spectinomycin 
 
Tetracyclines 
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Tetracycline Oxytetracycline 
 
 
 
Doxycycline  
Erythromycins 
 
 
Erythromycin ethyl succinate Azithromycin oral 
Quinolones: Fluoroquinolones 
 
 
Ciprofloxacin Ofloxacin 
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